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SUMMARY
Duchenne muscular dystrophy (DMD) is the most common, lethal 
X-linked mutation in the United Kingdom, affecting one in every 
three thousand male livebirths. Affected males have progressive 
muscle weakness and die as a result of respiratory or cardiac 
involvement in their late teens or early twenties. Whilst the 
X-linked nature of DMD has been recognised for many years, the 
regional assignment of DMD to Xp21 is relatively recent. This was 
first proposed on the basis of X,*autosome translocations and more 
recently has been supported by linkage analysis using polymorphic 
DNA probes from within and around the DMD locus.
X-linked ichthyosis (XLI) is the most common cause of early 
onset scaly skin (ichthyosis), affecting one in every five to six 
thousand male livebirths and is due to a deficiency of steroid 
sulphatase (STS). Although the X-linked nature of one form of 
ichthyosis had been recognised for many years, deficiency of STS in 
association with this condition was a relatively recent discovery. 
STS was assigned to Xp22 to Xpter on the basis of somatic cell 
hybrid mapping and to Xp22.3 to Xpter on the basis of a male with 
an XY translocation. The STS locus is of particular interest as it 
is one of the few known X-linked loci which escape inactivation in 
females.
The main aim of this project was to isolate DMA sequences
from the short arm of the X-chromosome (Xp) which could be used to
study either DMD or XLI.
In order to achieve this, an x-chromosome specific EcoRI 
library was constructed from flow-sorted chromosomes. In the 
initial screening of this library, one hundred and twenty plaques
were selected for further study of which twenty eight had human
inserts. Sixteen of these were single-copy or low-copy sequences 
with homology to the human x-chromosome, four were sequences with 
homology to the autosomes, six had homology to repeat sequences and 
a further recombinant had homology to multiple sequences in both 
man and mouse.
The X-specific inserts were further characterised by a somatic 
cell hybrid mapping panel and four were assigned to xp;
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GMGX9(DXS237) to Xp22.3-pter, GMGX10(DXS238) to Xp21-cen and 
GMGXll(DXS239) and GMGX12(DXS240) to Xp21-Xp22.3.
The ability of these four probes to detect restriction 
fragment length polymorphisms (RFLPs) was studied using panels of 
twelve to fourteen X-chromosomes digested with each of thirteen 
restriction enzymes. Only GMGX9(DXS237) detected an RFLP with 
Hindlll. This had alleles of 4kb and 2.5kb + 1.5kb, which occurred 
at frequencies of 0.67 and 0.33 respectively, and a Pic value of 
0.44.
These four probes were also tested in eleven individuals with 
DMD, BMD or contiguous gene syndromes including DMD, who all had 
deletions of pERT87(DXS!64) and/or XJ(DXS206) (which are deleted in 
6-10% of males with DMD/BMD). GMGXll(DXS239) was deleted in one 
individual with adrenal hypoplasia (AHC), glycerol kinase 
deficiency (GK) and DMD, whilst GMGX10(DXS238) was deleted in 
three individuals with large deletions.
These eleven individuals were also examined with twenty seven 
other Xp probes. Only two of these eleven deletions could not be 
resolved from the others by these probes and there was no smallest 
region of overlap. The deletion in one boy (pedigree number 5097) 
with BMD, apparently encompassed that of a second (5265) with DMD, 
thus excluding the notion of an unique BMD domain in Xp21.
Deletion studies in these eleven individuals and in somatic 
cell hybrids mapped GMGX10(DXS238) proximal to pERT84(DXS142), 
GMGX11(DXS239) between JBir(DXS270) and Ll-4(PXS68) and 
GMGX12(PXS240) between C7(DXS28) or B24(DXS67) and GMGX9(DXS239).
GMGX10(DXS238), GMGXll(DXS239), GMGX12(DXS240), p20(DXS269),
JBir(DXS270) and J66HI(DXS268) were used to screen one hundred and 
three boys with DMD or BMD, including nine of the eleven deletions 
described above. GMGX10(DXS238) and GMGX12(DXS240) detected no 
additional deletions. Thirty six additional deletions or altered 
fragment sizes were detected with GMGXll(DXS239), p20(DXS269), 
JBir(DXS270) and J66HI(DXS268). Thus 46% of boys in this group had 
deletions or altered restriction fragment lengths visualised with 
DNA probes. 18% were detected by GMGXll (DXS239) and 22% by 
p20(DXS269), with a slight degree of overlap.
GMGXll(DXS239) detected fifteen novel deletions (and three
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altered band fragments) amongst EcoRI digests and fourteen novel 
deletions (and three altered band fragments) amongst Hindlll 
digests. p20(DXS269) detected eight deletions, five partial 
deletions and ten individuals with novel fragment sizes (or novel 
fragment sizes associated with partial deletions) amongst Hindlll 
digests. Notably four partial deletions and two complete deletions 
of p20(DXS269) were observed amongst the fifteen families with BMD. 
None of the mutations detected by GMGXll(DXS239) were associated 
with BMD.
Pulse field gel electrophoresis (PFGE) data and mapping with 
respect to translocation breakpoints in females with DMD has placed 
GMGXll(DXS239) between JBir(DXS270) and J66HI(DXS268). Both genomic 
and cDNA clones which detect deletions at high frequency have been 
assigned to this interval. Comparative mapping studies show that 
GMGXll(DXS239) is not conserved and is thus unlikely to be 
expressed. GMGXll(DXS239) is linked to J66HI(DXS268) and 
p20(DXS269) to JBir(DXS270) by PFGE although the two loci have not 
been compared directly.
The study of new mutations in DMD/BMD should help determine 
how deletions arise, although such studies are complicated by 
germ-line mosaicism which makes reliable definition of a new 
mutation difficult. The origin of the mutation was identified in 
three DMD families (5313, 3485 and 7866). In each family the
mothers were heterozygous for probes deleted in their sons, 
suggesting that, in the absence of gonadal mosaicism, these were 
new mutations in a maternal gamete.
A deletion of probes Ll-4(DXS68), B24(DXS67) and C7(DXS28) was 
detected in a male (5996) with AHC and mental retardation but 
neither GK deficiency nor DMD. His deletion was encompassed by that 
of a male with DMD, GK and AHC (whose deletion included probes 
from pERT84(DXS142) to C7(DXS28) / B24(DXS67)). A second individual 
with DMD, GK and AHC, was deleted from GMGX10(DXS238) to 
J66HI(DXS268) inclusive. Comparison of these three deletions mapped 
AHC distal to GK and both genes between J66H1(DXS268) and 
Ll-4(pXS68). A further patient (5194) with AHC but not mental 
retardation was probed with the same probes but no deletion was 
detected.
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The GMGX9(DXS237) Hindlll RFLP was studied in normal three 
generation families (in which it was shown to segregate as a 
Mendelian trait) and in families segregating for X-linked 
ichthyosis (XLI). GMGX9(DXS237) was deleted in males from thirty 
seven out of forty-four (84%) unrelated families with XLI and could 
be used to predict carrier status in some families. Multipoint 
linkage analysis showed tight linkage of GMGX9(DXS237) to STS 
deficency-.
Comparative mapping studies showed that GMGX9(DXS237) was not 
conserved and was^  thus unlikely to represent an exon of the STS 
gene. STS cDNA clones, p2a4 and STB14 were also studied in thirty 
one affected males and detected deletions in the same individuals 
with only one exception. The exceptional male was deleted for p2a4 
but not the X-specific band of STB14. The X-specific band of 
GMGXY19 but not that of GMGXXY3 was also deleted in this 
individual.
The deletion in a male with XLI and Kallmann's syndrome (KAL) 
was apparently identical to those of patients with XLI only, whilst 
three patients with KAL only were not deleted for any probes 
tested. Two patients with XY translocations were additionally 
deleted for MlA(DXS31).
All but one of the deletions at the STS locus in this study 
were identical, in contrast to those at the DMD locus. Resolution 
of these deletions, however, was limited by the probes available 
and flow cytometry (FACS) suggested a range of deletion size up to 
5.2140 in affected males.
Deletions in XLI arising by reciprocal XY translocations were 
excluded by inheritance of Xg(a) in many affected males, and the 
mechanism by which deletions are generated at high frequency is 
unclear. Molecular studies on the origin of new mutations might 
define possible deletion mechanisms but as yet none have been 
described.
The present study emphasises the value of "reverse genetics" 
in the study of human disease. This procedure entails identifying 
gene-specific DNA sequences, by virtue of their chromosomal 
location. These are then used to isolate (or predict the structure 
of) the protein product. This approach is best exemplified by
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current progress in the study of DMD, but "reverse genetics" has 
been successfully applied to other conditions and is expected to 
make an important contribution towards the cloning of the genes 
involved in more than four thousand two hundred mendelian 
phenotypes.
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CHAPTER 1: INTRODUCTION
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1:1 GENERAL INTRODUCTION.
The primary aim of this project was to perform a molecular 
analysis of two X-linked disorders; Duchenne muscular dystrophy 
(DMD) and X-linked ichthyosis (XLI). These two disorders therefore 
provide the main focus of the introduction (sections 1:3 and 1:4 
respectively), following on from a general introduction.
This general section (section 1:1) introduces the concepts of 
X and Y linked inheritance, of X-inactivation and of mapping genes 
to the X-chromosome. Section 1:2 addresses the regional 
localisation of genes on the X-chromosome by X;autosome 
translocations, deletions, somatic cell hybridisation studies and 
linkage analyses.
1:1:1 Sex-linked inheritance and X-inactivation.
The X and Y chromosomes are particularly amenable to a 
molecular approach in the study of human development and inherited 
disorders in man, as both chromosomes lack homologues in males. 
Mutations of many genes on the X- and Y- chromosomes are thus 
expected to be evident in males, regardless of whether the traits 
are dominant or recessive. Phenotypic changes can thus be directly 
correlated with those changes evident at the molecular level.
The characteristic mode of inheritance of X-linked genes has 
resulted in recognition of the X-linked nature of many disorders. 
Both recessive and dominant X-linked traits have characteristic 
patterns of inheritance.
A recessive X-linked condition will affect hemizygous males, 
with a single X-chromosome, but not heterozygous females with two 
X-chromosomes (with only rare exceptions, as discussed below). 
"Carrier females" (who are asymptomatic) "carry" one x-chromosome 
with the defect and one X-chromosome without the defect. Half of 
the sons and half of the daughters of a carrier female receive each 
chromosome and thus half of the sons will be affected and half of 
the daughters will be carrier females. One consequence of this 
means of transmission is the characteristic "knight's move" pattern 
of affected males within a pedigree.
An X-linked dominant condition affects both males and females 
within a family. It can be distinguished from an autosomal dominant
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condition according to the sex of affected children born to an 
affected male. An affected male with an X-linked dominant condition 
will transmit this to all of his daughters but to none of his sons 
(whereas a male with an autosomal dominant trait would transmit the 
trait to both sons and daughters equally). Females heterozygous for 
an X-linked dominant trait are as severely affected as hemizygous 
males and transmit the condition to half their children, regardless 
of sex.
Occasionally an X-linked dominant disorder may be lethal in 
males. In such circumstances only affected females will be 
observed. If the disorder is also incompatible with female 
fertility every individual observed will represent a new mutation.
X-linked recessive conditions may occur in females with 
Turner's syndrome (45,X karyotype). It may also occur in females 
homozygous for a defective allele (who usually have consanguinous 
parents) providing the condition does not affect male fertility 
(either directly or by early death). Females with chromosome 
aberrations involving the x-chromosome (e.g. X;autosome 
translocations which disrupt specific loci) may also be _._affected 
as a result of non-random inactivation of the "normal" x-chromosome 
(section 1:2:1).
Inactivation of one or other X-chromosome is one means of 
ensuring the same relative dosage of X-specific and autosomal genes 
in males and females. The X-inactivation hypothesis was first 
proposed by Lyon in 1961. X-inactivation, reviewed by Gartler & 
Riggs (1983), generally occurs at random in cells of the inner cell 
mass (which give rise to adult somatic cells) in female embryos. 
X-inactivation "spreads" from a single inactivation centre, Xce, 
situated on the proximal long arm of the X chromosome (Xq). The 
inactivated X is stably inherited by cells of clonal origin, yet 
the process is reversible for example in the female germ-line.
Carrier females may manifest an X-linked recessive disorder if 
the X-chromosome with the normal allele is inactivated in a high 
proportion of cells of the appropriate type as a result of 
non-random x-inactivation. The phenotypic severity in such 
individuals is dependent on the proportion of cells inactivated. 
More rarely carrier females may manifest the disorder as a result
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of a second mutation in the normal allele.
Y-linked (holandric) inheritance should be characterised by 
limitation of a trait to males and transmission from father to son. 
No confirmed Y-linked diseases have been described although hairy 
ears was at one time suspected.
Difficulties can arise in distinguishing between a sex-linked 
disorder and an autosomal dominant condition whose expression is 
limited to males. These may be resolved for some X-linked 
conditions in which random X-inactivation (or "Lyonization") can be 
demonstrated in carrier females e.g. testicular feminisation 
(Meyer, Migeon & Migeon, 1975). Failure to observe random 
inactivation does not necessarily exclude X-linked inheritance 
however, as certain genes assigned • to the X-chromosome escape 
X-inactivation e.g. steroid sulphatase (STS). This phenomenon will 
be addressed in section 1:4:5.
Genes within "the pairing segment" which is responsible for 
the initiation of pairing of the x and Y chromosomes in male 
meiosis, will have homologues on both Xp and Yp. Certain loci 
within the pairing segment e.g. 29Ci (DXYS14) undergo obligatory 
recombination in male meiosis and therefore mimic autosomal 
inheritance (Cooke, Brown & Rappold, 1985). These loci have been 
termed "pseudoautosomal". Other more proximal pseudoautosoma1 loci 
recombine at frequencies less than 50% (Rouyer et al., 1986) and 
are more obviously X-Y homologous.
The importance of pedigree analysis in assigning genes to the 
X-chromosome can be be appreciated by the high proportion of 
(confirmed) loci known to be X-linked (table 1), given that the 
X-chromosome represents only 5-6% of the haploid genome (Mayall et 
al., 1984; Harris, Boyd & Ferguson-Smith, 1986). Almost half of the 
loci currently mapped to the X-chromosome were assigned before 1966 
(table 1), prior to the development of chromosome banding 
techniques which could distinguish the x-chromosome.
The colour-blindness gene on the x-chromosome was the first to 
be assigned to a specific chromosome in man (Wilson, 1911). Since 
then, more assignments have been made to the human x-chromosome 
than to any other chromosome in metazoa, apart from those those of 
Drosophila (McKusick, 1986). One hundred and forty independent
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Mendelian phenotypes (expressed loci) have been assigned to the 
X-chromosome, whilst a further one hundred and sixty eight 
Mendelian phenotypes have tentatively been designated X-linked 
(McKusick, 1987).
1:2 REGIONAL LOCALISATION OF X-LINKED TRAITS.
Over sixty genes have been regionally localised on the 
X-chromosome (Read, 1987). Regional localisation can be acheived
(i) by examination of breakpoints in translocations and/ or other 
chromosomal rearrangements in affected indviduals,' (ii) by 
association of a disorder with other well-localised phenotypes as a 
"micro-deletion syndrome" or "contiguous gene syndrome", (iii) by 
somatic cell hybrid analysis (for defined gene products) or (iv) by 
linkage to a suitable marker. The precision of any regional 
localisation is dependent largely on the breakpoints and markers 
available. These methods are considered in sections 1:2:1-1:2:4.
1:2:1 X;autosome translocations.
Structural chromosome aberrations often provide the first means 
of mapping a disorder to a specific locus. These generally fall into 
one of the following categories: translocations, inversions,
duplications or deletions.
In general, translocations and inversions only disrupt loci at 
their breakpoints. De novo translocations (or inversions) in 
association with a "new mutation" can thus provide information to 
localise an autosomal dominant or X-linked disorder to a specific 
chromosome band.
X-chromosome inactivation generally occurs at random in 
undifferentiated cells within the inner cell mass, as described 
earlier. In individuals with X-chromosome abnormalities, however, 
the inactivation pattern observed is usually that which would result 
in the most balanced genotype. Thus, for abnormalities involving the 
X-chromosome alone, (e.g. ring-chromosomes and isochromosomes), the 
abnormal X-chromosome is generally inactivated (Therman & Patau, 
1974).
The best genetic balance results from inactivation of the 
normal X-chromosome in balanced X;autosome translocations and from
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inactivation of the translocated x in unbalanced X;autosome 
translocations. Since the normal X-chromosome is inactivated in 
individuals with a balanced translocation, it follows that the 
expression of any X-linked genes disrupted by a balanced 
translocation will be adversely affected (section 1:3:3).
Clinically, a balanced X;autosome translocation is suspected 
when a female manifests an X-linked trait with the severity expected 
of an hemizygous male, and this provides an indication for 
chromosome analysis.
Mattei et al. (1982) summarised the data from one hundred and 
five X;autosome translocations. The normal x was consistently 
inactivated in 81% of individuals with balanced translocations, 
whilst the translocated X was consistently inactivated in 76% of 
individuals with unbalanced translocations. Most of the remaining 
individuals (15-18% in each category) had cells in which each 
X-chromosome was inactivated, 50% (or more) of which resulted in the 
most balanced genotype.
The translocated X-chromosome will be inactivated in 
individuals with an unbalanced translocation providing that it 
carries an inactivation centre. In such circumstances inactivation 
may spread to include autosomal sequences in some cells and result 
in partial monosomy for these loci. Somatic cell hybrids (section 
1:2:4) were used to show inactivation of an autosomal gene (esterase 
D) by spreading of X-inactivation (Mohandas, Sparkes & Shapiro,
1982). Derivative X-chromosomes which form part of an unbalanced 
translocation and lack an inactivation centre can not be 
inactivated, and will result in dosage imbalance.
1:2:2 Deletions
Duplications and deletions both disrupt gene dosage. Deletions 
are generally more deleterious than duplications and are more 
frequently detected. They may occur in association with a variety 
of X-linked and autosomal diseases as either dominant or recessive 
mutations and as either microscopic (cytogenetically detectable) 
deletions or sub-microscopic deletions (detectable only by 
molecular methods).
Complex phenotypes (involving several disorders) may result
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from micro-deletions ("microdeletion syndromes") or other 
chromosomal abnormalities resulting in loss of contiguous genes 
("contiguous gene syndromes"). These often form an heterogeneous 
group in which the region(s) altered or deleted in all individuals 
define(s) essential sequences in the genome. These regions are 
referred to as the smallest region of overlap or "SRO". This 
principle will be applied to ordering genes around DMD in this 
project.
The largest well documented micro-deletion in which random 
X-inactivation still occurred, was that of KC, a female with mild 
mental retardation, who had partial ornithine transcarbamylase 
(OTC) deficiency and was heterozygous for chronic granulomatous 
disease. Her deletion was estimated to represent less than 10% of 
Xp by cytogenetic means (Francke, 1984). This deletion, together 
with other deletions of Xp21 will be discussed more fully below 
(section 1:3:6).
Clinically, a deletion is indicated when several X-linked 
disorders co-exist or when mental retardation occurs in association 
with an X-linked condition when this is not a usual feature.
The majority of sub-microscopic deletions on the X-chromosome, 
described in the literature, were derived from regions of the 
genome which are well characterised at the molecular level e.g. 
deletions of hemophilia A (Factor VIII), (Gitschier et al., 1985), 
hemophilia B (Factor IX), (Gianelli et al., 1983), OTC (Old et al.,
1985) and Lesch-Nyhan disease (HPRT), (Yang et al., 1984). It is 
thus likely that sub-microscopic deletions will be described for 
other disorders as these are characterised more completely at the 
molecular level.
Males with interstitial deletions of their (unique) X 
chromosome are especially valuable for localisation of DNA markers, 
as they can be studied directly avoiding the necessity to construct 
somatic cell hybrids (section 1:2:3). Large deletions of the 
X-chromosome are less well tolerated in males than in females, 
however, so that deletions in males are likely to be more 
appropriate to refining the position of a probe than to its 
initial localisation.
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YEAR
PHENOTYPE 1958 1966 1978 1987
Autosomal dominant 285 269
(+568)
736
(+753)
1390
(+1084)
Autosomal recessive 89 237
(+294)
521
(+596)
623
(+852)
X-linked 38 68
(+51)
107
(+98)
140
(+168)
Proportion of "confirmed" 10% 13% 8.5% 7.0%
loci assigned to the X- 
Chromosome.
Table 1: Numbers of autosomal and X-linked assignments since 
1958.
(After McKusick 1987. Figures in parenthesis represent loci 
which are not fully identifed or validated).
1:2:3 Somatic cell hybrid analysis.
Somatic cell hybrids are invaluable in separating the two 
derivative chromosomes of an X;autosome translocation. Such hybrids 
were instrumental in the assignment of PGK, G6PD and HPRT to the 
long arm of the X-chromosome (e.g. Shows & Brown, 1973,1974) and 
the construction of the earliest gene maps of the X-chromosome 
(Pearson et al., 1974).
The earliest such assignment was that of PGK to Xq (Grzeschik 
et al., 1972). This study failed to assign HPRT and G6PD to Xq due 
to a rearrangement in the hybrid used. The positions of HPRT and 
G6PD were resolved by 1975 (Brown et al., 1975).
A panel of somatic cell hybrids is an effecient way of 
localising X-linked (or autosomal) biochemical markers which are 
expressed in mouse cells. This technique can also be applied to the 
localisation of DNA sequences. Somatic cell hybrids have also been 
derived from females heterozygous for interstitial deletions of the 
X-chromosome (such as that of KC, described above) and provide a 
valuable contribution to mapping panels.
1:2:4 Linkage analysis.
In the absence of other indications, linkage of an X-linked 
disorder to a defined marker is often the first step towards its 
regional localisation. Suitable markers include (i) other 
disorders, (ii) expressed antigens e.g. Xg, (iii) enzymatic 
activities e.g. Glucose-6-phosphate dehydrogenase (G6PD) or (iv) 
restriction length polymorphisms ("RFLPs", described below).
Two loci are "linked" when they fail to show independent 
assortment at meiosis. Recombination between two loci is expressed 
as a recombination fraction ,theta, with values from 0-0.5 or 
0-50%, and is related to the distance between them measured in 
centi-Morgans (0-50cM). This relationship is only linear over short 
distances (theta less than 0.25) due to double cross-overs. The 
maximum measurable distance between two loci by linkage analysis is 
comparable to that of two loci on separate chromosomes, which 
assort independently (i.e. greater than or equal to 50cM). The 
X-chromosome has been estimated at 200cM (Renwick & Schulze, 1964).
Linkage between two loci is measured in terms of the most
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likely recombination fraction between them. The probability of 
linkage (as opposed to that of obtaining the same results by 
chance) at any given recombination fraction is expressed as a 
logarithm, "DOD" score (or logarithm of odds). Probabilities from 
separate investigations can be most readily combined in logarithmic 
form (by addition as opposed to multiplication). It is accepted 
that two loci are linked if the LOD score is greater than 3 and 
excluded if the LOD score is lower than -2 (Maynard-Smith, Penrose 
& Smith, 1961).
Linkage is normally expressed as a maximum LOD score at the 
appropriate recombination fraction with confidence limits at the 
appropriate values of theta at a LOD score of the maximum LOD score 
minus one.
Linkage of two loci on the X-chromosome can be implied from 
lower LOD scores than for autosomal conditions, as the X-linked 
nature of a disorder (and thus linkage to an X-specific marker) can 
be readily discerned from its mode of inheritance.
Prior to 1958, colour blindness, which affects only 6% of 
males, was the only useful marker for mapping loci on the 
X-chromosome. In 1958, Childs et al. demonstrated the X-linked 
nature of G6PD deficiency. Unfortunately, since G6PD deficiency 
was extremely rare amongst Northern Europeans, G6PD was not a very 
useful marker for linkage studies in Northern European families.
The Xg blood group described by Mann et al. (1962), in 
contrast, was heterozygous in 45% of Northern European females 
(data summarised by Sanger et al., 1971). Linkage of Xg was 
established to X-linked ichthyosis (XLI), ocular albinism (OA) and 
retinoschisis (RS), and excluded with G6PD, hemophilia A, 
hemophilia B, deutan and protan colour blindness and Duchenne 
muscular dystrophy. These findings are summarised in Race & Sanger 
(1975).
Restriction fragment length polymorphisms (RFLPs) reflect 
small differences between alleles at a restriction enzyme 
recognition site, which result in different fragment lengths on DNA 
digestion with the appropriate enzyme. These differences are 
detected by DNA sequences which share (or partly share) sequence 
homology to the restriction fragments in question and segregate as
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mendelian traits. RFLPs can be considered as genetic markers and 
greatly enhance the reference points available for linkage analysis 
in the localisation of genetic disorders.
The first two X-linked RFLPs (RB6 and RC8) were reported at
the Sixth International Human Gene Mapping workshop in 1981
(Skolnick & Francke, 1981). One hundred and twenty five x-linked 
RFLPs have now been described (Ninth International Human Gene 
Mapping workshop (Paris), (table 2)).
As at least one hundred and forty genes are presently assigned
to the X chromosome, it follows that any DNA marker isolated on the 
X chromosome is likely to be closely linked to a number of 
disorders and to prove a valuable resource for the study of many 
conditions.
Linkage is difficult to establish at a distance of more than 
20cM, by virtue of the number of analyses required to obtain a 
significant LOD score. Ideally, the closest marker should be no 
further than 10cm from the locus under study. Thus, for the entire 
human genome (of approximately 30M), one hundred and fifty evenly 
spaced loci would be required (Botstein et al., 1980). 
Theoretically over ten times this number of randomly spaced probes 
are required to acheive this (Lange & Boehnke, 1982). Even then, 
RFLPs would not be informative in all families studied.
If the X-chromosome is assumed to represent 2M then 100 
randomly spaced RFLPs should ensure that no X-linked gene is 
further than lOcM from an RFLP. One hundred and twenty five 
X-linked RFLPs have now been described (table 2) and thus linkage 
studies are now theoretically possible for any locus on the 
X-chromosome.
For an X-linked condition, "Phase" (i.e. the determination of 
the combination of alleles derived from each chromosome) may be 
demonstrated by analysis of the maternal grandfather, mother and 
either an affected or an unaffected son. Alternatively it may be 
deduced using other relatives. This situation is considerably 
simpler than the situation for autosomal recessive conditions, 
which normally require results from an affected individual within 
the family. Thus diagnosis of the carrier state and prenatal or 
antenatal diagnosis (where appropriate) are often possible for
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X-linked disorders even in the absence of a surviving affected 
individual. The reliability of such a diagnosis is dependent on the 
distance of the disorder from the closest informative marker(s). 
The most reliable results will be obtained from multiple closely 
linked markers flanking and/or within the gene.
Individuals are more likely to be multiply informative if high 
frequency RFLPs (with a rare allele frequency greater than 20%) are 
applied. Such individuals enable linkage and family studies to be 
performed more readily. One measure of the value of a probe is the 
polymorphic information content or "PIC" (Botstein et al., 1980). 
For X-specific loci the PIC value is considered formally equivalent 
to heterozygosity i.e. 2pq for di-allelic probes, where p and q 
are the allele frequencies (Willard et al., 1985). The closer the 
PIC value is to one the more useful a given marker will be.
Multi-allelic probes, for which a greater proportion of 
individuals will be heterozygous, are especially valuable. The 
first multi-allelic locus to be described was that of a randomly 
isolated probe detecting fifteen alleles (Wyman & White, 1980). 
Subsequently, many additional loci have been described e.g. 5' to 
the insulin gene (Bell, Selby & Rutter, 1982). These may occur as 
multiple independent restriction site alterations or as variable 
numbers of short tandem repeats ("minisatellites" or "VNTRs"), 11 
to 60bp in length (Nakamura et al., 1987), in which the numerical 
variation may be revealed using any restriction endonuclease v/hich 
lacks a restriction site(s) within the repeat unit._______________
Hypervariable probes will also prove invaluable in new 
applications e.g. mapping of human disease by linkage to specific 
bands in "DNA fingerprints" (multiple fragments detected by a 
consensus core repeat sequence), (Jeffreys, Wilson & Thein, 1985; 
Jeffreys et al., 1986).
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DNA SEGMENTS
YEAR LOCATION GENES ARBITARY DNA TOTAL
1981 X-specific NONE 10 (2) 10 (2)
(HGM6) Total 16 (6) 35 (18) 51 (24)
1983 X-specific 7 (3) 75 (23) 82 (26)
(HGM7) Total 104 (35) 215 (95) 319 (130)
1985 X-specific 12 (5) 202 (63) 214 (68)
(HGM8) Total 249 (88) 559 (245) 808 (333)
1987 X-specific 32 (11) 273 (114) 305 (125)
(HGM9) Total 610 (216) 2057 (977) 2667 (1193)
Table 2: Numbers of cloned genes, arbitary DNA segments and 
reported for the X chromosome and total genome since 1981.
RFLPS
(After Willard et al (1985) and Pearson et al (1987). Numbers in 
parenthesis indicate the number of polymorphic DNA segments in 
each category).
1:3 DUCHENNE MUSCULAR DYSTROPHY (DMD).
This section focusses on Duchenne muscular dystrophy with 
reference to its phenotype, its X-linked nature and its regional 
assignment on the X-chromosome by means of both cytogenetic and 
linkage data. Contiguous gene syndromes which include DMD and a 
preliminary characterisation of the DMD locus using restriction 
fragment length polymorphisms are also presented.
1:3:1 Phenotype.
Duchenne muscular dystrophy (reviewed by Moser, 1984 and 
Emery, 1987) is a progressive myopathy which occurs at a frequency 
of 1 per 3000-4000 male live-births. DMD has an onset in the first 
five years of life and is characterised by pseudohypertrophy of the 
calves with wasting and weakness of the proximal muscles. Affected 
individuals become progressively weaker and are generally confined 
to a wheelchair by their twelfth birthday. In the terminal stages 
of DMD, muscle involvement is generalised and most boys with DMD 
will die as a result of respiratory or cardiac involvement in their 
teens or early twenties. Becker muscular dystrophy (BMD), which 
occurs in 1 in 30 000 male live-births is similar to DMD but has a 
milder clinical course.
Emery & Skinner (1976) reported that 97% of DMD patients were 
wheel-chair bound by age eleven and 94% died before attaining their 
sixteenth birthday. A child with DMD/BMD is thus usually defined as 
BMD if he is still ambulant at his sixteenth birthday. As both 
"mild Duchenne" and "severe Becker" mutations have been described, 
the division is somewhat arbitary and growing evidence from linkage 
analysis and deletion studies (see later) suggest that the two 
disorders are allelic.
DMD/BMD may occur in females (i) with Turner's syndrome (e.g.
Walton, 1957), (ii) as a result of a second mutation in a carrier
female (iii) as a result of non-random X-inactivation in carrier 
females (e.g. Emery, 1963) or (iv) in girls with x-autosome 
translocations disrupting the DMD gene (see below).
Inactivation of the normal X in the majority of cells in
critical tissue(s) is thought to be responsible for the DMD 
phenotype in obligate carriers of Duchenne muscular dystrophy
Page 36
(Dubowitz, 1982). Considerable heterogeneity in the severity of 
phenotype amongst manifesting carriers was attributed to the 
variation in the proportion of muscle cells in which the normal-x 
was inactivated (Moser & Emery, 1974).
Many muscle enzymes, notably creatine kinase, are elevated in 
individuals with DMD or BMD. These may also be elevated in 
individuals with other conditions but not to as great an extent as 
in males with BMD/DMD. Raised creatine kinase levels are evident in 
affected males before other symptoms become apparent. Many 
obligate carriers of DMD also have elevated levels of creatine 
kinase.
Prior to the application of RFLP analysis to the study of 
Duchenne muscular dystrophy (section 1:3:4), carrier analysis was 
dependent solely on the detection of elevated levels of creatine 
kinase in the heterozygous state and on pedigree analysis. Fetal 
sexing (and termination of all male pregnancies) was the only 
option available to those desiring prenatal diagnosis.
A third X-linked muscular dystrophy, Ernery-Dreifuss muscular 
dystrophy (EDMD), (Emery & Dreifuss, 1966), with onset in childhood 
and slow progression, is characterised by wasting and weakness of 
muscles predominantly affecting peroneal muscles. It can be 
distinguished from DMD and BMD by contractures involving the neck, 
elbows and ankles which are recognisable at an early stage and by 
the absence of pseudohypertrophy which is indicative of DMD/BMD. 
EDMD is frequently associated with cardiac involvement and sudden 
death.
1:3:2 Mapping DMD to the X-chromosome.
Duchenne muscular dystrophy was first described in detail by 
Duchenne in 1868 and subsequently (in English) by Gowers in 1879. 
The majority of affected individuals were male and many pedigrees 
were clearly consistent with X-linked inheritance (e.g. Kostakov, 
1934, cited in Gates 1946). This strongly suggested X-linkage but 
autosomal inheritance with limitation to males could not be 
excluded (section 1:1:1).
Emery (1964) reviewed three hundred and forty three families 
(including many previously described in the literature) with
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sufficient clinical information to indicate a diagnosis of Duchenne 
muscular dystrophy. Affected females were described in only seven 
of two hundred and thirty one sporadic cases, three of fifty three 
familial cases (in which affected individuals occurred in more than 
one branch of the family) and five of fifty nine isolated affected 
sibships.
Further evidence for the X-linked nature of Duchenne muscular 
dystrophy was provided by brothers with DMD with the same mother 
but different fathers (e.g. Walton, 1955), females with Turner's 
syndrome (e.g. Walton, 1957; Ferrier, Bamater & Klein, 1965) and 
clinical manifestations in obligate carriers of DMD (Emery, 1963).
1:3:3 Evidence from X;autosome translocations for the regional 
localisation of DMD on the X-chromosome.
A female with a de novo X;1 translocation-inversion 
rearrangement and a myopathy with the severity and clinical 
characteristics of DMD (but with no family history of DMD), was a 
vital lead in the localisation of DMD on the X-chromosome 
(Lindenbaum et al., 1979).
Lindenbaum et al. (1979) proposed that the de novo 
translocation was likely to be responsible for DMD in this girl 
(unless the DMD locus was smaller than 3kb) and postulated two 
locations on Xp for the DMD locus (Xpll.06 and Xp21.07) based on 
the breakpoints in this patient. Distal Xp, broken at Xp21.07, was 
exchanged with distal lp, broken at lp34.00 whilst proximal Xp was 
simultaneously paracentrically inverted between Xp21.07 and 
Xpll.06.
Twenty females with DMD/BMD and X;autosome translocations have 
been described to date (reviewed in Boyd et al., 1986). The 
clinical course in females with X;autosome translocations is often 
less severe than in affected males although considerable variation 
in phenotypic severity is observed. This may reflect the 
heterogeneity found in males and depend on the exact position of 
the breakpoint or it could result from variation in the proportion 
of cells (up to 10%) in which the normal X is expressed and the 
translocation chromosome is inactivated (Worton, 1986).
Boyd & Buckle (1986) examined translocation breakpoints in
Page 38
prometaphase chromosomes of nine females with X;autosome 
translocations. They were able to show cytogenetic heterogeneity of 
the breakpoints amongst these individuals, suggesting that the DMD 
gene was large, but could not correlate the differences observed 
with those evident at the phenotypic level. Six breakpoints were 
defined within Xp21.2, two within Xp21.1 and a third within either 
Xp21.2 or Xp21.3. These bands were estimated to represent 5 
Mega-basepairs (Mbp), 2Mb and 4Mbp respectively, assuming the 
X-chromosome is equivalent to 150Mbp or 5% of the haploid genome.
1:3:4 Linkage analysis and DMD.
Linkage of DMD to both Xg (reviewed in Race & Sanger, 1975) 
and colour-blindness (Emery, 1966; Greig, 1977) was excluded. 
Localisation of DMD to Xp21 was supported by linkage to the DNA 
probes Ll.28 and RC8 on Xp (Murray et al., 1982; Davies et al.,
1983).
RC8 and Ll.28 each lie about 15cM from DMD but on opposite
sides (Davies et al., 1983) and were used in the first RFLP
determination of carrier status (Wieacker et al., 1983a). 
Individuals doubly heterozygotes for both these probes are rare, 
and account for only 10% of the population, which severely limits 
their usefulness.
By 1985, however, seven additional xp markers flanking DMD 
which were closer to DMD than either Ll.28 (754 and OTC) or RC8 
(pXUT23, 99.6, D2, B24 and C7) had been isolated. At least one of 
these probes was heterozygous in 95% of individuals and a 
diagnostic reliability of greater than 96% for greater than 80% of 
potential carriers was predicted, (Bakker et al., 1985). The
positions of these two probes and many others described throughout 
this project are illustrated in the discussion (figure 14).
A maximum LOD score of 1.25 at theta = 0.25 gave a suggestion
of linkage of BMD to colour-blindness on distal Xq (Skinner, Smith
& Emery, 1974), which would have excluded the two phenotypes being 
allelic. BMD was subsequently linked to Ll.28 (Kingston et al.,
1983), suggesting a close association with, or allelism to, DMD. 
Linkage of EDMD has been shown to both the factor VIII gene and
DX13 (PXS15) in distal Xq (Boswinkel et al., 1985; Hodgson et al.,
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1986b; Thomas et al., 1986b; Yates et al., 1986).
1:3:5 Application of pERT 87 and XJ RFLPs to define the DMD locus.
The pERT87 locus (Kunkel et al., 1985a) was cloned from a 
male,"BB", with a microdeletion of Xp21 (Francke et al., 1985). The 
XJ locus (Ray et al., 1985) was cloned from a female with an X;21 
translocation which disrupted both the DMD/BMD locus and the
ribosomal RNA cluster on chromosome 21 (Verellin-Dumoulin et al.,
1984). The methods applied to clone both these loci will be 
summarised in the discussion (section 4:1)
Probes derived from the pERT87 locus (DXS164, Kunkel et al., 
1985a) and from the XJ locus (DXS206, Ray et al., 1985) were shown 
to detect deletions in 6-10% of boys with either DMD or BMD (Monaco
et al., 1985; Kunkel et al., 1986). It was soon apparent that no
probe which detected deletions was consistently missing in all
individuals with deletions.
X;autosome translocations were also studied with probes from 
these two loci. Three breakpoints were described proximal to both 
PERT87 and XJ, two breakpoints distal to both pERT87 and XJ and one 
(from which the XJ locus was derived) to the distal edge of the XJ 
locus but proximal to pERT87 (Boyd et al., 1986). These results 
indicated heterogeneity at the DMD locus, consistent with the 
findings of high resolution chromosome analysis (Boyd & Buckle, 
1986).
RFLPs at the pERT87 (Kunkel et al., 1985a) and XJ (Ray et 
al., 1985) loci recombined with the DMD phenotype at a frequency of 
5% (Berteleson et al., 1986; Davies (report on Fifth Muscular 
dystrophy group workshop), 1986; Fischbeck et al., 1986; Thompson 
et al., 1986). These probes were heterozygous in greater than 90% 
of individuals, but their relative positions with respect to the 
DMD mutation was dependent on the families studied, (Kunkel et al.,
1986).
It thus became apparent that it was advisable to use a 
combination of intragenic probes and probes flanking DMD, unless 
the precise site of the mutation in the family under study was 
known. The closest proximal marker is 754 (Hofker et al., 1985), 
approximately 6cM from DMD, whilst the closest distal markers are
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C7 (de Martinvilie et al., 1985) and B24 (Aldridge et al., 1984), 
more than lOcM from DMD.
The high recombination frequency, together with the detection 
of deletions in 5-10% of boys with DMD/BMD, indicated that the 
pERT87 and XJ loci were close to "the DMD mutation" and probably 
intragenic. The DMD gene was thus required to be either a single 
gene (larger than any previously described gene), or a large gene 
complex, which could encompass all translocation breakpoints and 
both XJ and pERT87 (which both recombined at a frequency of 5% with 
DMD). Either hypothesis could explain the phenotypic heterogeneity 
found amongst boys with DMD/BMD if certain domains or certain genes 
could exert specific effects and it was thus apparent that 
additional DNA markers were required to help define the gene.
1:3:6 Complex phenotypes in Xp21.
A number of individuals with complex phenotypes (or 
"contiguous gene syndromes") including Duchenne muscular dystrophy 
(i.e. with several distinct phenotypes, one of which is DMD) have 
been described. Many are associated with micro-deletions of Xp21 
and represent deletions of adjoining genes.
The microscopic deletion in KC, a girl with mild mental 
retardation, partial ornithine transcarbamylase (OTC) deficiency 
and heterozygous for chronic granulomatous disease (CYBB), was 
estimated (by cytogenetics) at less than 10% of Xp (Francke,
1984). Random X-inactivation was observed in KC which explains her 
partial OTC deficiency.
BB, a male with an interstitial deletion of Xp21, was affected 
with chronic granulomatous disease (CYBB), McLeod red blood cell 
phenotype (Kell antigen), (XK), Duchenne muscular dystrophy (DMD)
and one form of retinitis pigmentosa (RP3), (Francke et al., 1985).
His deletion confirmed that DMD mapped to Xp21 and was central to 
molecular studies of Xp21 (see section 4:1). As KC's deletion 
encompassed that of BB (Francke et al., 1985), it must also have 
included the loci for DMD, XK and RP3.
A similar deletion was reported in a male child with
oroticaciduria, lacticaciduria and glyceroluria (consistent with 
OTC deficiency and glycerol kinase (GK) deficiency) and
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histological alterations of his adrenal glands, consistent with a 
phenotype of congenital adrenal hypoplasia (AHC). A cytogenetic 
deletion was observed in his phenotypically normal mother, with 
presumptive breakpoints at Xpll.2 and Xp21 (Hammond et al., 1985). 
It can be assumed by comparison to the deletions in BB and KC that 
this deletion also included the loci for DMD and CYBB.
Many patients have been described with (infantile) GK 
deficiency in association with AHC, mental retardation and myopathy 
(DMD), (Renier et al., 1983). These were shown to have microscopic 
(Saito et al., 1986) and/ or molecular (Wieringa et al., 1985; 
Clarke et al., 1986; Dunger et al., 1986; Francke et al., 1987) 
deletions in Xp21. GK in association with AHC, without myopathy, 
has also been reported (Bartley, Miller & Hayford, 1982; Francke et 
al., 1987). One of these patients, YB, had a small microscopic 
deletion of Xp21 (Francke et al., 1987).
These deletions assign OTC, CYBB, XK, RP3, GK and AHC (and 
DMD) to Xp21. The clinical course of all these disorders are 
described by McKusick (1986). The chromosomal position of these 
genes and of others described throughout this project are 
illustrated in the discussion (figure 15).
Molecular techniques have permitted more detailed comparisons 
of micro-deletions and have enabled the relative order of many of 
these genes to be established (see discussion). Interstitial 
deletions of Xp21, particularly those in males, which avoid the 
need to construct somatic cell hybrids, are also of value in 
localising new probes.
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1:4 STEROID SULPHATASE (STS).
This section introduces X-linked ichthyosis (XLI) associated 
with steroid sulphatase (STS) deficiency. It focusses on the 
aetiology of XLI and the regional mapping of STS to the
X-chromosome by means of somatic cell hybridisation studies, 
chromosome aberrations and linkage analyses, it concludes with 
mechanisms of inactivation and evidence that STS escapes from 
inactivation.
1:4:1 Steroid sulphatase (STS) and STS deficiency.
Steroid sulphatase (STS), (reviewed by Shapiro, 1985) is a 
microsomal enzyme, present in all mammalian tissues, involved in
the hydrolysis of 3- beta- hydroxy steroid sulphates
(dehydroepiandrosterone sulphate, estrone sulphate and cholesterol 
sulphate) and necessary for the conversion of sulphated steroid 
precursors to estrogen during pregnancy in man.
Within microsomes, STS occurs as a polymer (Mr 533 000), (Noel 
et al., 1983). The largest form of the monomer found in fibroblasts 
is a glycoprotein (Mr 63 000), which is subject to
post-translational processing by removal of N-linked 
oligosaccharide chains within two days of its synthesis. The mature 
form of the monomer (Mr 61 000) has a half-life of four days
(Conary et al., 1986).
STS is deficient in individuals with X-linked ichthyosis and 
also deficient or severely reduced in individuals with multiple 
sulphatase deficiency, an autosomal recessive disorder in which 
arylsulphatases A, B and C are also deficient or reduced. Purified 
STS protein has itself been shown to have arylsulphatase C 
activity.
Complementation experiments indicated that these two disorders 
represent discrete defects, as indicated by their modes of 
inheritance (Ballabio et al., 1985). The primary defect in multiple 
sulphatase- deficiency has not been determined, but may involve 
post-translational processing or a co-factor (Steckel, Hasilik & 
von Figura, 1985).
X-linked ichthyosis, associated with scaly skin, occurs in 1
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in 5000-6000 male live-births. The rare female individuals with 
X-linked ichthyosis are either Turner's (45X) individuals (Solomon 
& Schoen, 1971) or homozygous for the deficiency e.g. as a result 
of consanguinity (Stern, 1973). STS escapes inactivation (see 
below) and thus affected females are not observed as a result of 
non-random inactivation.
Scaling in males with X-linked ichthyosis is believed to be 
due to an accumulation of cholesterol sulphate, a substrate of STS, 
which can induce similar scaling in mice when applied directly. 
Onset of ichthyosis usually occurs at about 3-6 months of age 
although it may be present from birth (Shapiro, 1985).
Deficiency of STS is also associated with lack of placental 
production of estriol in pregnancy and prolonged and delayed 
labour. These prenatal manifestations may often be the first to be 
appreciated.
The link between placental sulphatase deficiency and X-linked 
ichthyosis remained unnoticed until relatively recently (Jobsis et 
al., 1976; Koppe et al., 1978; Shapiro et al., 1978). Individuals 
with X-linked ichthyosis enjoy good health and fertility although 
some patients have been observed with testicular anomalies. Shapiro 
(1985) postulated that these patients may have deletions involving 
additional loci.
1:4:2 Regional localisation of STS to Xp22.3.
Cockayne (1933) recognised the x-linked nature of one form of 
ichthyosis but was unable to distinguish this clinically from the 
autosomal dominant form. This clinical distinction was first made 
by Kerr & Wells in 1965.
STS was localised in the region Xp22 to Xpter using a panel of 
human-Chinese hamster somatic cell hybrids (Mohandas et al., 1979) 
and to Xp22.3 on the basis of a boy with an XY translocation and 
X-linked ichthyosis, whose translocation breakpoint was at Xp22.3 
on his X-chromosome (Tiepolo et al., 1980).
Males with XY translocations are effectively nullisomic for 
distal xp and generally have x-linked ichthyosis and short 
stature. Most of these are not associated with additional disorders 
(see below), although chondrodysplasia punctata (CPDX) was not
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excluded in several cases. Metaxotou et al. (1983) described a 
male with a familial XY translocation and ichthyosis, hypogonadism 
and mental retardation.
Male fertility, but not female fertility is lost as a result 
of XY translocations. Female XY translocation carriers demonstrate 
prefential transmission of the translocated X-chromosome to their 
progeny, as demonstrated by the 13:3 ratio of translocation bearing 
to non-translocation bearing siblings (Allderdice et al., 1983). 
There is no evidence, as yet, to suggest that such anomalous 
segregation is found in the progeny of obligate carriers of 
X-linked ichthyosis.
A female who carried such an XY translocation was central to 
the assignment of Xg to distal Xp (Xp22.3 to Xpter). Her mother was 
Xg(a-) and her father Xg(a+) whilst she was Xg(a-). Her failure to 
inherit her father's Xg(a) allele, allowed Xg to be assigned to the 
distal portion of the x chromosome lost in the translocation 
(Ferguson-Smith et al., 1981).
Deletions were cytogenetically detectable in Xp22.3 in four 
affected individuals, obligate carriers and some potential carriers 
from two kindreds segregating for X-linked ichthyosis and 
chondrodysplasia punctata (CPDX), all of whom had short stature 
(Curry et al., 1982, 1984). The deletion in UCLAB2, a hybrid
derived from one of these individuals (Curry et al., 1984) was 
estimated at 5Mb (Mondello et al., 1987) and encompassed Xp22.3 
including MIC2, STS and probe MlA (DXS31).
X-linked ichthyosis has also been described in association 
with hypogonadism, anosmia and neurological defects (Sunohara et 
al., 1986) and with Kallmann's syndrome (hypogonadotropic 
hypogonadism and anosmia) alone (Ballabio et al., 1986).
1:4:3 Linkage analysis and X-linked ichthyosis.
Early studies showed linkage of Xg to X-linked ichthyosis, the 
first of which was by Kerr,Wells & Sanger in 1964. This data is 
summarised in Race & Sanger (1975) and in Keats et al. (1979) and 
placed XLI llcM and 15cM from Xg respectively.
STS levels in XX males (which arise from the interchange of Yp 
material, including the testis determining factor (TDF), with xp
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material, Ferguson-Smith, 1966) were typical of female levels with 
few exceptions, whilst the distribution of Xg phenotypes was
male-like. This suggested that Xg, but not STS, had been lost in
the interchange of Xp and Yp sequences, and thus that STS was
proximal to Xg (Ropers et al., 1981).
Wieacker et al. (1983b) examined sixteen families for linkage 
with RC8 (which was known to have positive LOD scores with xg). 
They found only one informative family which resulted in a maximum 
LOD score of 0.45 at 25cM. Ballabio et al. (1986) were able to show 
a suggestion of linkage to both Xg and Dic56 (DXS143) in a family 
segregating for X-linked ichthyosis, hypogonadotropic hypogonadism 
and anosmia (XLIHA). Maximum LOD scores of 1.44 for XLIHA-Xg and 
1.55 for XLIHA-Dic56 were obtained respectively, at theta = 0
(since no recombinants were observed).
1:4:4 The maintenance and "spreading" of X-inactivation.
One of the most interesting features of STS is that it escapes 
X-inactivation. Evidence for this will be presented in section 
1:4:5. Methylation is considered to be the most likely mechanism by 
which the pattern of X-inactivation is maintained, since 
methylation patterns are somatically heritable in mammalian cells 
and many genes have been reported which are underexpressed when
methylated at their 5' ends. (Other possible mechanisms are 
reviewed in Gartler & Riggs, 1983).
This is supported by experiments with 5-azacytidine (which 
inhibits methyltransferase activity and hence promotes 
demethylation of DNA). 5-azacytidine treatment is most effective in 
late S phase when the inactive X chromosome is replicating. It 
requires two cell cycles before a phenotypic effect is observed 
(which presumably allows complete demethylation).
5-azacytidine can cause reactivation of both HPRT and PGK in 
mouse-human hybrids and results in a stable revertant phenotype in 
the absence of selection, and in spite of the lack of spreading of 
inactivation in tissue culture (Mohandas et al., 1981).
X-inactivation may spread to adjacent autosomal loci in human 
X,*autosome translocations (Mohandas, Sparkes & Shapiro, 1981). 
Similar spreading of inactivation to autosomal sequences has been
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observed for Cattanach's translocation in the mouse, in which part 
of chromosme 6 with several well-defined markers, has been inserted 
into the X-chromosome. Coat colours are more frequently inactivated 
at either edge of the inserted segment than at its centre, and are 
maintained more stably. It may be that proximity to inactivated 
X-linked sequences stabilises inactivation and that those autosomal 
sequences at the centre of the insert are furthest from this
influence. This predicts that sequences (or structures) on the 
X-chromosome can in some way enhance X-inactivation or that
sequences (or structures) on the autosomes can hinder inactivation 
(reviewed in Gartler & Riggs, 1983).
The STS gene may thus lack sequences which enhance
inactivation or contain sequences which hinder it. Schorderet et 
al. (1987) have reported mouse cell revertants which demonstrate 
STS activity following treatment of two STS deficient cell-lines 
(which themselves arose from STS proficient lines) with
5-azacytidine. It would thus appear that, in these deficient 
cell-lines, STS deficiency was due to aberrant methylation and that 
inactivation can spread to regions of the X-chromosome which 
normally escape inactivation.
STS was shown to escape x-inactivation (Keitges et al., 1985; 
Keitges & Gartler, 1986) in the mouse, but to be pseudoautosomal 
with a functional Y-linked allele (Keitges et al., 1985, 1986).
The pattern of inheritance of X-linked ichthyosis precluded a 
functional Y-linked allele for STS in man. This begged the question 
as to how much homology (if any) there was to STS on the human 
Y-chromosome. This will be addressed further in the discussion.
1:4:5 Evidence that Xg, STS and MIC2X escape X-inactivation.
Xg, STS and MIC2X (which codes for a polypetide recognised by 
12E7 antibody), in distal Xp, are all known to escape (or partially 
escape) X-inactivation. Only MIC2X has a functional Y-homologue 
(MIC2Y).
The first indication that Xg escaped inactivation came with 
the realisation that all cells from Xg(a)/ xg individuals reacted 
with anti-Xg(a) antibody (Gorman et al., 1963). Similarly, both 
cell populations in females doubly heterozygous for X-linked
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sideroblastic anemia and xg, expressed Xg(a) equally (Weatherall et 
al., 1970). Furthermore Xg(a) was expressed from the inactive 
(maternal) X in individuals heterozygous for both HPRT and xg, 
(Fialkow, 1970).
Escape of STS from inactivation was demonstrated by both 
fibroblast and somatic cell hybrid studies. Fibroblast clones 
derived from obligate carriers of STS deficiency, and from 
individuals doubly heterozygous for G6PD variants and STS 
deficiency, all demonstrated STS activity, (Shapiro et al., 1979). 
Mohandas et al. (1980) demonstrated that human STS was expressed in 
somatic cell hybrids which contained an X-chromosome in an 
otherwise inactive state.
Normal males, who possess one dOse of STS, express STS at 
approximately half the level of normal females (with two doses). 
The ratio of expression in females to that in males is consistently 
less than two throughout a range of tissues e.g. fibroblasts and 
lymphocytes (Muller et al., 1980) and placenta (Bedin et al., 
1981). This implied that STS may not completely escape 
X-inactivation. This contention was supported by somatic cell 
hybrid studies in which the STS activity of the inactive X appeared 
lower than that of the active x (Migeon et al., 1982).
The MIC2 locus was cloned by Darling et al. (1986). Evidence 
that MIC2X escapes X-inactivation was provided by the expression of 
12E7 antigen in two independent human-rodent cell-lines with a 
single inactivated X-chromosome, in which three unrelated X-linked 
enzymes were not expressed (Goodfellow et al., 1984). However, 
12E7 antigen was expressed less strongly than in control hybrids, 
with either a Y chromosome or an active x-chromosome. This 
indicated that either the inactive X-chromosome had been lost from 
a proportion of cells, or that 12E7 was expressed at a lower level 
from the inactived X-chromosome, as proposed for STS.
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1:5 AIMS OF PRESENT RESEARCH.
The aim of this project was to perform a molecular analysis of 
Duchenne muscular dystrophy (dmd) and of X-linked ichthyosis (XLI) 
and of disorders found in association with either condition. It was 
thus necessary to isolate X-specific probes from within Xp21 (for 
DMD) or Xp22.3 (for XLI).
The aims, outlined below, involve the isolation of xp-specific 
sequences, an assessment of their value in the study of DMD or XLI, 
and the applications of suitable probes. They can be summarised as 
follows:
1) To construct an X-chromosome specific library using flow- 
sorted X-chromosomes.
2) To screen the library for single copy human recombinants.
3) To use somatic cell hybrids to determine which of these 
sequences were X-linked and to regionally localise these 
sequences on the X-chromosome.
4) To submit sequences assigned to Xp to further analysis by
(i) searching for restriction fragment length polymorphisms 
(RFLPs)
(ii) screening for deletions in affected males.
5) To study the DMD locus by
(i) using appropriately placed probes which detected RFLPs to
undertake family studies and perform a linkage analysis.
(ii) using probes which detected deletions in males with DMD to 
examine the frequency at which deletions occur.
6) To study the XLI locus by
(i) using appropriately placed probes which detected RFLPs to
undertake family studies and perform a linkage analysis.
(ii) using appropriately placed probes to study the molecular
pathology of X-linked ichthyosis.
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7) To compare data obtained using these probes with that obtained
using pre-existing probes, and to determine the extent of DMD
deletions.
8) To investigate conservation between mammalian species of any
Xp sequences of particular interest, which could serve to
indicate whether or not they might be expressed.
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CHAPTER 2: MATERIALS AND METHODS.
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MATERIALS AND METHODS.
2:1 MATERIALS 
2:1:1 General
Centrifuge tubes and other "disposable plastics" were supplied 
by Sarsdedt, with the exceptions of 50ml Falcon 2070 tubes, SW41 
ultra-centrifuge tubes (Sorvall), universals and bijoux (Sterilin 
128C and 129B), 1ml (blue) pipette tips (Treff), plastic pastettes 
(Alpha-Labs) and plastic petri dishes ("plates"), (Nunc 140mm and 
100mm).
The centrifuges used were (i) Sorvall RC-5B (HB4, SM24 and 
HS-4 rotors), (ii) IEC DPR-6000, (iii) Sorvall ultra-centrifuge 
and (iv) IEC centra-4X microfuge.
Other equipment and consumables are described at appropriate 
points in the text. Details of the solutions used are presented in 
section 2:1:2.
2:1:2 Solutions
All solutions were prepared with Sterile distilled water in 
clean glass-ware and were sterilised in a pressure cooker at 15psi 
(pounds per square inch) for fifteen minutes unless otherwise 
stated. These are listed in the order of their first appearance in 
the methods section which follows.
SM /litre: NaCl 5.8g
MgS04.7H20 2g
1M Tris.Cl (pH7.5) 50ml
2% gelatin 5ml.
L (Luria-Bertani)Broth /litre: Bacto-tryptone lOg
Bacto-yeast extract 5g 
NaCl lOg
L-plates were made 1.5% in Difco Bacto-agar, whilst top agar for 
preparing phage was 0.7% in Bacto-agar (or 0.5% in Bacto-agar for 
scraping protocol).
Page 52
TM: 50mM Tris.Cl (pH7.8)
lOmM MgS04
Phenol/ Chloroform: 50% Phenol,
(Not sterilised) 50% Chloroform,
0.1% 8-hydroxyqu inoline.
Phenol/chloroform was saturated and equilibrated to pH7.5 with TE 
buffer.
DNA isolation buffer: 150mM NaCl 
(Chromosomal) 10mM Tris.Cl (pH8.0)
lOmM EDTA
TE Buffer: lOmM Tris (pH7.5)
ImM EDTA (pH8.0)
0.5M Tris.Cl (PH7.4)
0.1M MgCl2-
0.1M Dithriothreitol (DTT) 
lmg/ml Bovine serum albumin (BSA)
Depurination solution: 0.2M HCl.
Denaturation Solution: 0.5M NaOH
1.5M NaCl.
Neutralisation Solution: 3M NaCl
0.5M Tris.Cl (pH 7.4).
20xSSC: 3M NaCl
300mM Na Citrate (pH7.4)
10 x Ligase buffer: 
(DTT was filter 
sterilised)
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Prehybridisation Buffer: 50% Formamide (deionised)
(Not sterilised) 5x Denhardts
5x SSC
50miyi Sodium Phosphate (pH6.8)
380pg/ml sonicated, denatured 
salmon sperm DNA
0.2% SDS 
10pg/ml Poly(A).
50% Formamide (deionised) 
lx Denhardts 
5x SSC
20 mM Sodium Phosphate pH 6.8 
100pg/ml sonicated, denatured 
salmon sperm DNA,
20pg/ml Poly (A)
10% Dextran Sulphate.
lOOx Denhardts Solution: 2% Ficoll
2% Bovine Serum Albumin 
2% Polyvinylpyrrolidone
Phosphate buffer/500ml: NaH2P04 37g (anhydrous 28g)
Nd2HP04 44g (anhydrous 35g)
Dextran sulphate/ litre: 750ml water was boiled in a 2 litre
beaker and 500g dextran sulphate added. 
This was stirred, heating as necessary 
until dissolved, and the volume
adjusted to one litre._______________
poly A: lOOmg was dissolved in 5ml sterile distilled 
water.
Deionised formamide: This was prepared immediately prior to use. 5g 
ion exchange resin (Bio-Rad Ag 501-X8 20-50 mesh) was added per 
50ml, stirred with a magnetic stirrer at room temperature for one 
hour and filtered twice through Whatman Number one filter paper.
Hybridisation Buffer: 
(Not sterilised)
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TES buffer: 0.3M Tris (pH9.0) 
0.15M EDTA 
1.5% SDS
"Oligo" reaction mix: solutions A:B:C in a 100:250:150 ratio:
Solution A: 1ml solution 0
(stored at-20°C) 18pl 2-mercaptoethanol
5pl each of lOOmM dATP,
dGTP and dTTP (in TE).
Solution O: 1.25M Tris.Cl (pH8.0),
(stored at 4°C) 0.125M MgCl2
Solution B: 2M HEPES (pH6.6)
(stored at 4°C)
SolutionC: Hexadeoxyribonucleotides (Pharmacia
(stored at -20°C) PL number 2166) evenly suspended at
90 OD units per ml.
lx "oligo" stop mix: 20mM NaCl
20mM Tris.Cl pH7.5 
2mM EDTA
lpM dCTP (normally omitted)
0.25% SDS
SOB: Bacto tryptone 2%
Bacto yeast extract 0.7%
NaCl lOmM
KCl 2.5mM
Filter sterilised 1M MgCl2 and 1M MgS04 were each added to lOmM 
prior to use. SOB botttom agar (for plates) was prepared by the 
addition of Difco bacto-agar to 1.5%.
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RFl : RbCl lOOmM
MnCl2.4H20 50mM
Potassium acetate (pH7.5) 30mM
CaCl2.2H20 lOmM
glycerol 15%w/v
The pH was adjusted to pH5.8
sterilised by filtration (prior
glycerol).
RF2: MOPS (Morpholinopropanesulfonic acid) lOmM
RbCl lOmM 
CaCl2.2H20 75mM 
glycerol 15%w/v 
The pH was adjusted to pH6.8 with NaOH. RF2 was sterilised by 
filtration (prior to the addition of sterile glycerol).
Ampicillin: Ampicilin was dissolved in sterile
distilled water at 25mg/ml and stored 
in 1ml aliquots at -20°C.
X-gal: lOOmg x-gal was dissolved in 5ml Dimethyl 
formamide (DMF) and stored at -20°C.
STET: 50mM Tris.Cl (pH8.0)
50mM EDTA 
8% sucrose
5% Triton X-100 (BDH Chemical Ltd.)
Bacterial lysis mix: 50mM Tris.Cl (pH7.5)
50mM EDTA 
15% sucrose
Anticoagulant: 4.5% (w/v) EDTA,
0.7% (w/v) NaCl
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Lysis Buffer: 0.32M Sucrose
lOmM Tris (pH 7.5)
20mM Mgcl2
1% Triton X100
NaCl/ EDTA: 0.075M NaCl
(proteinase K buffer) 0.024M EDTA (pH 7.5)
Loading mix: 50% Glycerol 
2% Ficoll 
50mM EDTA 
Pinch of Orange G.
50x EB/ litre: Tris base
glacial acetic acid 
0.5M EDTA (pH8.0)
Prehybridisation/ hybridisation 
solution: 50% formamide
3x Denhardt's 
5xSSC
25mM sodium phosphate (pH6.8) 
250pg/ml sonicated denatured 
salmon sperm DNA
1% SDS
20)Jig/ml poly A
10% dextran sulphate.
242g
57.1ml
100ml
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2:2 LAMBDA PHAGE METHODOLOGY.
2:2:1 Preparation of plating cells (Maniatis, Fritsch & Sainbrook, 
1982).
100ml cultures in L-broth (see section 2:5:1) of the
appropriate plating cells were incubated overnight, with vigorous
shaking, at 37°C. The cells were pelleted in sterile Falcon 2970
tubes by centrifugation (IEC DPR-6000) at 2.8K for ten minutes at 
4°C and resuspended in 10-20mls SM buffer. The optical density at 
600nm (OD^qq) was read on a Perkin-Elmer 6000 spectrophotometer and 
the cell concentration adjusted to an OD600 o^r
approximately 1600 million cells/ ml).
2:2:2 Titration of Phage stocks (plate lysis) (Maniatis et al, 
1982).
Serial dilutions (eg 10“ ,^ 10-~* and lO-"^ dilutions) of the
phage stock to be titred were prepared in SM buffer. lOOpl of each 
dilution was added to 100pl of the appropriate plating cells and 
left to adsorb for twenty minutes at 37°C in a bijou (Sterilin). 
3mls of 0.7% top agar were added to each bijou, the contents mixed 
gently and poured on L-plates. Control plates with (i) cells only 
and (ii) cells + SM buffer were also set up. The plates were 
inverted and incubated at 37°C overnight. The titre per ml was then 
calculated by multiplying the dilution factor by ten times the 
number of plaques obtained.
2:2:3 Optimisation of liquid lysis conditions.
A series of small scale liquid lysis preparations were 
performed in order to determine the optimum ratio of phage to 
cells. Ratios from 1:200 to 1:20 bacteriophage per cell are
generally required to obtain lysis, dependent on the bacteriophage 
strain used. Ratios from 1:50 to 1:1000 were prepared. The
appropriate amount of a 10  ^dilution of the bacteriophage stock
was added to 100pl plating cells in a universal and the volume
adjusted to 200pl with SM buffer. After twenty minutes at 37°C in 
order to allow adsorption to occur, 10ml L-Broth was added, and the 
universal taped in position in the shaking incubator overnight (or
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until lysis occurred). The ratio(s) at which optimum lysis occurred 
(eg 1:500 for NM1149 with NB78) were then used for large scale 
preparations (section 2:2:4).
2:2:4 Large scale Lysis (Blattner et al,1977; Maniatis et al, 
1982).
The optimum ratio, determined as described in section 2:2:3 
was scaled up to 6.25mls cells (ie 101® cells) and 2 x 10® phage 
(for NM1149). Adsorption was performed at 37°C for twenty minutes. 
500mls L-broth (prewarmed to 37°C) was added and the culture 
incubated at 37°C with vigorous shaking for six hours. Lysis was 
generally apparent. 10ml chloroform (Analar reagent grade) was 
added to each flask and incubation continued for a further thirty 
minutes.
2:2:5 Purification of bacteriophage lamda (Yamamoto et al, 1970; 
Vande Woude et al, 1979; Maniatis et al, 1982).
The culture was transferred to a second sterile flask and left 
to equilibrate at room temperature. DNasel (Boehringer Mannheim) 
and RNaseA (Sigma) were each added to a final concentration of 
lpg/ml and the culture incubated at room temperature for thirty 
minutes. Solid sodium chloride was added to a final concentration
of 1m and dissolved by swirling. The culture was left for one hour
on ice. The debris was pelleted by centrifugation at 2.8K for ten 
minutes at 4°C (Sorvall RC-5B, HS-4 rotor) and the supernatant 
transferred to a third sterile flask. Solid polyethene glycol 
(Sigma) was added to 10% (weight/ volume) and dissolved by slow 
stirring at room temperature. The bacteriophage suspension was then 
cooled on ice water overnight to enable the bacteriophage to
precipitate.
Bacteriophage were recovered by centrifugation (Sorvall RC-5B, 
HS4 rotor) at 2.8K for ten minutes at 4°C. The supernatant was 
discarded and the pellet drained thoroughly. The phage pellet was 
resuspended in 2.5-5ml TM (50mM Tris 7.8, lOmM MgS04) and
extracted once with chloroform. The suspension was then loaded on 
top of a glycerol step gradient prepared in a Sorvall SW41 tube. 
The step comprised 3ml 40% glycerol in TM, followed by 4ml 5%
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glycerol in TM. The volume was "made up" with TM. The step gradient 
was subjected to centrifugation at 35 000 rpm for one hour at 4°C 
(Sorvall OTP-65 ultracentrifuge, SW41 rotor). The supernatant was 
discarded and the bacteriophage pellet resuspended in 1ml TM.
2:2:6 Preparation of bacteriophage lambda DNA.
Pure DNasel and boiled RNAse A were added to the bacteriophage 
suspension to 5pg/ml and 10pg/ml respectively. Incubation for 
thirty minutes at 37°C was performed. 0.5M EDTA (pH 8.0) was added 
to 20mM, lOmg/ml proteinase K (Gibco, Bethesda Research 
Laboratories (BRL)) to 50pg/ml and 10% SDS (Sigma) to 0.5%, prior 
to incubation at 65°C for one hour. The phage suspension was then 
combined with an equal volume of phenol in a 13ml Sorvall tube, 
mixed by gentle inversion and the phases separated by 
centrifugation (Sorvall RC-5B, HB4 rotor, 6K, five minutes, room 
temperature).
The aqueous phase was removed with a plastic pastette (Alpha 
Labs), extracted once with equilibrated phenol:chloroform (50 parts 
: 50 parts) and then once more with chloroform. Phage DNA was 
precipitated at-20°C overnight, by the addition of sodium acetate 
(pH7) to 0.2M and an equal volume of isopropanol. Phage DNA was 
pelleted by centrifugation (10K, lOminutes, 4°C, Sorvall RC-5B, HB4 
or SM24 rotors), washed twice with 70% ethanol and resuspended in 
500pl TE.
2:3 CONSTRUCTION OF X-CHROMOSOME LIBRARY (Fuscoe, Clark & van 
Dilla, 1986).
The X-chromosome specific library was derived from complete 
(EcoRl) digestion of flow sorted X-chromosomes. This avoided the 
need to subclone recombinants prior to their localisation on Xp.
The library was constructed in bacteriophage lambda NM1149 
which accepts inserts from 0-llkb in size. The host bacteria NM514 
permitted only those phage disrupted at the cl gene (ie at the 
EcoRl or Hindlll insertion sites of the vector) to enter a lytic 
cycle and thus selected for recombinants. Non-recombinant phage 
were constrained to undergo a lysogenic cycle. NM514 was 
recombination proficient, however which is likely to have selected
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against inserts containing inverted repeats.
2:3:1 Preparation of bacteriophage (vector) arms.
50pg phage DNA was digested with 30U EcoRl (BRL) using BRL 
core buffer for three hours at 37°C. 25pg were treated with lu CIP 
(calf intestinal phosphatase, Boehringer Mannheim (22U/pl), diluted 
in core buffer) for thirty minutes at 37°C. The CIP was inactivated 
by heating to 70°C for five minutes and cooling on ice, twice.
Three phenol/chloroform extractions and a chloroform 
extraction were performed and the vector arms prepipitated by the 
addition of 0.5 volume of 7.5M ammonium acetate and 2.5 volumes of 
95% ethanol overnight at -20°C. The arms were pelleted by 
centrifugation (twenty minutes, 12 000 rpm, IEC Centra-4X
microfuge, room temperature), washed with 70% ethanol, vacuum dried 
(HETO CD3 vacuum drier) and resuspended at 100pg/pl in TE.
2:3:2 Growth of cell-lines and sorting of X-chromosomes.
Lymphoblastoid cell lines were established and maintained by 
L. Snaddon or M. Clarke, esssentially as described by Neitzel 
(1986). Samples for flow karyotype analysis were prepared and 
analysed by A. Cooke, essentially as described in Harris et al 
(1985).
X-chromosomes were sorted by virtue of their relative 
fluoresence after staining with ethidium bromide. The X-chromosomes 
used in his study were derived from the lymphoblastoid cell line of 
MD, a patient with a 4;7 translocation. This translocation alters 
the relative fluorescence of one chromosome seven and removes it 
from the chromosome peak which contains two chromosome sevens and 
two X-chromosomes (and some chromosome 8) in normal female 
individuals, such that the relative proportion of X-chromosomes 
obtained in this peak is correspondingly increased.
2:3:3 Preparation of Chromosomal DNA (Fuscoe et al, 1986).
The sorted chromosomes were combined in a 1.5ml eppendorf tube 
(Sarsdedt). This was placed within a 13ml Sarsdedt tube and spun at 
20K (SM24 rotor) for one hour at 4°C (Sorvall RC-5B centrifuge).
The supernatant was removed and the chromosomal pellet resuspended
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in lOOp'l DNA isolation buffer (150 mM NaCl, lOmM TrisCl pH 8.0, 
lOmM EDTA). 10% SDS was added to 0.5% and lOmg/ml proteinase K to 
lOOpg/ml prior to overnight incubation at 37°c.
The sample was transferred to. a 0.5ml eppendorf tube 
(Sarsdedt), an equal volume of phenol/chloroform added and the tube 
mixed by gentle inversion for ten minutes at room temperature. The 
phases were seperated by a two minute spin in a microfuge (IEC 
centra-4X) and the aqueous layer transferred to a fresh tube. The 
phenol/ chlorofom layer was extracted with 50pl TE (lOmM TrisCl 
PH8.0, 1 mM EDTA pH8.0) in the same manner and the aqueous phases
combined. A further phenol/ chloroform extraction was performed 
with 150pl phenol/ chloroform, the organic layer extracted with 
50pl TE and the aqueous phases combined.
The aqueous phase was then extracted with 200^1 chloroform and 
transferred to a mini-collodion bag (Sartorius). Dialysis against 
TE was performed for seven hours at room temperature with two 
changes of buffer. The DNA solution was then transferred to an 
0.5ml eppendorf and stored at 4°C.
2:3:4 Digestion of chromosomal DNA (Fuscoe et al, 1986).
Chromosomes were digested with 50U EcoRl in a reaction volume 
of 200pl under the manufacturer's recommended conditions (BRL lx 
core buffer) but without the addition of spermidine. Digestion was 
for four hours at 37°C. EcoRl was inactivated by placing the 
reaction at 65°C for fifteen minutes.
The digest was mixed with an equal volume of phenol/chloroform 
for ten minutes at room temperature and the phases seperated by a 
two minute spin in a microfuge. The aqueous phase was transferred 
to a 1.5ml eppendorf and the organic phase extracted with 50pl TE. 
The aqueous phases were combined and extracted with an equal volume 
of phenol/ chloroform. The aqueous phase was again transferred to a 
1.5ml eppendorf and the organic phase which remained extracted with 
50pl TE. The aqueous phases were combined and extracted once with 
an equal volume of chloroform.
The aqueous phase from this extraction was transferred to a 
mini-collodion bag and dialysed against sterile distilled water 
overnight at 4°C with two changes of buffer.
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2:3:5 Co-precipitation and ligation of vector and insert (Fuscoe et
al, 1986).
The X-chromosome digest was transferred to an 0.5ml eppendorf 
tube and combined with 2pg (lOOmg/ml) lambda phage EcoRl arms to
give a total volume of 400pl. The sample was then placed in the
freeze dryer for two hours to reduce the volume to 50-100pl. 
One-tenth volume of 3M sodium acetate (pH5.0) and two volumes of
cold 95% ethanol were added and the sample mixed well. The sample
was then subjected to three freeze/thaw cycles for thirty minutes 
each at -70°C. The DNA was then pelleted in the Centra-4x microfuge 
using a horizontal rotor (10 minutes, room temperature), washed 
once with 70% ethanol, vacuum dried for three minutes and 
resuspended in lOpl TE overnight at 4°C.
lpl lOx ligase buffer (0.5M Tris.Cl (pH 7.4), 0.1M MgCl2, 0.1M 
dithiothreitol, lmg/ml BSA), 2pl 5mM ATP (Sigma) and lpl lU/pl T4 
ligase (Boehringer Mannheim) were added and the reaction incubated 
at 15°C overnight. A further 0.5pl each of lU/pl T4 ligase, lOx 
ligase buffer and 5mM ATP were added to give a reaction volume of 
16pl and the reaction incubated for a further three hours. 4pl of 
the ligated reaction was then packaged as described below.
2:3:6 Packaging of the x-chromosome library.
Packaging of DNA into bacteriophage particles (Becker & Gold, 
1975) was done using Amersham packaging kits (Amersham
International, Code 334), derived from two strains of mutant phage 
with complementary defects in phage assembly.
The packaging effeciency was tested by packaging lpg wild type 
lambda. Serial dilutions of the packaged phage were made in SM
Q
buffer and the titre/ pg packaged phage determined as 1.8 x 10 
pfu/pg, which compared well with the packaging effeciency of 2 x 
10® plaque-forming units (pfu) per pg wild-type lambda DNA claimed 
by the manufacturers (Amersham batch analysis).
The phage extracts were thawed on ice. Ipg (4pl) of the 
ligated reaction was added to extract B and 15pl of extract A added 
immediately. The extracts were mixed gently with a yellow tip and 
the contents collected by a brief (ten second) spin in a microfuge. 
The reaction was then incubated at room temperature for two hours,
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after which time 0.5mls SM buffer and lOpl chloroform were added. 
The packaged phage were then stored at 4°C as normal.
Aliquots of the X -library were plated on both NB78 and NM514 
to determine the proportion of recombinants in the library and the 
approximate titre. Phage were then plated out on NM514 at a density 
which allowed the optimum number of plaques to be screened at any 
given time. This number approached 2-300 for a small plate (87mm in 
diameter) and three times this number for a large plate (137 mm in 
diameter) and represented the maximum plaque density at which 
plaques were well resolved.
2:4 SCREENING OF THE X-CHBOMOSOME LIBRARY.
Plaque lifts of the X-chromosome' library were hybridised with 
®^P labelled total human (female) DNA in order to select against
recombinants which contained repeated sequences (and would thus 
give a strong signal with total human DNA). The single (or 
low-copy) clones which did not result in a signal were then 
selected for further study (see sections 2:4:1-2:4:7 and 2:5:1).
2:4:1 Plaque Transfers.
Plaque transfers (Benton & Davis, 1977) to Hybond-N membrane 
(Amersham International pic) were performed according to the 
manufacturers recommended conditions (Amersham International, 
1985). Hybond-N membranes (RPN.87N (87mm) or RPN.132N (132mm)) were 
placed on the plates and orientated by corresponding ink markings 
on both the membrane and the plates. Membranes were removed after 
one minute and placed (plaque-side up) on a pad of Whatmann 3MM 
paper saturated with denaturation solution (0.5 M NaOH, 1.5M NaCl). 
After seven minutes they were transferred to a pad saturated with 
neutralisation solution (3M NaCl, 0.5M TrisCl pH7.4), left for 
three minutes and then transferred to a fresh pad saturated with 
neutralisation solution for a further three minutes. The membranes 
were finally washed in 2xSSC (0.3M NaCl, 30mM NaCitrate pH7.4), 
left to air dry, and the DNA bound to the filter by ultraviolet 
light treatment (plaque side down on a UV transilluminator (UVC 
incorporated)) for four minutes or latterly by baking for five 
hours at 80°C (Gallenkamp BS Oven 250).
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2:4:2 Screening plaque transfers.
Plaque lifts were pre-wet in lxSSC, 0.1% SDS and prehybridised 
for a minimum of two hours in prehybridisation solution (50% 
deionised Formamide, 5x Denhardts (0.1% ficoll, 0.1% bovine serum 
albumin, 0.1% polyvinylpyrrollidone), 5xSSC, 5QmM Sodium phosphate 
pH6.8, 380pg/ml sonicated denatured salmon sperm DNA,0.2% SDS and 
10pg/ml Poly (A)) at 42°C in a shaking water-bath (Tecam SB-16).
A nick-translated probe was prepared from total human DNA (see 
below). This was boiled for five minutes, cooled on ice and added 
to ten volumes (generally five millilitres) hybridisation buffer 
(50% deionised Formamide, lx Denhardts (0.02% ficoll, 0.02% bovine 
serum albumin, 0.02% polyvinylpyrrollidone), 5xSSC, 20mM Sodium 
phosphate pH6.8, 100|ig/ml sonicated denatured salmon sperm DNA, 
20pg/ml Poly (A) and 10% dextran sulphate).
The prehybridisation buffer was replaced with hybridisation 
buffer containing the appropriate probe and left to hybridise 
overnight at 42°C.
Filters were washed at lxSSC, 0.1%SDS for thirty minutes at 
room temperature, at 0.5xSSC, 0.1%SDS for a further thirty minutes 
at room temperature, blotted dry, placed between plastic sheets in 
an autoradiography cassette and covered with a sheet of Kodak XAR-5 
(fast) film. The casette was equipped with Dupont lightning plus 
intensification screens and was placed at -70°C overnight. Films 
were developed using Kodak XAR developer and fixative and a Fuji 
RGII automatic film processor.
2:4:3 Selection of plaques.
Phage which failed to give a signal on hybridisation with 
nick-translated total human DNA were selected by comparing the 
autoradiograph with the original plate and picked using a sterile 
pasteur pipette (Bilbate) with a rubber bulb. Each agar plug was 
expelled into 1ml SM buffer, in a 1.5ml eppendorf tube. A drop of 
chloroform was added and the tube was left at room temperature for 
one hour to enable the phage (1-10 million) to diffuse out of the 
agar. The picked plaques stocks were then stored at 4°C as normal, 
(Maniatis et al, 1982).
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2:4:4 Plaque purification and preparation of high titre stocks.
10- dilutions of picked phage stocks were made in SM buffer. 
10pl of each dilution was added to lOOpl of plating cells and 
allowed to adsorb at 37°C for twenty minutes in a bijou (Sterilin). 
3mls of 0.7% top agar were addded. The contents of each bijou were 
mixed by gentle inversion and then poured on top of an L-plate. 
Once the top agar was set the plates were inverted and incubated 
overnight at 37°C. Well-separated plaques were obtained and these 
"purified plaques" were picked with a sterile pasteur pipette and 
expelled into SM buffer/ chloroform as described above.
lOpl of each "purified plaque" stock was addded to 112pl of 
plating cells in a bijou. Adsorption was for twenty minutes at 37°C 
after which time 3mls of 0.7% top agar were added, the bijoux 
inverted gently and the cells and phage poured over pre-warmed 
L-plates. The plates were incubated at 37°C overnight but were not 
inverted as confluent lysis was desired. Phage were recovered from 
the top agar by one of two methods (Maniatis et al, 1982):
For the first method, 5mls SM buffer were added to each plate. 
Plates were left shaking gently at 4°C for four hours (Luckham R100 
shaking platform). The SM buffer was transferred to a 13 ml 
sarsdedt tube and chloroform added to 1%. The tubes were spun at 8K 
(ten minutes, 4°C, SM24 rotor, Sorvall RC-5B) and the supernatant 
transferred to a fresh tube. The resultant high titre stock was 
made 0.05% in chloroform and stored at 4°C.
Alternatively, the top agar (0.5% for this protocol) was 
scraped into a 13ml sarsdedt tube tube using a sterile bent pasteur 
pipette. 5mls of SM buffer and 100pl chloroform (to 2%) were added 
and the contents mixed in the shaking incubator (New Brunswick G25) 
at 150-200rpm for thirty minutes. The tubes were spun at 8K (ten 
minutes, 4°C, SM24 rotor), the supernatant transferred to a fresh 
tube and chloroform added to 0.5%. The resultant high titre stock 
was stored at 4°C.
For applications in which only a small amount of high titre 
stock was required e.g. the inital screen of the library the first 
approach was used. The second method was easier to scale up and was 
used to produce a larger volume of high titre stock for storage.
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2:4:5 Preparation of liquid lysates.
lpl of each high titre stock (approximately 3x 106 phage) was 
added to 112pl (10-*-®) of the appropriate plating bacteria and 
allowed to adsorb for twenty minutes at 37°C in a universal 
(Sterilin). 5mls of L-broth were added and samples incubated 
overnight in the shaking incubator (New Brunswick G25). Lysed 
cultures were transferred to 13ml Sarsdedt tubes, lOOpl chloroform 
added to each, and incubation continued for a further fifteen 
minutes. The bacterial debris was pelleted (Sorvall RC-5B, SM24 
rotor, 8K, twenty minutes, room temperature) and the supernatant 
transferred to a fresh tube. A further 20pl of chloroform was added 
(to 0.4%) and the liquid lysates stored at 4°C, (Leder, Tiemeier & 
Enquist, 1977; Maniatis et al, 1982)..
2:4:6 Small scale phage DNA preparations (Cameron, Phillipson & 
Davies, 1977).
2mls of liquid lysate were transferred to a 13ml Sarsdedt 
tube. lOmg/ml DNase was added to 70pg/ml and the lysate incubated 
at 37°C for one hour. 0.8mls TES (0.3M Tris (pH9.0), 0.15M EDTA and 
1.5% SDS) was added, samples placed at 70°C for 15 minutes and then 
cooled to room temperature.
0.8mls of 5M Potassium acetate (pH8.0) was added, the samples 
placed on ice for thirty minutes and spun at 9K for twenty minutes 
(Sorvall SM24 rotor at 4°C) with the brake off. 4mls of supernatant 
were transferred to a fresh tube, mixed with an equal volume of 
isopropanol and spun for a further twenty minutes (9K, 4°C).
The phage pellet was washed with 70% ethanol, dried, 
resuspended in lOOpl TE and transferred to an 1.6 ml eppendorf 
tube. lOpl boiled RNaseA (25mg/ml) was added and incubation 
performed at 37°C for thirty minutes. 4pl each of 10% SDS and 
proteinase K (lOmg/ml) were added, prior to incubation at 55°C for 
fifteen minutes.
A tenth volume of 3M sodium acetate (pH7.0) was added and 
phenol/chloroform extractions performed until the interface was 
clear. Two volumes of 100% ethanol were added to the aqueous phase 
at this point and samples placed at -20°C for ten minutes.
Phage DNA was pelleted by centrifugation (9K, twenty minutes ,
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4°C), washed once with 70% ethanol, dried and resuspended in 32pl 
sterile distilled water, prior to digestion with the appropriate 
restriction enzyme.
2:4:7 Isolation of phage inserts.
EcoRl digestion of phage recombinants was performed in a total 
reaction volume of 40^1 (containing a tenth volume of BRL "React 2" 
(or BRL "core") buffer, a twentieth volume of O.lM spermidine 
(final concentration 5mM) and l-2pl (10-20U) EcoRl) overnight at 
37°C.
5pl of the digest was placed aside for sub-cloning at a future 
stage (refer to section 2:5:2). 5pl loading mix (50% Glycerol, 2% 
Ficoll, 50mM EDTA with a "pinch" of Orange G) was added to the 
remaining sample which was then loaded on a 1% LMP agarose (BRL) 
gel prepared in EB buffer. Gels were subjected to constant current 
electrophoresis at 250 mA, stained in a 5pg/ml solution of ethidium 
bromide in EB buffer, and visualised over ultra-violet light.
"Insert bands" were excised using a sterile scapel blade, 
transferred to 1.6ml sarsdedt tubes, weighed and a volume of 
sterile distilled water (SDW) equivalent to twice the weight of the 
insert added. The tube containing DNA/agarose/SDW was placed in 
boiling water for ten minutes and used directly for oligonucleotide 
labelling (see section 2:5:2) or stored at -20°C.
2:5 PREPARATION OF RADIOACTIVELY LABELLED PROBES.
Alpha-32P dCTP (Amersham international, specific activity 3000 
Ci/mmol (or llOTBq/mmol) labelled probes were prepared by (i) 
nick-translation of whole plasmid DNA or genomic DNA or (ii) random 
oligonucleotide primed labelling of phage or plasmid inserts.
2:5:1 Nick translation (Kelly et al, 1970; Maniatis et al, 1982).
Nick translation was performed using nick translation kits 
(Amersham international, N5000). Essentially, l-2pg of DNA (made up 
to 17(jl with SDW) was combined with 6pl of 5X Amersham reaction mix 
(100pM each in dATP, dGTP and dTTP), 5pl (approximately 50pCi) 32P 
dCTP and 2pl of Amersham enzyme solution (which contained 0.5U/pl 
DNA polymerase I and 10pg/pl DNase I). The reaction was incubated
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at 14-16°C for an hour and a quarter and then stopped by the 
addition of 5pl 0.5M EDTA. Labelled DNA was separated from 
unincorporated oligonucleotides by chromatography through a 
Sephadex G-50 column.
Amersham reaction mix and enzyme solution were in Tris/HCl and 
MgCl2 at pH7.8 and pH7.5 respectively. The molarities were not 
specified but probably approximate to final concentrations of 50mM 
Tris.HCl and lOmM MgS04 as specified in Maniatis et al (1982).
2:5:2 Oligo-nucleotide primed ("oligo-") labelling (Feinberg & 
Vogelstein, 1983, 1984).
20pl of excised insert (diluted with SDW) was boiled for ten 
minutes and equilibrated at 37°C for. fifteen minutes. This was 
added to 15pl SDW, 10 pi lOx "oligo" reaction mix and 2pl lOmg/ml 
bovine serum albumin (BSA, Sigma). 20-30pCi 32P dCTP was added to 
each reaction together with 0.5-lpl (5-10U) Klenow fragment
(Amersham).
The reactions were incubated at 20°C overnight and stopped by 
the addition of 50pl of 4x stop mix (lx stop mix: 20 mM NaCl, 20mM 
Tris-Cl pH7.5, 2mM EDTA, lpM dCTP (normally omitted) and 0.25% 
SDS). Incorporated label was resolved from unincorporated 
nucleotides on a Sephadex G-50 column.
2:6 PLASMID TECHNIQUES.
2:6:1 Storage and culture of bacterial strains and plasmid 
recombinants.
Plasmids were firstly stored as a DNA stock (at 4°C). They 
were then transformed (see section 2:5:2) into an appropriate 
bacterial strain (generally pUCl9), plated out and single colonies 
selected. Bacteria containing recombinant plasmids were stored by 
(i) "stabs" (ii) glycerol stocks and (iii) (for short-term storage 
only) by streaking out on to L(-amp) plates. Bacterial strains with 
no plasmid recombinants were also stored in this manner (eg NM514 
and NB78, which were used in constructing the library) but without 
anti-biotic selection.
The specifications of plasmid DNA clones, which were used in
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this study but were obtained from other sources (see 
acknowledgements), are summarised in table 3.
To'create "stabs" part of the colony was picked with a sterile 
wire loop, stabbed into a bijou or 2ml starsdedt tube containing 
1.5% L-agar and grown up (loosely capped) at 37°C overnight. These 
were tightly capped, wrapped in Nesco-film to prevent evaporation 
and stored at room temperature.
Glycerol stocks were established by selecting part of the 
colony with a sterile wire loop to innoculate 5ml L broth (+/- 
50-100pg/ml ampicillin) in a sterile universal. The culture was 
grown overnight at 37°C in a shaking incubator with vigourous
shaking (200-300 rpm). 1ml was removed to a sarsdedt 1.6ml sterile
screw-cap tube, 0.6ml sterile glycerol added and the two mixed 
well, resulting in a bacterial stock just less than 40% in
glycerol. This was stored at -20°C
Single colonies of interest were also streaked onto a fresh 
L(-amp) plate with a sterile wire loop to give decreasing
concentrations of bacteria proceeding clockwise round the plate. 
After overnight incubation at 37°C well spaced single colonies were 
almost invariably observed in some area of the plate, thus ensuring 
ready access to single colonies. The plates were wrapped in 
Nesco-film and stored at 4°C for a maximum of two months.
Single colonies were (i) selected directly from the 
appropriate plate stored at 4°C, (ii) obtained by streaking out of 
a stab or glycerol stock or (iii) when only plasmid DNA was 
available, by transforming bacteria, plating out and selection of 
the appropriate recombinants (see section 2:6:2).
Single colonies were used to prepare overnight cultures by 
inoculating 5mls L-broth (which was 50-100pg/ml in ampicillin where 
appropriate) and incubating overnight at 37°C with vigorous 
shaking. Where large scale cultures were required the 5ml culture 
was grown up for several hours and then used to "seed" 100ml of 
pre-warmed L-broth. These overnight cultures provided the starting 
point for plating cells (section 2:2:1) and plasmid preparations 
(sections 2:6:4 and 2:6:5)
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2:6:2 Preparation of competent cells and bacterial transformation.
Frozen competent cells (JM83) were prepared by frozen storage 
protocol III of Hanahan (1985). A freshly streaked SOB plate was 
prepared from a single colony. Ten colonies, 2-3mm in diameter, 
were picked from this plate, dispersed in 1ml SOB by vortexing and 
used to inoculate lOOmls SOB in a 1 litre Erlenmyer flask.
The culture was grown to a density of 4-7 x 107 cells/ml, 
split between two Falcon 2070 (or Sarsdedt 60.547) tubes and placed 
on ice for fifteen minutes. Cells were pelleted (2800rpm, fifteen 
minutes, 4°C, IEC DPR-6000), drained and resuspended in one-third 
volume (2xl6mls) RFl buffer and incubated on ice for fifteen 
minutes. Cells were pelleted once more by centrifugation (as 
above), resuspended in 2x 4mls RF2 buffer and left on ice for a 
further fifteen minutes. Competent cells were then aliqoted into 
chilled 1.6ml sarsdedt screw-cap tubes, "flash-frozen" in liquid 
nitrogen and stored at -70°C.
These were thawed at room temperature as required for 
transformation. Cells were divided into lOOpl aliqouts in Sarsdedt 
1.6ml screw-cap tubes and placed on ice. lOOng-lpg of DNA in a 
volume of up to 10pl was added and the tube swirled to mix the 
sample well. Samples were left on ice for twenty to forty five 
minutes prior to "heat-shock" at 42°C for thirty to forty five 
seconds. Samples were immediately returned to ice after heat-shock 
and plated onto L-plates (+/_ ampicillin). Control plates were 
prepared using competent cells with no transforming DNA.
2:6:3 Sub-cloning of phage inserts.
PUC19 vector was prepared by digestion with EcoRI and calf 
intestinal phosphatase treatment (as described in section 2:2:1). 
l|al (20ng) of plasmid vector was ligated with 2^1 of the 
appropriate phage digest (section 2:3:8) for one hour at room 
temperature and then at 4°C overnight. The total reaction volume of 
10pl comprised: lpl plasmid vector, 2|ul phage digest, lpl lOx 
ligase buffer, 2pil 5mM ATP, 1U T4 DNA ligase and 3pl SDW.
The ligation reaction was used directly in transformation of 
JM83 cells without phenol/chloroform extractions to remove T4 DNA 
ligase.
page 71
2:6:4 Selection of transformants.
Transformed cells and controls were spread with a sterile 
glass rod onto L- plates (made 50-100pg/ml ampicillin for 
sub-cloning into pUCl9, or for any ampicillin resistant plasmids 
cloned in either the pUC or pBR322 series of vectors).
X-gal selection, was used whenever possible (eg for "pUC" 
vectors using JM83 competent cells). 40pl of 20mg/ml X-Gal in 
dimethyl formamide was added to each L-amp plate prior to use. JM83 
has a LacZ mutation and thus cannot produce beta-galactosidase 
necessary to metabolise x-gal (5-bromo- 4-chloro- 3-indoyl-beta-D- 
galactopyrosanide). The lacz' gene at the polylinker (or multiple 
insert) site in pUCl9 complements the defect and thus JM83 cells 
containing this plasmid metabolise X-gal. This reaction results in 
a blue colour. Recombinant plasmids (which interrupt the lacZ1 
gene) are "white" and can be distinguished from (blue) religated 
vector clones. Small scale DNA preparations were performed for each 
well-spaced single colony selected (see section 2:6:5).
2:6:5 Rapid (small scale) plasmid preparation by the boiling method 
(Holmes & Quigley, 1981).
5ml cultures, derived from 20|il glycerol stock or, preferably, 
from single colonies were grown overnight in L-broth (made 
50-100pg/ml in ampicillin if appropriate), in sterile Universals 
(Sterilin) within a shaking incubator at 37°C.
1.5ml of overnight culture was transferred to an eppendorf 
tube. Cells were pelleted by centrifugation for five minutes in a 
microfuge (IEC centra-4X). (The remainder of the culture was made 
40% in glcerol and stored at -20°C as a glycerol stock). The 
supernatant was discarded, the cells resuspended in 700pl ice-cold 
STET (50mM Tris 8.0, 50mM EDTA, 8% sucrose and 5% Triton X-100) and 
50|il lOmg/ml lysozyme (in STET) added. The tubes were left on ice 
for fifteen minutes to enable the cells to lyse, placed in boiling 
water for forty five seconds, and returned to ice.
The bacterial debris was pelleted by centrifugation at maximum 
speed for thirty minutes and the supernatant transferred to a fresh 
tube. Sodium acetate was added to 0.3M and phenol/ chloroform 
extractions performed until the interface was clear. Plasmid DNA
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was precipitated at -20°C for thirty minutes, by the addition of 
0.6 volumes of isopropanol. DNA was pelleted by centrifugation, 
washed twice with 70% ethanol and air- or vacuum- dried. The pellet 
was resuspended in TE (for storage at 4°C) or more often in a small 
volume of sterile distilled water which formed the basis of the 
desired restriction digest.
Small scale preparations yielded plasmid DNA of a quality 
suitable for "oligo"-labelling (section 2:5:2), normally sufficient 
for twenty to thirty labelling reactions.
2:6:6 Large scale cleared lysate plasmid preparation (BRL 
protocol).
100ml cultures were grown overnight in L-broth at 37°C 
within a shaking incubator. These were generally "seeded" with 5ml 
cultures grown up from a single colony (or 20[xl glycerol stock of 
the appropriate colony) during the day. Ampicillin was added to 
50-100pg/ml if appropriate.
Cells were pelleted by centrifugation at 2500 rpm for 
fifteen minutes at room temperature. The supernatant was discarded. 
Cells were resuspended in lOmls bacterial lysis mix (50mM Tris 7.5, 
50mM EDTA and 15% sucrose) and left at room temperature for fifteen 
minutes. lOmg of powdered lysozyme (Sigma) was added to lmg/ml and 
the cells were then left for a further twenty minutes at room 
temperature.
0.5mls 10% SDS (to 0.5% SDS) was added and the tube inverted 
gently. 1ml 5M Potassium acetate (to 0.5M) was then added, the tube 
inverted gently once more and placed on ice for thirty minutes.
Bacterial chromosomal DNA was removed by centrifugation 
(10K, thirty minutes, 4°C, HB4 rotor) and the supernatant 
transferred to a fresh tube. Plasmid DNA (and RNA) were 
precipitated on ice for twenty minutes by the addition of two 
volumes of cold 95% ethanol and pelleted by centrifugation (10K, 
twenty minutes, 4°C, HB4 rotor).
The pellet was then resuspended in 4mls TE and solid 
ammonium acetate added to 2.5M (0.77g). This was left on ice for a 
further twenty minutes and then subjected to centifugation (10K, 
twenty minutes, 4°C, HB4 rotor). The supernatant was transferred to
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a fresh tube and a further two volumes of 95% ethanol added. This 
was left on ice for a further twenty minutes and spun down (10K, 
twenty minutes, 4°C, HB4 rotor) to precipitate plasmid DNA.
The pellet was dried and resuspended in 2mls of 0.05M Nad 
in TE (in 13ml Sarsdedt tubes). Boiled RNAse A was added to 25^g/ml 
and the tube incubated at 37°C for forty five minutes. 0.6 volumes 
of 2M NaCl in TE were added and phenol chloroform extractions 
performed until the interface was clear. Plasmid DNA was 
precipitated at -20°C for thirty minutes by the addition of a 
further two volumes of cold 95% ethanol.
Plasmid DNA was pelleted by centrifugation (10K, twenty 
minutes, 4°C, HB4 rotor), resuspended in TE and subjected to two 
further rounds of purification by ammonium acetate precipitation. 
(Each round of purification involved the addition of a half volume 
of 7.5M ammonium acetate and of two volumes of 95% ethanol. Plasmid 
was precipitated at -20°C for thirty minutes and then recovered by 
centrifugation). The final pellet was dried prior to resuspension 
in 200-500pl TE.
2:7 SOUTHERN ANALYSIS.
2:7:1 Preparation of genomic DNA from blood and cell lines (Kunkel 
et al, 1977).
Genomic DNA was prepared as described below from blood 
(10-20mls in Nad anticoagulant) or from lymphoblastoid and somatic 
cell hybrid cell-lines. Fibroblast DNA was also prepared according 
to the same protocol with the quantities scaled down ten fold.
Blood samples were thawed (if frozen). lOmls blood was 
placed in each of two 50ml Falcon 2070 (or Sarsdedt 60.547) tubes. 
40mls of lysis mix (0.32m Sucrose, 10mM Tris pH 7.5, 5mM MgC^/ 1% 
Triton X-100) was added to each tube and the contents were mixed 
thoroughly. Cell pellets were resuspended directly in 50ml lysis 
mix and the tubes left on ice for ten minutes to ensure complete 
cell lysis.
Cell nuclei were pelleted in the IEC DPR-6000 centrifuge 
(2.8K, fifteen minutes, 4°C) and resuspended in lOmls NaCl/EDTA 
(0.075M NaCl, 0.024M EDTA). Any sample which had been split into
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two, was recombined at this point. 0.75mls 10% SDS and 200pl
lOmg/ml proteinase K were added, the tube inverted gently and 
incubated at 55°C for one to three hours.
The samples were allowed to cool to room temperature. A 
tenth volume of 3m sodium acetate (pH7.0) and an equal volume of 
phenol/chloroform (50% Phenol, 50% Chloroform, 0.1% 
8-hydroxyquinoline equilibrated with TE) were added. The tubes were 
mixed gently by rotation (Stuart tube rotator TR-2) for fifteen 
minutes and the phases separated by centrifugation in the IEC 
centifuge (2.8K, fifteen minutes, room temperature).
The aqueous phase was removed with a plastic pastette and
transferred to a fresh Falcon 2070 tube. Further phenol/chloroform 
extractions were performed until the interface was clear and the 
aqueous phase was once more transferred to a fresh tube. Two 
volumes of cold 100% ethanol were added to precipitate the DNA 
which could then be spooled around a sealed sterile pasteur
pipette. The DNA was washed in a small quantity of 100% ethanol and 
allowed to air dry. DNA samples were rehydrated in 500|il-lml TE. 
These were left at 4°C for a minimum of twenty four hours before
use to ensure that they had dissolved adequately, mixed with a wide 
bore 1ml blue tip (Treff) and 10-20pl removed with which to measure 
the optical density at 260nm (Perkin Elmer 6000 spectrophotometer). 
For a lOpl dilution in 1ml TE, the DNA concentration in pgms/ml was 
obtained by multiplying the optical density by five thousand.
2:7:2 Restriction Digests, electrophoresis and Southern blots
(Southern, 1975).
Restriction enzyme digests were performed using 7pg genomic or 
somatic cell hybrid DNA at 37°C overnight. The reaction consisted 
of DNA, one-tenth volume of the recommended lOx buffer (generally 
supplied), one-twentieth volume of 0.1M spermidine (Sigma), 10-20U 
restriction enzyme (BRL, New England Bio-labs, or Anglian 
Biotechnology) and sterile distilled water to an appropriate volume 
(normally 40pl). The samples were mixed well with a yellow pipette 
tip and spun briefly to collect the contents, prior to incubation.
Samples were spun briefly to collect the contents of the tube 
and one-sixth volume loading mix (50% Glycerol, 2% Ficoll, 50mM
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EDTA and "a pinch" of Orange G.) added. The sample was loaded onto 
an 0.8% agarose (Sigma A6013) gel prepared in electrophoresis 
buffer (EB, ie in 40mM Tris-acetate, 2mM EDTA). Electrophoresis was 
performed in EB at 150-250mA constant current for three to four 
hours, or until the orange-G marker dye had reached the foot of the 
gel. Gels were stained in a dilute ethidium bromide solution 
(5pg/ml in EB) and photographed with a polaroid GU-5 land camera 
using polaroid 667 (black and white) film over the ultraviolet 
transilluminator.
Gels were soaked in acid (0.2M HCl) for twenty minutes, in 
denaturation solution (0.5M NaOH, 1.5M NaCl.) for 2x twenty minutes 
and in neutralisation solution (3M NaCl, 0.5M Tris.HCl pH 7.4) for 
a further 2x twenty minutes. DNA was transferred from the gel to 
the membrane (Amersham Hybond-N) in the presence of lOx SSC (1.5M 
NaCl, 0.15M sodium citrate) as described below.
A tank was filled with lOxSSC. A wick was prepared by laying a 
double thickness of Whatman 3MM paper over a glass plate placed 
across the tank such that either end of the 3MM paper was within 
the buffer. Once it was ensured that the wick was entirely wet and 
uniformly flat, the gel was placed on top of the wick. Hybond-N 
membrane (Amersham international pic), labelled and cut to size, 
was laid gently on top of the gel. Two sheets of 3MM paper (soaked 
in 2xSSC and cut to size) and two additional (dry) sheets of 3MM 
paper (also cut to size) were placed on top of the membrane. The 
remaining area of the wick was shrouded with plastic sheeting and a 
stack of paper hand-towels (Bowater-Scott), a glass plate and a 
small weight placed on top of the gel.
Transfer occurred overnight after which time the blotting 
apparatus was dismantled, the membrane rinsed briefly in 2xSSC to 
remove traces of agarose and baked at 80°C for five hours (or 
subjected to uv treatment for four minutes).
2:7:3 Hybridization of Southern Blots
Filters were prehybridised and hybridised as described in 
section 2:3:2) or prehybridised and hybridised in the same buffer, 
using 3-5ml buffer per 10cm x 13cm filter. This buffer was 50% 
formamiae, 3xDenhardt's, 5xSSC, 25mM sodium phosphate pH6.8,
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250pg/ml sonicated denatured salmon sperm DNA, 1% SDS, 20pg/ml poly 
A and 10% dextran sulphate. The denatured probe was added directly 
to the plastic bag containing the. prehybridised filters. 
Hybridisation was overnight (sixteen hours) for probes labelled by 
nick translation or for two nights (forty hours) for probes 
labelled by oligonucleotide priming.
Excess probe was removed by washing the filter in 2xSSC, 0.1% 
SDS at room temperature for twenty minutes. Filters were washed 
sequentially in solutions of increasing stringency for twenty to 
thirty minutes each as required; lxSSC, 0.1% SDS (room 
temperature), lx SSC, 0.1% SDS (65°C), 0.5x SSC, 0.1% SDS (65°C), 
O.lx SSC, 0.1% SDS (65°C) and 0.05x SSC, 0.1% SDS (65°C). The 
strength of the signal was assessed . between washes with a ngm 
mini-monitor" (Type 5.10). Filters were blotted dry and placed 
between plastic sheets. The filters were then placed on a sheet of 
Kodak XAR-5 film in an autoradiographic cassette with "Dupont 
lightning plus" intensification screens and exposed overnight at 
-70°C (or from four hours to ten days as necessary). Films were 
developed as described in section 2:4:2.
2:8 PHOTOGRAPHY.
Autoradiographs were photographed using a Pentax 35mm camera 
(p30 SLR) with a SMC Pentax-A macro 50mm f/2.8 lens and Ilford PanF 
film. Films were developed for five and a half minutes in an 1:9 
dilution of Ilford Ilfospeed developer, stopped in 3% acetic acid 
for thirty seconds, fixed in an 1:4 dilution of Hypam fixative 
(with l/40th part Aculux hardener) for three and a half minutes 
minutes and rinsed with tap water and a few drops of photoflow 
(Kodak) for fifteen minutes. Negatives were enlarged on an Leitz 
(Wetzlar) enlarger and prints produced on Ilford number 3 paper. 
Prints were developed for one minute using an 1:9 dilution of 
Ilfospeeed developer at 20°C, rinsed in water, fixed for sixty 
seconds in an 1:9 dilution of Hypam fixative, rinsed in water again 
and dried using an Ilford Ilfospeed 1050 print drier.
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2:9 SOMATIC CELL HYBRIDS.
AMIR2N was the gift of Dr p Goodfellow (Goodfellow et al, 
1983), ' derived from the translocation in AM (1729), 
46,Yt(X;Y)(p22.3;qll.2), (Ferguson-Smith et al, 1981). The 
breakpoint at Xp22.3 is proximal to the locus for STS.
Hybrids LNA9, EHA9, W2A9 and W5A9 were cloned by N. Morrison
and L.Florentin in this department. LNA9 was derived from a patient 
LN, with an 46,XXp- karyotype, EHA9 was derived from EH, with a 
46,XX,t(X;ll)(p22;pl5) karyotype, W2A9 was derived from the 
lymphoblastoid line of an individual with a 46,XX,t(X;8)(p21;q24) 
karyotype and W5A9 was derived from the lymphoblast oid cell line of 
individual with an 46,XX,t(1;X)(p32;p21) karyotype and a 
paracentric inversion betweeen Xpll and Xp21, described by 
Lindenbaum et al (1979). The region of the X-chromosome retained in
these hybrids is illustrated in figure 1.
H0RL9X (Goodfellow et al, 1980) was a somatic cell hybrid 
containing only the X-chromosome whilst 3E7, isolated by M.Marcus & 
R. Voss from the hybrid described by Marcus et al (1976), contained 
only the Y-chromosome.
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AMIR2NH0RL9X LNA9
Figure 1: Diagrammatical representation of the extent of the
X-chromosomal region in the somatic cell hybrids studied.
CHAPTER 3: RESULTS
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3:1 CONSTRUCTION OF AN X-CHROMOSOME SPECIFIC LIBRARY IN
LAMBDA-PHAGE NM1149.
An EcoRI library was prepared in lambda NM1149 from 1.13 x 106 
sorted "X-chromosomes" (200-250ng DNA) as outlined in section 2:3. 
It was tit red on both NB78 and NM514 and values of 116 000 and 
68 100 plaque forming units (pfu) / total library (4ml) were 
obtained. As all bacteriophage will form plaques on NB78 and only 
recombinant phage form plaques on NM514, the difference in titre 
gives an indication of the proportion of non-recombinants. Thus, 
non-recombinants represent about one-third of this library.
The titre of the library fell prior to the second round of 
plating out, so that it no longer represented the entire X 
chromosome (which requires 50 000 recombinants). Thus, due to the 
reduced titre and the high proportion of non-recombinants, 
amplification of the X-library was undesirable and the library was 
plated out directly (on NM514 cells).
3:2 SCREENING OF THE LIBRARY.
32Plaque transfers were performed and screened with JZ,P labelled 
nick-translated total human (female) DNA in order to select for 
"single copy" inserts or inserts with low level repeats. Those 
recombinant plaques which failed to demonstrate hybridisation (and 
thus contained no repeat sequences or a low copy number of repeat 
sequences) were picked, 10-  ^dilutions in SM buffer were prepared 
and putative recombinants were plated out again at low density. 
These techniques are described in section 2:4.
A second round of screening, which would have selected against 
some of the recombinants containing more highly repeated sequences, 
was not performed at this stage. This accounts for the moderate 
repeats apparent in some of the recombinants characterised (figure 
2). A second round of screeening would also have increased the 
relative proportion of non-recombinants amongst the plaques 
selected.
One hundred and twenty single plaques were selected and DNA 
was prepared from liquid lysates as outlined in section 2.4. Fifty 
of these phage were shown to have inserts (figure 2) and were
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labelled by the random hexa-nucleotide primed ("oligo-") method 
(section 2:5:2) .
3:3 REGI0NA1 MAPPING OF PROBES ON THE X-CHROMOSOME.
Each insert was hybridised to an X-chromosome EcoRl 
mini-panel, consisting of 7pg DNA from each somatic cell hybrid
(section 2:9) as follows:
1. female DNA
2. Horl9X X-only hybrid
3. LNA9 Xcen-Xqter
4. AMIR2N Xp22.3-Xqter
5. EHA9 Xp22.1-Xqter
6. W2A9 Xp21-Xqter
7. A9 mouse parent
Of fifty inserts, sixteen were X-specific (hybridised to the 
X-only hybrid), four were autosomal and six were highly repeated 
sequences. One was a moderate repeat with mouse homology. The 
remaining twenty two inserts demonstrated no, or non-specific, 
hybridisation and were presumably of phage or E.coli origin (figure 
2).
Excluding data from EHA9 (see below), this panel assigned 
X-specific inserts to Xq or to one of three regions on Xp; (i) 
Xcen-Xp21, (ii) Xp21-22.3 or (iii) Xp22.3-Xpter. These assignments 
are summarised in table 4. Autoradiographs of these results (except 
for those obtained with X37 and X89) are shown in appendix 1. 
Probes X37, X38, X48 and X74 contained moderate repeats.
Specifications of the X-specific inserts are shown in table 5.
Four Xp probes, including representatives of each of the three 
classes described earlier, were obtained. GMGX10 (X24) was assigned 
to Xp21-Xcen, GMGXll (X66) and GMGX12 (X112) to Xp21-Xp22.3 and 
GMGX9 (X47) to Xp22.3-Xpter. These four inserts were subcloned 
into the EcoRI site of pUCl9 (section 2:6:3).
The breakpoint in hybrid EHA9 was ascertained cytogenetically 
as Xp22.1 which was inconsistent with results with probe GMGX9 
(X47). Data with GMGX9, (table 4 and appendix 1), indicated that
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EHA9 had a more distal breakpoint than AMIR2N, at Xp22.3. Probes 
GMGXlO, GMGXll and GMGX12 were all present in EHA9. EHA9 thus has 
Xp sequences both proximal and distal to the breakpoint in W2A9. 
This anomaly might be explained by an interstitial deletion, a 
rearranged X-chromosome in EHA9 or a more distal breakpoint in EHA9 
than AMIR2N. No conclusions were drawn from data with EHA9.
3:4 INITIAL CHARACTERISATION OF GMGX9-12.
Only the Xp-specific probes were characterised further. Probes 
are most useful when they detect RFLPs and/or deletions and thus 
these possiblities were explored for each of the four Xp probes 
(GMGX9, GMGXlO, GMGXll and GMGX12).
3:4:1 Search for RFLPs.
A search for high frequency restriction length polymorphisms 
(RFLPs) was performed for the four Xp probes (GMGX9, GMGXlO, GMGXll 
and GMGX12) using panels of two males and five females (or seven 
females) digested with each of the following restriction enzymes: 
Alul, Bell, Bglll, Ddel, Dral, EcoRV, Haell, HincII, Hindlll, Mbol, 
MspI, PstI, PvuII, Rsal, TagI and Xmnl.
No polymorphisms were detected with GMGXlO, GMGXll or GMGX12 
with these sixteen enzymes. Only one polymorphism was detected with 
GMGX9 using HindiII. This is a two allele system which detects 
either a 4kb band or two bands of 2.5kb and 1.5kb in normal 
individuals, and is illustrated in figure 3.
Forty normal males and forty normal females were screened in 
order to calculate the allele and heterozygote frequencies for 
GMGX9. These were determined as 67% for the 4kb and 33% for the 
2.5/1.5kb alleles respectively. The heterozygote frequency was 53% 
and the polymorphic information content (PIC) value was 0.44 (i.e.
2x 0.67 x 0.33).
Applications of this polymorphism will be discussed below
(section 3:4:2 and sections 3:7:1-3).
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Flow sorted 
X-chromosomes
X-library
Screen with Total human DNA
Non-hybridising plaques Hybridising plaques 
(n=120) \  (n=395)
Inserts
(n=50)
X-specific Autosomal
(n=16) (n=4)
Repeated Other
(n=6+l) (n=23)
Xp Xq
(4 probes) (12 probes)
GMGX9 GMGX8
GMGXlO GMGX13
GMGXll GMGX14
GMGX12 GMGX15
GMGX16
GMGX17
GMGX18
GMGX19
GMGX20
GMGX22
GMGX23
GMGXY12
Figure 2: Characterisation of the x-chromosome library.
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INSERT I 2 3 4 5 6 7
X23/GMGX8 + + + + + + -
X24/GMGX10 + + - + + + -
X30/GMGX19 + + + + + + -
X37/GMGX22 + + + + + + -
X38/GMGX20 + + + + + + -
X47/GMGX9 + + - - + - -
X48/GMGX18 + + + + + + -
X53/GMGXY12 + + + + + + -
X60/GMGX16 + + + + + + -
X66/GMGX11 + + - + + - -
X74/GMGX13 + + + + + + -
X89/GMGX17 + + + + + + -
X92/GMGX14 + + + + + + -
X94/GMGX15 + + + + + + -
X110/GMGX23 + + + + + + -
X112/GMGX12 + + - + + - -
Table 4: Hybridisation of recombinants to the EcoRI somatic cell 
hybrid panel. These hybrids are described in materials and methods. 
Autoradiographs of these results are shown in appendix 1.
Name Lab name Vector Insert Location DXS number
GMGX8 X23 NM1149 5kb Xq 236
GMGX9 X47 PUC19 7kb Xp22.3-pter 237
GMGXlO X24 PUC19 6kb Xp21-cen 238
GMGXll X66 PUC19 1.2kb Xp21-p22 239
GMGX12 X112 PUC19 4.5kb Xp21-p22 240
GMGX13 X74 NM1149 2.5kb Xq 241
GMGX14 X92 NM1149 2.5kb Xq 242
GMGX15 X94 NM1149 3.5kb Xq 243
GMGX16 X60 NM1149 4kb Xq 244
GMGX17 X89 NM1149 5k b Xq 245
GMGX18 X48 NM1149 2.5kb Xq 246
GMGX19 X30 NM1149 8kb Xq 247
GMGX20 X38 NM1149 4kb Xq 248
GMGX22 X37 NM1149 2.5kb Xq 250
GMGX23 X110 NM1149 5kb Xq 251
GMGXY12 X53 PUC19 1.6kb Xq/Y /
Table 5: Specifications of X-specific recombinants.
All are inserts are released by EcoRI digestion.
?o
—
4kb
•
•  •
2.5kb
1.5kb m fe
Figure 3: The GMGX9(Hindlll) polymorphism, shown in a normal
family.
3:4:2 The preliminary deletion screen with GMGX9, GMGXlO, GMGXll
and GMGX12.
The panel which was used to screen for deletions at the DMD 
locus consisted of two individuals with complex phenotypes (BB and 
MJ, described below) and nine individuals with BMD or DMD with 
deletions of pERT87-8 and/or XJ1.1. These nine boys had been 
detected from amongst eighty seven boys with DMD or BMD prior to 
beginning this project (D. Wilcox, unpublished observations). The 
pedigrees of these nine individuals are illustrated in appendix 2A.
Scottish individuals are identified by both initials and 
pedigree numbers (indicated in parenthesis) in the text and by 
pedigree numbers in the figures and appendices. Other individuals 
are identified by their initials and/or place of origin eg
"(Oxfo)"; Oxford, "(Card)”; Cardiff.
BB had chronic granulomatous disease, retinitis pigmentosa and 
the McCleod syndrome in association with DMD (Francke et al, 1985) 
whilst MJ (Oxfo) had DMD, congenital adrenal hypolplasia (AHC) and 
glycerol kinase deficiency (GK), (Davies et al, unpublished
observations). AM (5996) and JR (5194) who both have AHC but not 
DMD or GK deficiency are also included in this panel.^AM (5996) but 
not JR is mentally retarded. Results for AM(5996) and JR (5194) 
will be presented in section 3:5:6.
GMGXlO was deleted in BB and MJ (Oxfo) and also in SS (and his 
cousin JD, 5099), (table 6 and appendix 2). GMGXll was only
deleted in MJ (Oxfo) (table 6 and appendix 2B) and GMGX12 was not
deleted at all (table 6).
BB and SS (and his cousin JD, 5099) had large deletions
(visible on FACS analysis, Wilcox et al, 1986) as did MJ (Oxfo) (A.
Cooke, unpublished observations) which suggested that both GMGXlO 
and GMGXll might be further from "the DMD gene" than either pERT87 
or XJ.
GMGX9 was not deleted in any of these individuals (appendix
2b ) as predicted by its assignment to Xp22.3. It was, however,
unexpectedly shown to detect deletions in individuals with X-linked 
ichthyosis. This became apparent whilst undertaking RFLP analysis 
in these families (sections 3:7:1-3) and greatly increased the 
value of GMGX9.
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C O  5 5 3 5 5 4 5 0 5 5 5
a x  0 0 4 1 3 0 3 1 2 0 9
r f  9 9 8 1 1 9  1 2 6 9 9
d o  9 9 5 6 3 7 1 ^ 0 5 7 6
DH MJ BB SS JD SJ SB NJ SM PE AB AK JB AM
Telomere
GMGX12 + + + + + + + + + + + + + +
D2 + + + + + + + + + + + + +
99.6 + + + + + + + + + + + + +
B24 — + + + + + + + + + + + + —
C7 - + + + + + + + + + + + + -
Ll-4 — + + + + + + + + + + + + —
J66H1 — — + + + + + +■+ + + + + +
GMGXll - -  + + + + + + + + + + + +
p20 - + + + + + + + + + + + +
J-Bir - + - -  + + + + + + + + +
PERT87.30 +
pERT87.15 +
PERT87.8 +
PERT87.1 - - - - - - - -  + + + + +
XJ 10.1 — — — — — — + + + + — — +
XJ2.3 — — — — — — + + + — — — +
X J 1.1
XJl.2 - — — — — — + + + — — — +
HIP25 +
XJ5.1 — — — — — — + + + — + —
JMD - + + + - + +
J47 + - - -  + + + + + - + +
PERT84 - - - - -  + + + + + + + + +
754—11 — — — — + + + + + + + + +
754-6 — — — — + + + + + + + + +
754 — — — — — + + + + + + + + +
GMGXlO - - - -  + + + + + + + + +
OTC + + + + + + + + + + + + +
LI. 28 + + + + + + + + + + + + +
p58.1 + + + + + + + + + + + + +
Centromere
Table 6: Results of hybridisation of Xp probes to the DMD deletion 
panel.
(+/ hybridisation; deletion; blank/ not tested. See appendices 2 
and 3 for autoradiographs. The position of GMGX12 is approximate.)
3:4:3 A summary of initial findings.
In summary a library was constructed and sixteen X-specific 
recombinants were defined, four of which mapped to Xp.
GMGX9 was assigned to Xp22.3-pter and was the only probe to 
detect a polymorphism.
GMGXlO was mapped to the interval Xp21-cen and detected 
deletions in three unrelated individuals with DMD and/or complex 
syndromes including DMD.
GMGXll and GMGX12 were assigned to Xp21-p22.3. GMGXll was 
deleted in an individual with DMD, GK defeciency and AHC, whilst 
GMGX12 did not detect deletions.
3:5 FURTHER CHARACTERISATION OF GMGXlO, GMGXll AND DMD DELETIONS.
3:5:1 Extension of the preliminary deletion screen to include other 
probes.
Of the nine deleted boys with BMD/DMD described above, three 
were deleted for XJl.l alone, three for pERT87-8 alone and three 
for both probes corresponding to 7% (six out of eighty seven) boys 
at each locus. All eighty seven boys were screened with XJ1.2, 
early in the project but no new deletions were found.
These nine individuals, together with BB, MJ (Oxfo) and AM 
,(5996) were studied with twenty seven probes (listed in table 6) 
which spanned Xp21 from Xpll to Xp22 (figure 14). A composite of 
most of the autoradiographs obtained is presented in appendix 2C, 
whilst the results are tabulated in table 6.
These eleven deletions could be resolved into ten groups as 
follows (table 6) : MJ (Oxfo) was deleted from GMGXlO to J66H1, BB 
from GMGXlO to pERT87-30, SS (5099, and his cousin, JD) from GMGXlO 
to JBir, SB (5116) from JMD to pERT87-30, SJ (3485) from JMD to 
PERT87-15, NJ (5313) and SM (4907) from pERT87-l to pERT87-30, PE 
(5311) from pERT87-8 to pERT87-30, AB (0120) from J47 to XJ10.1, AK 
(5265) from Hip25 to XJ2.3 and JB (the only Becker deletion, 5097) 
from XJ5.1 to XJ2.3 Only NJ (5313) and SM (4907) were not resolved 
by these probes.
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A further individual, DH (Card) (from P.Harper), with a
"complex phenotype" (DMD/ GK/ AHC and mental retardation) was 
included belatedly and has not been completely characterised.
DH (Card) had an extensive deletion including probes pERT84 and
C7/B24 (table 6 and figure 4).
An attempt was made to relate the extent of the deletion to 
the severity in phenotype but no clear correlation was apparent, 
for example the deletion in JB (5097), with BMD, encompasses that 
of AK (5265), with DMD. This argued against a BMD-specific domain.
Only JB (5097) was classified as BMD. SS (5099) was severely 
mentally retarded (and his cousin JD less so). JD (5099) was 
included in the analysis, although he was not an independent 
mutation, because of this discrepancy. The other eight 'boys were 
not mentally retarded and did not have glycerol kinase defeciency 
or congenital adrenal hypoplasia.
Anomalous hybridisation was observed with probe J47 in MJ 
(Oxfo) (table 6 and appendix 2), which suggests that his deletion 
is not contiguous or that a complex rearrangement or inversion has 
occured prior to the generation of his deletion. Other anomalies 
appear in the flow karyotype of his lymphoblastoid cell line (A. 
Cooke, personal communication) but it is nevertheless difficult to 
explain how this might have arisen.
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Figure 4: Results of hybridisation to Card(DH), Oxfo(MJ) and to
somatic cell hybrids W2A9 and W5A9.
(FC, female control; 5311, male with DMD only; A9,-mouse parent cell 
line. Details of Card(DH) and Oxfo(MJ) are given in the text whilst 
W2A9 and W5A9 are described in materials and methods).
3:5:2 Fine mapping of GMGXlOf GMGXll and GMGX12 arising from the 
extension of the deletion screen.
Based on the assumption that the deletions were contiguous, it 
was possible to deduce the approximate position of any new Xp21 
probes isolated with respect to those already available (table 6 
and figure 5).
GMGXlO was assigned to the region of overlap in the deletions 
of SS and JD (5099), BB and MJ (Oxfo), and excluded from the region 
of their overlap with other deletions e.g. SJ (3485). 754 and 
PERT84 both detected deletions only in these individuals. This 
localised GMGXlO between OTC and J47, (which flank 754 and pERT84), 
(table 6 and figure 5).
Two somatic cell hybrid lines, W2A9 and W5A9, (section 2:9) 
were used to further refine the localisation of GMGXlO. Since 754 
was present in both these hybrids, the breakpoints in W5A9 and W2A9 
were distal to 754. W2A9 but not W5A9 was deleted for pERT84 
(figure 4) and thus the breakpoint in W2A9 was proximal to pERT84. 
GMGXlO was present in W2A9 which localised it proximal to pERT84, 
(figure 5).
GMGXll was deleted in MJ (Oxfo) (and DH (Card) (figure 4)). 
J66H1 was also deleted in these two individuals but not in other 
members of the deletion panel. This localisation was supported by 
the following observations. Firstly, as GMGXll was absent in W2A9, 
it mapped distal to 754. Secondly, GMGXll was not deleted in SS or 
JD (5099) and thus mapped distal to JBir (which is deleted in these 
cousins, see table 6). Thirdly, as GMGXll, but not Ll-4, was 
deleted in MJ, GMGXll mapped proximal to Ll-4. GMGXll was thus 
localised between JBir and Ll-4 but not orientated with respect to 
J66H1 (figure 5). Further evidence pertinent to the localisation of 
GMGXll (and of GMGXlO) will be presented in the discussion (section 
4:2:1).
GMGX12 was absent in W2A9, placing it distal to 754 and 
present in DH (Card), (figure 4), placing it distal to B24/C7. 
GMGX12 was also present in AMIR2N which placed it proximal to the 
Xp22.3 breakpoint i.e. proximal to GMGX9 and STS (figure 5).
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3:5:3 Screening of all DMD/BMD boys for deletions with GMGX10, 
GMGXll and GMGX12.
EcoRI and HindiII digests were prepared from eighty seven 
unrelated DMD males, fifteen unrelated BMD males and a further 
male, SR (2161), aged ten, with either BMD or DMD. These were 
screened with GMGX10, GMGXll and GMGX12 in order to search for new 
deletions.
GMGX10 detected only those deletions which had already been 
described in SS and JD (5099), BB and MJ (Oxfo) (section 3:4:2). 
GMGXl2 detected no deletions. GMGXll detected sixteen deletions 
amongst the EcoRl digests, fifteen deletions amongst HindiII 
digests and altered fragment sizes in a further two patients, 
NR(7589) and PS (4033) (table 7). Thus GMGXll detected 
abnormalities in eighteen of one hundred and three (18%) boys. 
Autoradiographs showing hybridisation of GMGXll to HindiII filters 
of these boys are presented in appendix 3.
Differences were detected by GMGXll between EcoRl and Hindm 
digests in four boys. Two of these, SR (5561) and MT (0107), 
revealed a larger than normal Hindm fragment but were deleted for 
the EcoRl fragment detected by GMGXll. The third, DM (3328), was 
deleted for the HindIII fragment but revealed a larger than normal 
EcoRl fragment whilst the fourth, PS (4033), had two EcoRI 
fragments smaller than the expected size but was not deleted for 
the Hindm  fragment (table 7 and appendix 3).
These altered bands were not due to plasmid contamination, 
partial digestion or degradation as normal band sizes were detected 
on sequential hybridisation of these filters with other probes 
(section 3:5:4). They may therefore represent rare polymorphisms, 
partial deletions, point mutations altering the restriction site in 
question or endpoints associated with other chromosomal aberrations 
such as inversions or duplications.
The endpoints of the deletion (or rearrangement) are most 
precisely defined for NR(7589) and PS(4033) who are not completely 
deleted for either EcoRI or HindiII fragments but differentiate
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between the two enzymes at the GMGXll locus.
3:5:4 Extension of the deletion analysis to include probes in the 
vicinity of GMGXll.
JBir and p20 (proximal to GMGXll) and J66H1 (distal to GMGXll) 
were used to examine the extent of the deletions detected by GMGXll 
and to search for further mutations. These probes were tested on 
the EcoRI and HindiII filters used in the screen for deletions with 
GMGX10, GMGXll and GMGX12.
p20 was tested on the Hindlll filters and detected eight 
deletions, five partial deletions and nine individuals with novel 
fragment sizes (including seven with two or more of the three 
Hindlll fragments detected in the majority of individuals, see 
table 7).
p20 demonstrates an Mspl polymorphism with constant bands of 
1.5kb and l.Okb and alleles of 6kb and 3kb (table 3). Mspl digests 
were performed on all boys with deletions or alterations detected 
by GMGXll, JBir or p20. Complete deletion of p20 (i.e. deletion of 
both constant bands and alleles) was observed in JB(5534), AS 
(2672), SMcK (7501), AW (7866), GN (4947), PM (3623), EH and JL 
(5190), DMcC (1596), JS (3896) and DC (4051)), whilst the allelic 
bands ("Al" (3kb) or "A2" (6kb)) but not the "constant bands" were 
deleted in three families, (SR (2161), RW, (3468) and DW (3995)), 
(table 7). A small extra band was observed in MT(0107) and 
JB(4629). Examples of these results are illustrated in appendix 4.
The number of "deletions" detected by p20 differed according 
to the restriction enzyme (Mspl or Hindlll) used (table 7 and 
appendix 4). At least nine of the individuals tested exhibited 
enzyme specific differences (WB (3405), AW (7866), SMcK (7501), GN 
(4947), JC (4221), JB (4629), MB (0187), BP (3552) and AP (5110)). 
Some individuals deleted for the Mspl fragments of p20 but not 
Hindlll fragments may not have been detected as Mspl digests were 
only performed for those individuals already known to be deleted.
As p20 was derived from two sequences some 30-40kb apart, 
either fragment, both fragments or neither fragment might be 
altered or deleted in the vicinity of a restriction site dependent 
on the restriction enzyme used, thus accounting for the variation
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observed.
It is worthy of note that six of the families which show an 
altered pattern of hybridisation to p20 have been classified as 
BMD: 4629, 5190, 3468, 3995, 4002 and 4051. SR (2161) may represent 
a seventh BMD family with an altered pattern of hybridisation to 
p20 but his DMD/BMD status is still in question. These six families 
represent at least 40% BMD families in this study. Three of these 
have the same Hindm  fragments (table 7), which are also shared by 
SR (2161) and DP (4786) with DMD. Examples of autoradiographs 
obtained with p20 are presented in appendix 4.
JBir was hybridised to Hindm filters and J66H1 to EcoRI 
filters. JBir detected deletions in SS and JD (5099), as described 
earlier (table 6), MT (5657) and IM (4180). JBir also detected an 
altered fragment size in JL(1406). These results are also presented 
in appendix 4.
J66H1 detected a fragment of altered size in MT(5310)
(appendix 4). Sixteen individuals were observed to have a fragment
of similar size to that in MT(5310), in addition to the normal 
fragment. Ten of these individuals are deleted or have fragments of 
altered size for JBir, p20 or GMGXll and are amongst those listed 
in table 7. Mutations were not detected with p20, GMGXll or J66H1 
amongst the other six affected males; JT (3568, BMD), AC (5113, 
DMD), RC (7500, DMD), ML (7502, DMD), SM (3997, DMD) and MP(7497, 
DMD). Autoradiographs showing hybridisation of J66HI to MT(5310), 
AC (5113) and RC (7500) can be found in appendix 4.
The significance of this finding with J66HI is not yet
determined. Some of these individuals may have contiguous deletions 
with an endpoint detected by J66HI, but as some are additionally 
deleted for p20, but not GMGXll, (table 7), it seems more likely 
that the extra band represents a polymorphism rather than the 
endpoint of a mutation.
The pedigrees of individuals listed in table 7 are shown in 
appendix 5. Pedigree 5099 is shown in appendix 2.
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Name Ped.No JBir(H) p20(H) p20(M) GMGXll(H) GMGXll(R) J66(R)
JB 5534 D + — _ +
JB 0198 D + 123 12A2 — +
WB 3405 D + 13H 12A1 — _
JH 5098 D + 123 7 _ _ +L
SR 5561 D + 123 12A2 H _ +L
JS 5538 D + 7 12A1 — — +
AS 2672 D + - - _ +
MT 0107 D + 123 12A2L H — +L
AW 7866 D + 123 - — _ +
NR 7589 D + 123 12A2 H H +L
NMcD 5540 D + 123 12A2 - — +
FMcG 4045 D + 123 12A2 — _ +
SMcK 7501 D + I - — — +L
PS 4033 D + 123 12A1 + 2x L +
GN 4947 D + L - - _ +L
SM 5120 D + 123 12A2 — — +
KM 5120 D + 123 12A2 - — +
PM 3623 D + - - - _ +
DM 3328 D + 123 12A2 - H +
MT 5310 D + 123 12A1 + + L
MT 5657 D - 123 12A2 + + +
IM 4180 D - 123 12A2 + + +
SS 5099 D - 123 12A2 + + +
JD 5099 D - 123 12A2 + + +
JL 1406 D H 123 12A1 + + +
MJ Oxfo D - - - - — _
JC 4221 D + 13H 12A2 + + +
JB 4629 B + 123L 12A2L +H + +L
MB 0187 D + 121 12A2 + 7 +L
EH 5190 B + - - + + +
JL 5190 B NT - - NT + +
DMcC 1596 D + - - + + +
SR 2161 B/D + 23 12 + + +
BP 3552 D + 13H 12A1 + + +
AP 5110 D + 13H 12A2 + + +
JS 3896 D + - - + + +
RW 3468 B + 23 12 + + +
JH 3468 B + 23 NT + NT +
RMCL 3468 B + 23 NT + NT +
DW 3995 B + 23 12 + + +
CS 3995 B + 23 NT + + +
DC 4051 B + - - + NT +
SB 5972 D + 123L NT + NT +
CK 4002 B + 23 NT + + +
DP 4786 D + 23 NT + + +L
Table 7: Deletions detected by JBir, p20, GMGXll or J66HI.
(+, positive signal; -, deletion*, NT,-' not tested; ?; unclear 
result.(H);Hindlli; (M),MspI; (R),EcoRI. 123, normal restriction 
fragment pattern with p20 (Hindlll); 12A1 or 12A2,- normal pattern 
with p20 (Mspl), 1 and 2 are constant bands, Al represents the 
3.5kb allele and A2 the 6kb allele. H, higher than normal fragment; 
L, lower than normal fragment; I, novel p20 Hindlll fragment of 
intermediate size (between "2" and "3"). Sample autoradiographs are 
shown in appendices 3 and 4).
3:5:5 Contiguous gene syndromes involving DMD, ordering of loci in
Xp21 and the definition of a deletion in an individual with AHC.
BB was affected with DMD and also with chronic granulomatous 
disease (CYBB), retinitis pigmentosa type 3 (RP3) and the Mccleod 
syndrome (XK). BB was deleted from GMGX10 to pERT87.30. His 
deletion was very similar to that of SS (5099) which extended from 
GMGX10 to JBir inclusive (table 6). SS (5099) had DMD and mental 
retardation but none of the other disorders described in BB. SS's 
deletion extends more distally than BB's which suggests that CYBB, 
RP3 and XK are all proximal to DMD (figure 6).
DH (Card) and MJ (Oxfo) both suffered from DMD, GK and AHC. 
MJ(Oxfo) was deleted from GMGX10 to J66H1 whilst DH was deleted 
from 754 to B24/C7. SS (5099) had neither GK nor AHC and was 
deleted from GMGX10 to JBir. Direct comparison of the deletions in 
MJ (Oxfo) and SS (5099) assigns GK and AHC distal to JBir and 
proximal to Ll-4 (which is present in MJ (Oxfo)) (table 6 and 
figure 6).
AM (5996) was affected with AHC and was also severely mentally 
retarded. Thus, although he did not suffer from GK deficiency or 
DMD, he was a "good candidate" for a micro-deletion. AM (5996) was 
deleted for Cl (appendix 2C) and also for B24 and Ll-4 (appendix 2C 
and figure 7) but not for J66H1 or D2, or other Xp probes tested, 
(table 6 and figure 7).
As AM (5996) is not deleted for J66HI, his deletion places AHC 
distal to J66HI. Assuming that the deletions in MJ and AM (5996) 
are overlapping this deletion also suggests that AHC is distal to 
GK deficiency (figure 6).
The mother of AM (5996) , but not his grandmother, was mildly 
mentally retarded which suggested his mother (but not his 
grandmother) carried the deletion. His grandmother was found to be 
heterozygous for B24 confirming that she did not carry the 
deletion. (C7 was not informative and Ll-4 is not polymorphic).
DNA studies were performed on flanking markers and AM (5996) 
was shown to have inherited proximal markers from his grandfather 
(754 and J66H1) and the distal marker GMGX9 from his grandmother. 
Other distal markers tested (99.6, D2, 782 and RC8) were
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uninformative.
Although the GMGX9 result suggests that the deletion in AM 
(5996) might have occurred by recombination in a maternal gamete, 
GMGX9 (within Xp22.3) is not tightly linked to B24/C7 (within 
Xp21.2 -Xp21.3). It seems more probable that the deletion occurred 
in a grandpaternal gamete, which was passed to his daughter and 
then to AM. This would explain why AM's mother but not his 
grandmother was mildly mentally retarded.
JR (5194), with AHC, but not affected by DMD, GK or mental 
retardation, was tested for a sub-microscopic deletion in this 
region. JR (5194) was not deleted for Ll-4, B24 or C7 (figure 8) 
although AHC segregated with pERT87.1 (Msp I) and B24 (Mspl) in his 
family (figure 8).
3:5:6 Summary of deletion data.
Thirty-six new mutations were detected with JBir, GMGXll and 
p20 (table 7) and nine deletions with pERT87 and XJ (table 6). DNA 
analysis therefore detected mutations in a minimum of 45% of one 
hundred and three boys with DMD or BMD. Only MJ and DH, who had 
complex phenotypes and extensive deletions, were deleted for 
GMGXll, p20 and J66HI in addition to probes from the pERT87 and XJ 
loci. The thirty three deletions detected by GMGXll and p20 thus 
represent a discrete deletion-rich region.
18% deletions are detected by GMGXll and 22% by p20. There is 
considerable heterogeneity amongst these thirty three deletions 
(table 7) and only three individuals (JB (5534), AS (2672) and PM 
(3623)) are consistently deleted for both GMGXll and p20. Eight of 
the nine deletions at the pERT87 and XJ loci were also resolved in 
this study (table 6) which suggests that there is also considerable 
heterogeneity amongst deletions at these loci.
AM (5996) with AHC, but not GK or DMD, whose deletion includes 
Ll-4, B24 and C7, allows the ordering of the genes for DMD, GK and
AHC in Xp21.
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Figure 8: Results of deletion analysis of JR (5194) and his family.
3:6:1 RFLP analysis of deletions at the DMD locus.
GMGX10, GMGXll and GMGX12 did not detect RFLPs and so linkage 
analysis was not performed. RFLPs defined by other probes were 
used to determine which deletions were new mutations and their 
origins.
The mothers of seven of the nine boys with deletions of pERT87 
or XJ (table 6) were screened with polymorphic probes deleted in 
their sons, in order to determine their status with respect to the 
deletion. These results are summarised in table 8. The mother of SS 
(5099) was not studied as inheritance of his deletion from his 
grandmother had already been demonstrated (Wilcox et al, 1986). The 
mother of SM (4097) had died.
Heterozygosity was demonstrated in the mothers of NJ (5313) 
and SJ (3485). This generally implies absence of the deletion but 
may also indicate germ-line mosaicism. NJ's mother was 
heterozygous, for pERT87-30 (Bglll), pERT87-15 (BamHI), pERT87-8
(Tagl) and pERT87-l (Mspl). SJ's mother was heterozygous for 
PERT87-1 (Mspl) and XJ5.1 (SphI). NJ (5313) and SJ (3485) are 
therefore likely to represent new mutations which most probably 
occurred in a maternal gamete, unless their mothers are germ-line 
mosaics. This will be considered further in the discussion.
The mothers of NJ (5313) and SJ (3485) were also analysed with 
flanking markers in order to determine which grandparent(s) the 
deleted chromosome had been derived from and to determine whether 
the deletion had arisen as a result of recombination. NJ failed to 
inherit his grandpaternal 99.6 (PstI), XJ2.3 (Tagl), XJl.l (Tagl), 
XJ1.2 (Bell), XJ5.l(Sphl), 754 (PstI) and 754-11 (Bglll) alleles
and so appears to have inherited his grandmaternal X-chromosome 
without recombination. These results are presented in appendix 6.
SJ’s grandfather was dead but it can be inferred that SJ has 
inherited his grandfather's 99.6 and 754-11 alleles, and thus his 
grandfather's X-chromosome, with no evidence of recombination. This 
suggests that his grandmother was not a carrier as had been 
assumed, on the basis that his grandmother's brother (individual 
11  ^ in the pedigree reproduced in appendix 2) had been affected 
with DMD. The results for this family are presented in appendix 7.
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The mothers of AB (0120), AK (5265), JB (5097), PE (5311) and 
SB (5116) were not heterozygous for any of the probes deleted in
their sons (table 8) and may be homozygous or hemizygous at these
loci. Grandparental samples, which might assist in defining 
maternal carrier status were only available for AB (0120).
The mother of AB (0120) exhibited the alternative XJl.l, 
XJ1.2, XJ2.3 and XJ5.1 alleles from her own mother. Thus AB (0120) 
had inherited his deletion from both his mother and his
grandmother. These results are presented in appendix 8.
The mothers of AK (5265), JB (5097), PE (5311) and SB (5116) 
are hemizygous or homozygous for three, four, three and eight loci 
respectively for which their sons are deleted (table 8).
If XJ1.2, XJl.l and XJ2.3- (which are in linkage
disequilibrium, Thompson et al, 1986) and pERT87-l and pERT87-8 
(which are also in linkage disequilibrium, Lindlof et al, 1987) are 
each considered as one locus, MB, the mother of SB (5116) can be 
considered to be hemizygous or homozygous for five loci. These loci 
have heterozygote frequencies of 0.32-0.46, with a mean value of 
0.42 (table 3). The theoretical probability that none of these five 
loci are polymorphic is approximately (0.58)~* or 6-7%. This is in 
reasonable agreement with the findings of Bakker et al. (1986) who 
found that 97% of females were heterozygous for at least one pERT87 
or XJ RFLP.
This estimate, combined with a prior risk of 4p (Emery, 1976) 
that MB (5116) is a carrier and CK values which give odds of 1.6:1 
that MB (5116) is a carrier, suggests that MB (5116) is a carrier 
(presumably deleted) with a probability of 0.99 and that SB (5116) 
does not represent a new mutation.
PE (5311) has an affected brother with Duchenne muscular 
dystrophy and mental retardation whilst JB (5097) has an uncle 
affected with Becker muscular dystrophy (ambulant until 14, died 
age thirty nine). These pedigrees are shown in appendix 2. It is 
thus unlikely that PE (5311) and JB (5097) represent new mutations 
and probable that the mothers of these boys do carry the deletion. 
However, as neither affected relative of these boys was available 
for study, it was not possible to confirm that DMD segregated with 
the deletion in these families.
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The sister of PE (5311") exhibited different XJ5.1 and pERT87-l 
alleles from her brother PE (5311). She was also heterozygous for 
pERT87-30 for which he was deleted. Thus she does not have the 
deletion. Similarly the sister of JB(5097) was not a deletion 
carrier as she was heterozygous for XJ1.2, for which JB (5097) was 
deleted. These results are presented in appendix 9.
As GMGXll was not polymorphic, family members of boys from 
nine families deleted for GMGXll (WB (3405), JH (5098), AS (2672), 
AW (7866), FMCG (4045), SMcK (7501), GN (4947), SM and KM (5120) 
and PM (3623) were investigated with two polymorphic markers which 
flanked GMGXll; J66H1 (PstI) and p20 (Mspl).
None of the mothers of these boys were doubly heterozygous for 
p20 and J66HI. Five of these boys (AS (2672), AW (7866), SMcK 
(7501), GN (4947) and PM (3623)) were also deleted for p20 (Mspl). 
None were deleted for J66HI(PstI), although J66HI detected an 
additional EcoRI band in both SMcK (7501) and GN (4947), (section 
3:5:4). The mother of AW (7866) was heterozygous for p20 and thus 
he is likely to represent a new mutation. His sister is also 
heterozygous and thus does not carry the deletion. This result is 
also presented in appendix 9.
Time did not allow the extension of this analysis to include 
JBir and pERT87 proximally or B24/C7 distally or to analyse 
deletions subsequently revealed by p20.
3:6:2 Summary of RFLP analysis at the DMD locus.
In summary, RFLPs, detected by DNA probes other than GMGX10, 
GMGXll and GMGX12, demonstrated that the mothers of three boys with 
deletions (NJ (5313), SJ (3485) and AW (7866)) were heterozygous 
for deleted probes and and were thus unlikely to be carriers for 
the deletion. The mother and grandmother of a fourth boy AB(0120) 
were shown to carry the deletion. The mother of a fifth boy SB 
(5116) was implicated as a deletion carrier by virtue of absence of 
heterozygosity at eight loci deleted in SB (5116).
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M PED. S <-------------- PROBES------------   >
XJ5.1 XJ1.2 XJl.l XJ2.3 87.1 87.8 87.15 87.30
MJ 3485 SJ + • • • + • • •
MB 5116 SB • • • • • • . • •
MJ 5313 NJ / / / / + + + +
JE 5113 PE / / / / . / • • •
MB 0120 AB • • • • / / / /
IK 5265 AK / • • • / / / /
JB 5097 JB / / / /
Table 8: Results of the screen for heterozygosity in the mothers of 
DMD boys with deletions.
(M>- mother; PED, pedigree number; S, son; +, heterozygous; 
., hemizygous or homozygous; /, not applicable (son not deleted). 
87.1, pERT87.l; 87.8, pERT87.8; 87.15, pERT87.15; 87.30, pERT87.30. 
Some of these results for families 0120, 5313, 3485, 5097 and 5113 
are presented in appendices 6-9).
3:7 FURTHER CHARACTERISATION OF GMGX9 POLYMORPHISM AND DELETIONS AT 
THE STS LOCUS.
3:7:1 RFLP analysis with GMGX9.
Linkage studies with GMGX9 were first performed in normal 
three generation families with three or more sons - "Tom, Dick and 
Harry" familes (TDH familes) - which each provided three or more 
informative meioses. Eight out of ten mothers in these families 
were heterozygous. These results are illustrated schematically in 
appendix 10, together with autoradiographs from three TDH families. 
The 4kb allele is represented by an "A" and the 2.5/1.5kb allele by 
a "B" in these schematic diagrams. These results show that GMGX9 
segregates as a mendelian trait.
GMGX9 was then applied to the study of five families 
segregating for XLI (steroid sulphatase deficiency). Eight obligate 
carrier females from five families (two from family 3673, three 
from family 3496 and one each from families 4024, 1348 and 2994), 
were screened with GMGX9 in order to select for heterozygotes. No 
heterozygotes were found.
However, one of three obligate carrier sisters, (JP, 3496) had 
the alternative allele to her two sisters (MJ and HR, figure 9B). 
This indicated inheritance of a null allele from their father, as 
these sisters shared an affected father and each had affected sons. 
DNA samples were available from nine affected males in family 3496 
and GMGX9 was found to be deleted in all nine (figure 9C).
These five families were then studied in full. These results
are also illustrated schematically in appendix 10. Affected
individuals were consistently deleted in all but one family (4024),
in which GMGX9 was also uninformative. Persistence of the deletion 
through three generations was demonstrated in family 3673 (figure
10) and implicated by inheritance patterns in families 1348, 2994 
and 3496 (appendix 10).
GMMGX9 results for families 1348, 2994, 3496, 3673 and 4024, 
(described above), for a sixth family segregating for XLI (1034) 
and for the TDH familes (appendix 10) were combined with those with 
D2, 782, Dic56 and Mic2 (D.Goudie) and Xg (P.Tippett) for
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multipoint linkage analysis (Yates et al, 1987b). The results of 
this linkage analysis are summarised in the discussion.
An Italian family (Ital) segregating for X-linked ichthyosis 
was studied and shown to segregate for a deletion of GMGX9. This 
result is shown in appendix 11. Prediction or exclusion of carrier 
status is possible using GMGX9 in families which segregate for a 
deletion, providing that the parents of the individual under 
investigation have different alleles.
It is possible to predict that individuals Illy (Ital), and 
Illg (3496) who failed to inherit maternal alleles are carriers, 
and that Illy (3496), III9 (3496) and lll15 (3496), who are 
heterozygous for GMGX9, are not (appendix 11 and figure 9A). The 
accuracy of these predictions depends on the frequency of 
recombination between STS and GMGX9 and will be addressed in the 
discussion.
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Figure 10: Deletion analysis of family 3673 with GMGX9.
(A: Pedigree of family 3673. "A'V4kb allele; "B",-2.5/1.5kb allele;
deletion. (B): hybridisation of GMGX9 to the entire family).
3:7:2 Deletion analysis with GMGX9 and other distal Xp probes.
Males from twenty three independent "Glasgow" families 
segregating for STS deficiency, including the six families 
described above, were screened with GMGX9 (table 9). Only four of 
these families (4024, 7664, 3000 and 3307) were not deleted for
GMGX9. XLI segregated with the 4kb allele in families 4024 and 7664 
and with the 2.5/1.5kb allele in families 3000 and 3307.
Eight of nine German families (from A. Gal) were deleted for 
GMGX9. XLI segregated with the 2.5/1.5 kb allele in the ninth 
family (2/85 Br). These results are illustrated schematically in 
appendix 12, together with an autoradiograph showing results in 
families 1/85 (Ln), 2/85 (Br) and 3/85 (Ls). Segregation of the 
deletion with XLI in family 5/85 (Ge) was first inferred by the 
failure of II2 to inherit the 2.5/1.5 kb allele from I5 and was 
confirmed by A. Gal, who showed GMGX9 to be deleted in an affected 
male (III2) - Two out of four Dutch families were also deleted for 
GMGX9 (appendix 12).
Seven of eight affected Italian individuals (from A. Ballabio) 
were deleted for GMGX9 (figure 11). The eigth individual, Ba, has 
the 4kb allele of GMGX9 and will be discussed more fully below.
Thus, thirty-six of forty-two males with XLI (i.e. 86%) were 
deleted for GMGX9. These forty-two males were also investigated (by 
A. Ballabio) with p422, situated 3' to the STS gene. Thirty-seven 
of them were deleted for p422 (A. Ballabio, personal
communication). These included the thirty-six males detected by 
GMGX9 and also Ba, who was not deleted for GMGX9. The cloning of 
STS will be presented in the discussion.
The twenty-three "Glasgow" families were examined with other 
distal Xp probes and markers e.g. Xg (P. Tippett), Dic56, 782, Mic2 
(pl9b), MlA, and STB14 to determine the extent of these deletions. 
(The location and details of these probes are presented in figure 
14 and table 3). Die 56, 782 and pl9b results in families 1034, 
1348, 2994, 3496, 3673 and 4024 were the work of D. Goudie.
p2a4 and the x-specific bands of three Xp-Yq homologous 
probes, GMGXXY3, GMGXY19 and STB14 were deleted in the nineteen 
individuals deleted for GMGX9. (All GMGXXY3 and GMGXY19 results
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referred to throughout this thesis were obtained by M. Mitchell). 
All affected individuals hybridised to 782 and Dic56 and to the 
X-specific sequence of MlA. The majority of affected males tested 
(i.e. ten/ fifteen) were Xg(a) +ve which demonstrates the 
interstitial nature of these deletions. This data is summarised in 
table 9. Examples of the autoradiographs obtained with these probes 
are illustrated in appendix 13.
Ba, who was deleted for p422 but not GMGX9 was tested with 
additional probes in distal xp. He was deleted for p2a4 (figure 11) 
and also for GMGXXY3, but not for STB14 or GMGXY19. Ba is included 
in table 9 for comparison. The other Italian patients were deleted 
for p2a4 (figure 11), GMGXXY3 and GMGXY19.
Thus, Ba had a deletion breakpoint close to or within the STS 
gene which divided probes into two groups; those within his 
deletion (p422, p2a4 and GMGXXY3) and those outwith his deletion 
(GMGX9, STB14 and GMGXY19). STSB14 is known to lie at the 5' end of 
STS but GMGX9 and GMGXY19 could lie to either side of the deletion. 
In common with all males with XLI, Ba was not deleted for the 
X-specific band of MlA.
Several distal Xp probes e.g. MlA, GMGXXY3, GMGXY19 and STB14 
demonstrate homology to Yq whilst others e.g. pl9b and 29Ci 
demonstrate homology to Yp. STS sub-clone p2a4 (and also p422, A. 
Ballabio, personal communication) failed to demonstrate Y homology 
at normal stringency. GMGX9 also failed to detect any homology to 
the Y-chromosome (figure 12), even when hybridisation was performed 
under conditions of low stringency (30% formamide,42°C).
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PED.NO. STS 782 DIC56 XXY3 X9 XY19 p2a4 MlA Xg(a) pl9b/PSGl
JM 3673 nil + + -
SC 2994 nil + + -
DG 1034 2.4% + + -
JA 3710 nil + + -
TR 4024 nil + + +
TM 1348 nil + + -
RJ 3496 nil + + -
JD 0698 nil + + -
SL 7568 NT + + -
AB 4076 nil + + -
DC 3000 nil + + +
DC 7474 nil + + -
FM 7685 NT + + -
GB 7664 nil NT + +
NJ 7750 nil NT + -
EC 3307 nil + + +
HL 7605 nil NT + -
RF 7304 nil NT + -
YM 8056 nil NT + -
CK 5626 nil NT + -
RM 4143 nil NT + -
WR 7672 nil NT + -
RH 8009 nil NT + -
AM 1729 nil + + -
JH 7079 nil + + -
Ba ITALY NT NT +
— - - + + +
- - - + + X
- - - + + X
- - - + + X
+ + + + + +
- - - + + +
- - - + + +
- - - + + X
- - - + + X
- - - + - X
+ + + + - X
- - - + NT X
- - - + NT +
+ + + + - +
- - - + - +
+ + + + NT +
- - - + NT X
- - - + NT X
- - - + NT +
- - - + + +
- - - + - X
- - - + NT X
:
— + NT X
+
—
+ NT NT
Table 9: Screening of Scottish XLI males with distal Xp probes.
(Affected males are identified by their initials and pedigree 
numbers. AM (1729), JH (7079) and Ba are included for 
comparison. +, hybridisation (heterozygote for pl9b/pSGl);
deletion; NT, not tested; x, not informative; XY3,GMGXY3; 
X9,GMGX9; XY19,GMGXY19. PED.NO.,Pedigree number; STS,* STS 
levels^ measured in hair-roots (Ferguson-Smith & Aitken, 1982), 
using H-Dehydroepiandrosterone sulphate (DHEASCL) as substrate 
with the exceptions of 3673, 2994 and 1034 (measured in
fibroblasts) and 7474 (measured in white_ blood cells). The 
assay was a modification of that described by Shapiro et al 
(1977)).
M 1 2 3 Ba 5 6 7 XY Sa F L
GMGX9(ECORI)
p2a4(EcoRI)
Figure 11: Deletion analysis of Italian males.
(M,male control; 1-7,males with XLi; Sa, male with XLI and KAL; 
XY,male with XY translocation; F,female control; L,lambda marker. 
Ba (male 4) and Sa are further described in the text. This blot was 
provided by A. Ballabio).
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Figure 12: Hybridisation of GMGX9 to 3E7 (Y-chromosome specific
hybrid).
(M,-male control; F,female control. Hybrids are as described in 
materials and methods. Unlabelled tracks represent further hybrids 
isolated within this department; lanes 11 and 12 contain only Xq 
sequences, lane 15 is a further mouse cell line).
3:7:3 Analysis of complex phenotypes associated with XLI.
Sa was affected with both Kallmann's syndrome (KAL) and 
X-linked ichthyosis (Ballabio et al, 1986) and was potentially of 
value in ordering disease phenotypes and gene probes in distal xp 
(compare this section with section 3:5:5). He was deleted for GMGX9 
and p2a4 (figure 13), GMGXXY3 and p422 (Ballabio et al, 1987a) but 
not for Dic56 (Ballabio et al, 1986). Thus, his deletion was not 
distinguished from deletions associated with XLI alone.
Three individuals, RR (8050), SS(8012) and JG(8049) affected 
with KAL but not XLI were tested with 782, Dic56, GMGX9, p2a4, 
GMGXXY3, GMGXY19 and pl9b, all of which failed to demonstrate a 
deletion (appendix 14). These individuals represent sporadic cases 
of Kallmann's syndrome, however, and it is possible that they are 
not associated with an abnormality in this region of the 
X-chromosome.
3:7:4 Deletion analysis with GMGX9 and other probes in individuals 
with XY translocations.
AM (1729) and JH (7079) are males with XLI as a consequence of 
XY translocations. AM (1729) is deleted for xg. JH (7079) was 
Xg(a)-ve although his mother and grandparents were Xg(a)+ve. It is 
thus likely (but not proven) that JH (7079) is also deleted for Xg.
Both AM (1729) and JH (7079) are deleted for GMGX9 and p2a4 
and for the X-specific bands of STB14, MlA and pl9B. Some of these 
results are illustrated in appendix 15. The position of MlA 
relative to GMGX9 is not known. AM (1729) and JH (7079) are also 
deleted for the X-specific bands of GMGXXY3 and GMGXY19. Neither 
individual is deleted for 782 or Dic56.
3:7:5 A brief summary of STS deletion data.
In summary GMGX9 detects deletions in thirty-six of forty-two 
(86%) families segregating for STS deficiency. These deletions are 
all detected by other probes including STS cDNA clones and appear 
very similar at the molecular level. Only one of thirty-one 
patients studied in detail revealed a difference between GMGX9 and 
STS cDNA clones. F u r t h e r m o r e  the deletion in an individual with
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both KAL and XLI could not be resolved from that in deleted males 
with XLI. Two XY translocations also failed to separate GMGX9 and 
STS cDNA clones.
3:8 COMPARATIVE MAPPING
3:8:1 Comparative mapping with GMGXll.
It was of interest to determine whether GMGXll was homologous 
to DMD cDNA clones which detected deletions at high frequency or 
represented an additional subset of microdeletions. An Ecori blot 
was prepared with DNA from different mammals as follows: Lanes (1) 
human male, (2) human female, (3) male gorilla, (4) female gorilla, 
(5) male orang-utan (1), (6) male orang-utan (3), (7) male
chimpanzee, (8) ram, (9) ewe, (10) dog, (11) bitch, (12) stallion, 
(13) mare and (14) bull, in order to establish whether 
this sequence was conserved between species.
GMGXll was conserved in primates (gorilla, orang-utang and 
chimpanzee) but not in other mammals (figure 13A). It thus seems 
improbable that GMGXll is expressed.
3:8:2 Comparative mapping with GMGX9.
The high proportion of deletions detected by GMGX9 in STS 
defecient individuals suggested that it might form part of the STS 
gene, it was thus of interest to determine if GMGX9 represented 
part of the coding sequence of STS. Two blots were prepared for
comparative mapping studies using GMGX9. The first consisted of 
primate DNA digested with HindiII as follows: Lanes (1) human male, 
(2) human female, (3) male gorilla, (4) female gorilla, (5) male 
orang-utan 1, (6) male orang-utan 3, (7) male chimpanzee and
(8) male with XLI (RH, 8009). The second consisted of DNA from 
other mammals digested with HindiII as follows: Lane (1) human 
male, (2) human female, (3) ram, (4) ewe, (5) dog, (6) bitch, 
(7) stallion, (8) mare, (9) bull and (10) cow.
GMGX9 was conserved throughout primates (figure 13B) and also 
detects homology with bovine DNA (figure 13C). Weak homology to
bovine DNA is common to many single copy sequences and does not
imply that these sequences are expressed (Monaco et al., 1986).
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Comparative mapping would thus suggest that GMGX9 is not expressed. 
GMGX9 also detects differences between male and female gorilla 
which might represent a polymorphism in these species.
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Figure 13: Hybridisation of GMGX9 and GMGXll to "conparative
mapping" blots.
(M,male; F, female; GM,- gorilla male; GF-,gorilla female; 
0M1, orang-utan male 1 (faint track); 0M3,orang-utan male 3; 
CM;chimpanzee male; R,:ram; E,ewe; D,dog; B,bitch; s, stallion; 
M;mare; Bu,bull; C,cow; RH (8009);male with XLI. (A) EcoRl filter 
hybridised with GMGXll. (B) Hindlll "primate" filter hybridised to 
GMGX9).
C) GMGX9(HindiII)
Figure 13 continued. (C) Hindlll "farm" blot hybridised to GMGX9 
(faint hybridisation).
CHAPTER 4: DISCUSSION
4:1 THE ISOLATION OF Xp SPECIFIC PROBES.
This section considers the likelihood of isolating DNA
sequences which lie within Xp21 or Xp22.3 by "random" selection
from an x-chromosome library, based on estimates of their size with
respect to the X-chromosome as a whole. Similar estimates are given 
for the isolation of sequences within the DMD gene, within
deletions in individuals with XLI and within the large Xp21 
deletion described by Francke et al., (1985). Both random and 
targeted approaches to cloning are discussed with particular 
emphasis on X-chromosome libraries.
4:1:1 Predicted success of random cloning strategy.
This aim of this project was to isolate Xp DNA sequences from 
a chromosome specific library, in order to conduct an analysis of 
Xp, focussing on Xp21 and the analysis of DMD and on Xp22.3 and the 
analysis of STS deficiency, in particular.
The X-chromosome represents approximately 5% of the haploid 
genome or 150Mb, determined by both flow cytometry (Harris et al., 
1986) and cytophotometric data (Mayall et al., 1984). Xp accounts 
for approximately one-third of the x-chromosome whilst Xp21 
represents 20% of Xp (or lOMbp). The size of Xp22.3 has been 
estimated at 5Mb (or 10% of Xp), (Mondello et al., 1987).
On the basis of these approximations, it may be predicted 
that, without targeted selection (see below), one-third of X-linked 
clones would map to Xp, one in fifteen X-linked clones would map to 
Xp21 and one in thirty X-linked clones to Xp22.3 (table 10).
Of sixteen X-linked probes isolated at random from this 
library, four were Xp specific: GMGX9 (DXS237), GMGX10 (DXS238), 
GMGXll (DXS239) and GMGX12 (PXS240). GMGX10 (DXS238) and
GMGXll (PXS239) were mapped to Xp21 and GMGX9 (DXS239) to Xp22.3. 
GMGX12 (PXS240) mapped between GMGXll(DXS239) and GMGX9(DXS237), 
(table 10).
DNA sequences have now been cloned from three hundred and five 
loci on the X chromosome (table 2). There is considerable variation 
in size between these sequences from less than Ikb to several over 
lOOkb. An (arbitary) average value of lOkb indicates that only 3Mb 
or one-fiftieth of the x-chromosome has been cloned.
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Interval Probes isolated from this interval
xp 1/3 0.998 GMGX9, GMGX10, GMGXll, GMGX12
Xp21 1/15 0.67 GMGX10, GMGXll
Xp22.3 1/30 0.42 GMGX9
"BB" deletion 1/25 0.48 GMGX10
"DMD" 1/75 0.19 GMGXll
"STS." 1/1000 
to 1/75
0.015 
to 0.19
GMGX9
Table 10: Predicted success of a random approach in cloning
sequences within specific intervals of interest on Xp21.
(The probability, P, of isolating at least one probe in a given 
region is 1- [(l-p)n]), where p is the theoretical probability 
that any one probe will lie within that region (based on its size) 
and n is the number of X-specific probes isolated. This has been 
calculated for each category assuming n = sixteen, the number of 
X-linked probes isolated in this study. The "BB" deletion is 
described by Francke et al (1985)).
A minimal estimate of 2Mbp for the size of the Duchenne gene 
has recently been deduced by extrapolation of the mean intronrexon 
size ratio (Koenig et al., 1987). The smallest deletions visualised 
by flow cytometry (FACS) analysis at the STS locus are estimated 
at 2Mb (Cooke et al., in press) whilst the STS gene has been 
estimated to represent 140kb (Yen et al., 1987b). Cloning of these 
loci will be presented later.
These data predict that one in seventy-five probes assigned to 
the X-chromosome would lie within the DMD gene and between one in a 
thousand and one in seventy-five probes would be deleted in 
individuals with STS deficiency. Of sixteen X-linked probes derived 
from the library constructed in this project, GMGXll(DXS239) mapped 
within the DMD gene but outwith the deletion described by Francke 
et al. (1985), and GMGX9(DXS237) was deleted in 84% of individuals 
with steroid sulphatase deficiency, (including some with deletions 
not detected by FACS analysis), (table 10).
It can be seen that the probability of isolating one or more 
probes in each of the categories defined in table 10 (except that 
of STS deletions) was 0.19 or more, based on a group of sixteen 
probes isolated at random. Such calculations are only an 
approximation, but serve to demonstrate that attempts to isolate 
probes which mapped within Xp21, Xp22.3, the deletion described by 
Francke et al. (1985) or even the DMD gene were realistic. A more 
accurate determination of the minimum size of STS deletions, 
possibly by pulse field gel electrophoresis (PFGE), will be 
required to assess the probability of detecting deletions at this 
locus more accurately.
4:1:2 Random and targeted approaches to cloning.
Many single copy Xp DNA sequences presently in common use were 
derived from flow-sorted x-chromosome libraries by "random" 
selection for single copy sequences and were localised to Xp using 
somatic cell hybrids. One disadvantage of this approach, however, 
is that selection for single copy sequences results in an increased 
background of non-recombinants (self-ligated vector) and of 
non-human recombinants. Fuscoe (1987) used an oligonucleotide 
complementary to the insertion site of the vector to detect
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non-recombinants. This had the added advantage of detecting all 
recombinants, regardless of their status with respect to repeated 
sequences.
Flow cytometry can resolve all human chromosomes except 
chromosomes 10, 11 and 12 in individuals with appropriate karyotype 
anomalies (Harris et al., 1985). Libraries are usually constructed 
from the complete digestion of one to two million chromosomes 
(Fuscoe et al., 1986), although Kunkel et al. (1985b) reported a 
library constructed from partial digestion of ten million 
X-chromosomes. Complete digestion of human DNA will result in some 
DNA fragments with sizes outwith the acceptance range of the chosen 
vector which cannot be represented in the library. Representation 
may be slightly improved by construction of complementary 
libraries using different restriction enzymes. Inserts containing 
inverted repeat sequences are also resistant to cloning in 
recombination proficient hosts (Wyman, Wolfe & Botstein, 1985; 
Donlon et al., 1986) and may be rearranged or lost entirely.
Fuscoe et al., (1986) predicted that only 65% of a given 
chromosome is clonable in lambda Charon 21A, due to constraints on 
insert size. Lambda Charon 21A has a comparable insert acceptance 
range (l-9kb) to lambda NM1149 (0-llkb). The range of these vectors 
is more representative of the fragment distribution in digested 
genomic DNA than that of lambda gtWES (5-14kb) and results in fewer 
non-X recombinants (Hofker et al., 1985).
Sixteen of fifty inserts isolated from the x-chromosome 
library constructed in lambda phage NM1149 were X-specific. This 
was comparable with the representation of X-specific recombinants 
in the lambda phage Charon 21A library described by Hofker et al. 
(1985), (table 11). The proportion of non-recombinants in the 
NM1149 library (almost two-thirds of the plaques selected) was much 
higher than in the lambda Charon 21A library, however, despite 
selection for recombinants disrupted at the insert site which 
should have reduced this, and was comparable with that in lambda 
gtWES (Hofker et al., 1985 and table 11),.
Other Xp probes have been derived by cosmid cloning e.g. 
cX5(DXS148), (Hofker et al.r 1986b) or by "targeted approaches" 
based on knowledge of the location of a mutation. Cosmid clones are
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generally constructed using somatic cell hybrids. Selection for 
human inserts depends on hybridisation to human repeated sequences 
and thus repeated sequences are present in all recombinants 
obtained. Cosmids facilitate the characterisation of large 
contiguous regions of the genome but are less appropriate in the 
direct isolation of single copy sequences, as sub-clones (free of 
repeated sequences) must first be isolated.
Two "targeted approaches", applied to cloning sequences from 
the DMD locus, are described below. A targeted approach is most 
valuable when the target is represented by only a few clones. 
Fuscoe et al. (1986) state that five chromosome equivalents are 
required for a 0.99 probability of including any given (clonable) 
sequence.
One targeted approach, using the "phenol enhanced 
reassociation" technique, relied on a large Xp21 deletion in a male 
with chronic granulomatous disease, Duchenne muscular dystrophy, 
McLeod Syndrome and retinitis pigmentosa type 3 (Francke et al., 
1985). Digested DNA from a normal male was reassociated with an 
excess of sheared DNA derived from the affected boy, and thus the 
proportion of clonable fragments from within his deletion was 
enhanced. Four of eighty-one clones (eighteen of which were 
X-specific), including pERT84(DXS142) and pERT87(PXSl64), were 
mapped within the deletion in this way (Kunkel et al., 1985a).
This deletion was estimated to represent 6000kb by flow 
cytometry (Wilcox et al., 1986), or three-fifths of Xp21. Thus, one 
in twenty-five randomly selected X-linked probes could be expected 
to map within this deletion. The targeted approach thus increased 
the proportion of clones within this deletion to a considerable 
extent. One of the sixteen X-linked clones isolated in this 
project, GMGX10(DXS238), mapped within this deletion (table 10).
A second targeted approach depended on a female with DMD and 
an X;autosome translocation, which disrupted both the ribosomal rNA 
(rRNA) gene cluster on chromosome 21 and the DMD gene 
(Verellen-Dumoulin et al., 1984). DNA clones from the rRNA locus 
(Wellauer and Dawid, 1979) were used to initiate "chromosome walks" 
(i.e. to continually select for overlapping sequences) in order to 
locate the junction fragment in somatic cell hybrids derived from
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BACTERIOPHAGE VECTOR: gtWES Charon2lA NM1149
Insert sizes (kb):
Low copy clones:
"single copy clones":
Clones with inserts:
Human inserts:
Of which:
Repetitive:
X-linked:
Autosomal:
Not tested:
5-14 1-9 0-11
134 86 120
79 73 /
45 70 50
26 69 27
15 13 7
3 22 16
2 26 4
6 8 /
Table 11: Comparison of the X-chromosome library with two 
others constructed in different vectors.
(After Hofker et al, (1985) The Hindlll libraries in 
bacteriophage lambda gtWES and Charon2lA are described in 
Hofker et al (1985). "Low copy clones" corespond to those 
selected after Benton-Davis type screening with total 
human DNA. "Single copy clones" correspond to those 
selected after a second round of screening by dot blot 
analysis. This was not performed for the NM1149 library).
each translocated chromosome (and free of additional acrocentric 
chromosomes with rRNA loci), (Worton et al., 1984). The first clone 
isolated in this manner was XJ1(DXS206), (Ray et al., 1985).
4:2 DUCHENNE MUSCULAR DYSTROPHY.
Restriction fragment length polymorphisms were not detected by 
GMGX10(DXS238), GMGXl1(DXS239) or GMGX12(PXS240). The emphasis in 
this project was thus to study deletions at the DMD locus, rather 
than to perform linkage analyses. This section reviews the 
contribution of pulse field gel electrophoresis (PFGE) in 
determining the limits of the DMD gene, cloning of the coirplete DMD 
cDNA and comparison of the genomic and cDNA maps are presented 
along with data which maps DMD, GK and AHC relative to each other. 
Deletion data is discussed in the light of other genomic and cDNA 
probes and correlated with that obtained by PFGE. Possible 
relationships between the size and localisation of deletions at the 
DMD locus and the severity of phenotype are presented. The problems 
of a causal relationship between deletions and DMD/BMD and of 
germ-line mosaicsm in deletion analysis are addressed. The origin 
of deletions and mechanisms by which deletions might arise are 
discussed. This section concludes with recent work which defines 
the DMD gene product, "dystrophin" and its implications for future 
work and therapy for DMD.
4:2:1 Physical mapping of the DMD gene.
Pulse field gel electrophoresis (PFGE) can resolve DNA 
fragments from 50kb to 2000kbp in size (Schwartz and Cantor, 1984). 
PFGE has complemented deletion analysis and linkage analysis in 
ordering Xp21 probes, and has defined maximum and minimum distances 
between many loci. Burmeister and Lehrach (1986), for example, 
predicted that XJ(DXS206) and pERT87(DXS164) could be no further 
than 300kb apart. Burghes et al. (1987) confirmed this by linking 
the two loci in a chromosome walk, resulting in a contiguous
DXS206/DXS164 clone of 350kb.
PFGE has thus been of value in constructing a map of the DMD 
gene (Burmeister and Lehrach, 1986; van Ommen et al., 1986). The
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map positions of loci which lie proximal or distal to DMD are less 
well defined. There is conflicting evidence to support either C7 or 
B24 as the closest distal polymorphic marker for DMD. A male with 
DMD, GK and AHC and a deletion of C7 and Ll-4 but not B24 (van 
Ommen et al., 1986) suggests Cl is the closest distal marker whilst 
a recombination event places Cl distal to B24 (and further from 
DMD), (Norby and Scwhartz, 1987). PFGE data places Cl and B24 more 
than 2Mb from DMD and 500kb apart. PFGE fragments are shared by B24 
and Cl and also by Ll-4 and B24 but not by Cl and Ll-4. This
supports the order Xcen Ll-4— B24— Cl— pter (Burmeister et
al., unpublished observations).
Interestingly, distances on the pulse field map for DMD failed 
to correspond to those of the genetic (recombination) map. Although 
754 is deleted in several individuals affected solely with DMD or 
with DMD and mental retardation (e.g. in family 5099, (Wilcox et 
al., 1986) or the family described by Greenberg et al. (1987)), the 
genetic distance between 754 and DMD is large (approximately lOcM). 
van Ommen et al. (1986) infer from PFGE data that the physical 
distance between 754 and DMD can be little more than 1-2 Mbp and 
thus that, in this region, 1% recombination is comparable to 
100-200kbp instead of the usual lOOOkb.
Wieacker et al. (1984) proposed that the genetic 
(recombination) and physical (cytogenetic) maps of Xp do not 
correspond and that genetically, the distal half of Xp may be twice 
as long as the proximal half (55-60cM v 25-30cM). Such disparity 
between physical and genetic maps is also observed in the 
pseudoautosomal region on the Y chromosome, (Rouyer et al., 1986), 
where it is attributed to an obligatory XY cross-over in a 
relatively small region.
GMGXll was mapped between JBir and J66HI by PFGE, (Burmeister 
et al., unpublished observations), thus orientating GMGXll with 
respect to J66HI. This localisation was confirmed using somatic 
cell hybrids with breakpoints between JBir and J66HI, derived from 
girls with X;autosome translocations (Boyd et al., unpublished 
observations). Wapenaar et al. (1987) assigned p20 to the same 
region, by PFGE.
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4:2:2 Cloning of the DMD cDNA and comparison to the genomic map.
Cloning of the DMD cDNA has also refined the map of the DMD 
gene. The first candidate cDNA clones from the pERT87 locus were 
isolated on the basis of conservation of exons of a key 
developmental protein between mammalian species (man, cebus monkey, 
cow and hamster) rather than by more conventional approaches, such 
as hybridisation to Northern blots or to a cDNA library, (Monaco et 
al., 1986). One candidate clone, pERT87-25, which hybridised to a 
14kb transcript, was expressed in fetal muscle, but not in human 
myoblast cells or in He-La transformed cells.
cDNA clones from the XJ region were derived by direct 
screening of an adult muscle cDNA library, constructed in the 
expression vector lambda gtll, (Burghes et al., 1987), with 
subclones from within the XJ region. Cross species homology was 
again observed.
The 5' and 3' ends of the DMD gene were obtained by 
searching for overlapping clones in a second fetal muscle library, 
(Koenig et al., 1987). The resulting 14kb cDNA was divided into 
subclones of approximately lkb and detected sixty-five X-specific 
Hindlll fragments. As there were five Hindlll sites within the 
14kb cDNA itself, this indicated that the mRNA was transcribed from 
at least sixty exons.
Some fragments were ordered with respect to each other using 
•deletions and translocation breakpoints, whilst others were ordered 
by comparison of the restriction patterns obtained to those of DNA 
sequences derived from chromosome walks around defined Xp21 loci.
All probes from pERT84 to J66HI inclusive (figure 14), were 
shown to be intragenic, with at least one third of the DMD gene 
lying distal to J66. This indicated that GMGXll was intragenic. The 
first 6kb of DMD transcript were seen to correspond to a minimum of 
800kb on the genomic map - from the first (most 5') exon within the 
PERT84(PXS142) locus to an exon within the JBir locus, distal to 
PERT87.
Since GMGXll is only conserved amongst primates (and not 
amongst other mammals), it is unlikely to be a coding sequence and 
may be situated in one of the introns associated with cDNA 
subclones 7 or 8 (Koenig et al., 1987) and/or Cf23a (Forrest
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et al., 1987a) or Cf56a (Forrest et al., 1987b). These cDNA clones 
detect a high frequency of deletions in the region between JBir and 
J66HI as observed for GMGXll. p20 may also be situated in one of 
these introns.
Relatively few reference points which might facilitate 
genomic mapping of the 3' end of the gene have been described. 
Extrapolation of the mean intron and exon sizes (35kb and 200bp 
respectively), however, predicts that the DMD locus extends over 
2Mb and thus represents nearly 0.1% of the human genome (Koenig et 
al., 1987). This corresponds to the predictions of PFGE data
(Burmeister et al., unpublished observations) and provides a 
partial explanation for the high frequency of recombination within 
the DMD gene itself, for heterogeneity in the site of the mutation 
and also for extreme variation in the severity of phenotype.
4:2:3 The ordering of Duchenne muscular dystrophy, glycerol kinase 
deficiency and congenital adrenal hypoplasia (AHC) and the 
characterisation of a deletion associated with AHC.
AM (5996) represents the first individual described with AHC 
and mental retardation (but without GK or DMD) with a 
micro-deletion of Xp21. His deletion could be visualised
microscopically, by FACS analysis and by molecular studies (Yates 
et al., 1987a). JR (5194) with AHC but not mental retardation, was 
also studied by cytogenetic, FACS and molecular analysis but no
deletion was detected.
The deletion in AM (5996) (which includes Ll-4, B24 and C7), 
overlaps with that of DH (Card) with DMD, GK and AHC (section 
3:5:5). The deletion in MJ (Oxfo) also affected with DMD, GK and
AHC, included probes GMGX10 to J66HI (within the DMD locus) but not
Ll-4. These three deletions placed AHC between J66HI and Ll-4.
Furthermore as MJ (Oxfo), but not AM (5996), is additionally GK 
deficient, this suggested that AHC was at the distal end of the 
region of overlap. This supports the order DMD-GK-AHC-pter (figures 
6 and 15).
Other molecular studies, concurrent with this study and
reviewed by Francke et al. (1987), placed the AHC and GK genes
between JBir (proximal to J66HI) and Ll-4. Chelly et al. (1987b)
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placed GK and AHC between J66HI and Ll-4 in agreement with the 
above data.
As the deletion in KC (Francke, 1984) extends distally from 
OTC to exclude B24 and C7 (Francke, 1985), it must also include the 
genes for AHC and GK (figure 6). Thus KC must also be hemizygous 
for AHC and GK .
The distance between J66H1 (the most 3' probe known to lie 
within the DMD gene) and Ll-4 represents some 2Mb or more as 
estimated by PFGE (Burmeister et al., unpublished observations). 
There are no points of reference in this interval which might allow 
GK and AHC to be localised more precisely. Ll-4, which might 
provide an appropriate starting point for obtaining further probes, 
seems particularly resistant to chromosome walking and related 
cloning strategies (Kunkel et al., 1985b).
The deletion in AM (5996) was estimated by flow cytometry 
(FACS analysis) to represent some 2.3% of his X-chromosome or 3.4Mb 
(Yates et al., 1987a). Much of his deletion may lie outwith the 
gene itself, although Ll-4 and C7 are at least lOOOkb apart, 
(Burmeister et al., unpublished observations). The parents and 
grandparents of AM (5996) were also studied and his mother (who was 
mildly mentally retarded), but not his grandmother (of normal 
intelligence), was shown to be deleted by FACS analysis. This was 
supported by the finding that his grandmother was heterozygous for 
B24 (section 3:5:5).
Marlhens- et al. (1987) have recently described an individual 
with a microscopic deletion of Xp21.2 with both GK and AHC who was 
not deleted for JBir, Ll-4 or C7. This might be explained by the 
lack of suitable molecular markers in the 2Mb interval which 
represents the smallest region of overlap (SRO) of deleted 
individuals with AHC and GK deficiency.
Many boys with DMD have been assessed for the presence of 
glycerol in their urine as an indication of glycerol kinase 
deficiency. Clarke et al. (1986) and Chelly et al. (1987a) observed 
slightly elevated levels of glycerol in the urine of one of thirty, 
and five of three hundred and two, males with DMD, respectively. 
The increase was ten to one hundred fold less than that in males 
with both GK deficiency and AHC. Only one of the five individuals
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described by Chelly et al. (1987a) was shown to be glycerol kinase 
deficient serologically, it thus appears that GK is more closely 
associated with AHC than with DMD.
The uniqueness of AM's phenotype suggests that his proximal 
breakpoint separates the genes for GK and AHC, and could represent 
a valuable starting point in cloning the two genes. Polymorphic 
probes within his deletion might also represent suitable flanking 
markers for the study of DMD, which would be closer and possibly 
more polymorphic than either B24 or C7. It would thus be worthwhile 
to search or select for X-specific clones deleted in AM (5996).
4:2:4 Deletion analysis (genomic probes)
In a preliminary screen, which was included in the 
collaborative study of Kunkel & co-authors (1986), deletions were 
detected in nine of ninety (10%) Scottish boys with either DMD 
(seventy eight boys) or BMD (twelve boys) by pERT87-8 and/or XJl.l, 
(Wilcox et al., unpublished observations). These nine boys included 
one, JB (5097), with BMD.
That collaborative study involved twenty laboratories in the 
screening of one thousand three hundred and forty-six DMD and BMD 
males with probes from the DXS164 locus. Eighty-eight males (6.5%) 
were deleted for at least one of these probes, fifty-three of which 
were further investigated with additional pERT87 clones. Screening 
with PERT87-1, PERT87-8, pERT87-15 (and XJl.l) was advocated, as a 
means to determine the majority of deletions, (Kunkel & co-authors,
1986).
Using this approach, Hart et al. (1986) detected fifteen 
deletions amongst one hundred and forty DMD families (10.7%) whilst 
Thomas et al. (1986a) detected nine deletions for at least one 
sub-clone in one hundred and seventeen unrelated individuals (8%) 
with DMD. Thomas et al. (1986a) also studied forty-eight BMD 
patients in whom they failed to detect a deletion.
One hundred and three Scottish DMD/BMD boys were screened for 
deletions with XJ1.2, GMGX10, GMGXll, GMGX12, p20, JBir and J66H1 
in this study, and mutations were detected in a further thirty six 
(36%) individuals. No additional mutations were detected with 
XJ1.2, GMGXlO or GMGX12 whilst eighteen new mutations (18%) were
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defined using GMGXll and twenty-two (22%) with p20. Seven 
individuals had mutations detected by both GMGXll and p20. J66HI 
detected a fragment of altered size in one individual whilst JBir 
detected a further three mutations.
The thirty-three mutations detected by GMGXll and p20 
represent a new and distinct deletion-rich region from that of 
pERT87/XJ (figure 16). jn this study, only MJ(Oxfo) and DH(Card), 
who have complex phenotypes, have deletions which encompass both 
pERT87/XJ and GMGXll/p20.
GMGXll and p20 both detect restriction fragments of altered 
size which may represent partial deletions, point mutations 
producing rare polymorphisms or one endpoint of an inversion or 
duplication. These alternatives may also explain the altered 
fragments detected by JBir in JL (1406) and by J66HI in MT(5310), 
and could be investigated by cloning the junction fragments in 
these boys.
The detection of altered fragment sizes and/or deletions with 
GMGXll and p20 is partly dependent on the restriction enzyme 
involved. Only three individuals were deleted for Hindlll and Mspl 
fragments of p20 as well as the EcoRI and Hindlll fragments of 
GMGXll. As p20 was derived from two sequences some 30-40kb apart 
(van Ommen et al, personal communication), either fragment could be 
independently altered or deleted in the immediate vicinity of a 
deletion, dependent on the restriction enzyme used. GMGXll, in 
contrast, consists of a unique fragment 1.2kb in length, which 
suggests that enzyme specific differences at this locus are small 
deletions or subtle changes in which at least one endpoint is 
well-defined.
J66H1 detected an additional EcoRI fragment, approximately 
2kb in size (in addition to the "normal" EcoRI fragment of 
approximately 4kb) amongst sixteen males with DMD. The significance 
of this finding has not yet been determined, but could- be 
investigated in several ways. Firstly, the families of those boys 
with this extra band should be studied, to determine if it 
segregates as a mendelian trait. Secondly EcoRI digests of normal 
males should be screened for the presence of this fragment. 
Finally, it might also be valuable to screen other restriction
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enzyme digests of these sixteen males to determine if this 
represents a site specific mutation.
Den Dunnen et al. (1987) demonstrated deletions in 17% 
(eighteen of one hundred and four) DMD patients using probe JBir in 
addition to pERT87 and XJl.l. Bakker et al. (1987b) reported that 
XJ, pERT87 and JBir were deleted in 10% individuals with DMD, and 
that p20 was deleted in an additional 18% individuals from the same 
group, in good agreement with the 22% observed in this study. 
J66H1, which was very effective at detecting deletions by pulse 
field analysis (as described below, section 4:2:5), detected only 
four deletions amongst four hundred and fifty individuals by 
Southern analysis, (Ginjaar et al., 1987).
Amongst those genomic probes • which detect deletions by 
Southern analysis, p20 and GMGXll detect the most deletions 
(figure 16). Some cDNA clones, however, are able to detect 
deletions in more than 50% affected individuals (Forrest et al., 
1987b) and this has increased the proportion of affected 
individuals with deletions detectable by Southern analysis to 70% 
(Forrest et al., 1987b). Deletions of cDNA probes are described 
below (section 4:2:6).
4:2:5 Deletion analysis (PFGE)
Den Dunnen et al. (1987) were able to detect twenty deletions 
and a duplication amongst thirty-nine DMD patients by PFGE as 
compared to only seven deletions by Southern analysis. They used 
partial Sfil digests and the probes XJl.l, pERT87 (sub-clone not 
specified), JBir and J66H1 (which span 2.2Mb using partial Sfil 
digests). Sixteen of these deletions (and one duplication) were 
detected with either JBir or J66H1. This predicted an especially 
deletion-rich region in the 950kb between JBir and J66H1.
The resolution of PFGE is greatest for large DNA fragments 
(outwith the "compression zone" of unresolvable fragments). Thus 
deletions as small as 30kb can be detected using probes as distant 
as 800 kb (van Ommen et al., 1986). GMGXll(DXS239) is about 300kb 
proximal to J66 and 400-500kb distal to JBir (Burmeister et al., 
unpublished observations). Thus deletions of more than 30kb at the 
DXS239 locus would be readily detected by PFGE analysis with either
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Figure 16: Schematic representation of mutations described in this
study.
(PERT87-8 results were obtained by D.Wilcox. Figures are expressed 
as percentages of the total number of boys screened with each probe. 
Eighty seven individuals were studied for XJl.l and pERT87-8. One 
hundred and three individuals were studied with JBir, p20, GMGXll 
and J66HI. Those boys with an extra EcoRI J66HI fragment in 
addition to one of normal size are not included).
J66 or JBir. Additional deletions might also be detected by PFGE 
with GMGXll or p20 if these probes are situated far enough (several 
hundred kilobases) from a deletion rich region.
P20, cDNA sub-clones 7 and 8 (Koenig et al., 1987), and Cf23a 
and Cf56a (Forrest et al., 1987a, 1987b) are also situated between 
JBir and J66 and deletions of these loci are likely to correspond 
to many of those detected by PFGE with JBir or J66HI. The extent to 
which deletions detected by these probes overlap and the distances 
between them have not been established.
4:2:6 Deletion analysis (cDNA probes).
Koenig et al. (1987) detected deletions in 50% (fifty three of 
one hundred and four) DMD patients using subclones of the 14kb 
cDNA, approximately lkb in size. They noted (i) a non-random 
distribution of deletions, (ii) a slight increase in the proportion 
of deletions associated with sub-clone lb (which roughly 
corresponds to the XJ/ pERT87 junction on the genomic map), (iii) a 
large increase in the frequency of (small) deletions associated 
with sub-clones 7 and 8 (which lie within the region defined by
JBir and J66 on the genomic map) and (iv) an absence of deletions
associated with five of the six distal subclones tested. Forty-two 
out of fifty-three (80%) deletions detected were deleted for 
sub-clone lb (fifteen deletions) or sub-clone 8 (twenty seven 
deletions).
Forrest et al. (1987a, 1987b) described two distal cDNA clones 
Cf23a and Cf56a, which detect deletions in DMD and BMD patients. 
Cf23a extends distal to JBir and detects deletions in 28% 
individuals with DMD and 51% those with BMD. Cf56a, which lies 3'
to Cf23a, detects deletions in 51% individuals with DMD and in 52%
those with BMD. The extent to which these cDNA clones overlap with 
cDNA clones 7 and 8 (Kunkel et al., 1987) is yet to be defined.
Deletions were detected in 70% DMD/BMD families by Southern 
analysis using Cf23a and Cf56a, in conjunction with two further 
cDNA sub-clones, CalA which is distal to pERT87-30, (Cross et al., 
1987) and Cf27 (in the vicinity of XJl.l and HIP25). These 
subclones represent twenty-seven exons from the 5' and central 
regions of the DMD gene.
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As cDNA deletions potentially define the critical domains of 
the DMD gene, cDNA clones which detect deletions at high frequency 
are likely to supercede random DNA clones in deletion screening.
4:2:7 Deletion/ phenotype correlations
There is no clear correlation between the size or location of 
deletions at the DMD/BMD locus and either the severity of phenotype 
or mental retardation. Three conclusions can be drawn from the data 
outlined below: (i) that no "Becker-specific" domain of the DMD 
gene exists, (ii) that the extent of the deletion is not a rigorous 
guide to the severity of phenotype and (iii) that deletions of 
certain probes e.g. GMGXll are more frequently associated with a 
severe phenotype than others e.g. p20 or Cf23a.
Assessment of intelligence quotient (IQ) in eight hundred and 
ten boys with DMD (summarised in Emery, Skinner & Holloway, 1979) 
suggests that about a third of such individuals have an IQ less 
than seventy-five. Mental retardation in association with BMD is 
not unknown (Emery and Skinner, 1976) but is not a common feature.
SS (5099), with the largest deletion in this study, and to a 
lesser extent JD, (his cousin who has the same deletion), were 
severely mentally retarded with short stature. Not all mentally 
retarded boys have such large deletions, however. Greenberg et al. 
(1987) described a family with a similar microscopic deletion, 
including 754, pERT87 and XJ, in which affected males had "normal 
growth parameters" and were described as "slow-learners". Probes 
which might distinguish between these two deletions (e.g. GMGX10) 
could prove of especial value in examining mental retardation in 
boys with DMD.
In this study, JB (5097) with a severe Becker phenotype was 
deleted for DNA probes from the XJ/DXS206 locus. JB was quite 
severely affected (wheei-chair bound at thirteen, presently aged 
twenty). He had an affected uncle who was wheel-chair bound at 
fourteen and died aged thirty nine. His deletion encompassed that 
of AK (5265) with a Duchenne phenotype.
Liechti-Gallati et al. (1987) have recently reported an 
XJ/PXS206 deletion (including XJl.l and XJ2.3) in a mildly affected 
BMD patient. Other deletions which result in a BMD phenotype, have
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been reported within the pERT87/DXS164 locus (Hodgson et al., 1986; 
Kunkel & co-authors, 1986; Hart et al.,1987). Cross et al. (1987) 
reported a patient with mild BMD whose deletion extends distally 
from pERT87-30 and includes J-Bir whilst Lindlof et al. (1987) 
recently reported a family with three BMD males deleted for XJ2.3 
in addition to pERT87-l, pERT87-8 and pERT87-15 (but not 
PERT87-30).
Hart et al. (1987) described three BMD individuals with pERT87 
deletions. One of these was only 6kb in size and was associated 
with a mild BMD phenotype. The other two deletions encompassed 
probes pERT87-l, pERT87-8 and .pERT87-15. One was at the severe end 
of the BMD spectrum (wheel-chair bound at sixteen years and two 
months) whilst the other was milder in phenotype (able to walk 
until thirty-eight years).
Four out of fifteen BMD families in this study had a deletion 
breakpoint within p20, whilst a further two BMD families had 
deletions of p20. p20 also detected deletions in sixteen DMD
families. Whilst one third of all alterations to the restriction 
fragment length pattern detected by p20 were associated with a BMD
phenotype, all mutations detected by GMGXll, were associated with a
Duchenne phenotype. This suggests that GMGXll, which lies 3' to
p20, may lie close to an essential region of the DMD gene.
Individuals with BMD have also been reported with deletions of 
exons from cDNA clones CalA (distal to pERT87-30, Cross et al., 
1987), Cf23a and Cf56a, which lies 3' to Cf23a. Cf23a detected more 
BMD deletions than Cf56a, including all those detected by Cf56a. 
Cf56a detected twice as many DMD deletions as Cf23a. Most of the 
deletions detectable by both probes had an endpoint between two 
particular exons of Cf23a, which also represented an endpoint for 
30% of DMD deletions, (Forrest et al., 1987a, 1987b).
Cf23a thus appears to detect mutations in a deletion-prone 
region, of which several result in a less severe phenotype, as 
observed for p20. Disruption or loss of these loci thus appears 
less deleterious than disruption or loss of GMGXll. Separate 
patient groups were tested for deletions with p20 and Cf23a, so it 
is not yet known if these two groups are partially-, completely- or 
non- overlapping.
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Cross et al. (1987) reported a deletion of a minimum of nine 
exons from the DXS164 locus (normally transcribed in adult DMD 
mRNA) in a sixty-one year old patient with an exceptionally mild 
BMD phenotype. The most extreme example of failure to correlate 
phenotype with deletion size was that of a normal male who was 
deleted for at least two exons of the DMD cDNA, (Koh et al., 1987). 
The severity of phenotype may be governed by whether a deletion 
causes an in-frame mutation, resulting in a shortened protein 
product, or an out-of-frame mutation which might completely disrupt 
transcription of the gene. This would predict that disruption of 
the GMGXll domain normally prevents formation of the DMD gene 
product and that disruption of the p20 and Cf23a loci could give 
rise to a defective gene product.
The forty-five mutations detected at the DMD/BMD locus in this 
study are highly heterogeneous, representing at least twenty-five 
distinct groups. It is apparent that it will be necessary to 
precisely define many of these at the DNA sequence level before 
accurate correlation with phenotype can be assessed. It may 
eventually be possible to predict the extent to which a 
well-characterised deletion will disrupt protein formation, and 
thus to predict the severity of phenotype from a defined mutation.
In rare instances, a muscular dystrophy which is clinically 
indistinguishable from DMD is observed. This appears to be 
inherited as an autosomal disorder (McKusick number 25310), (Somer 
et al., 1985). In such instances Xp21 RFLP haplotypes will fail to 
segregate with a muscular dystrophy phenotype.
4:2:8 Causal nature of DMD deletions
Although it has generally been accepted that a deletion in the 
PERT87 and/or XJ regions is causal to DMD/BMD, Koh et al. (1987) 
have recently reported a normal male with a deletion of DXS206 
including XJl.l and XJ10.1 and at least two exons of the DMD gene. 
This boy's brother, with DMD, apparently has the same deletion. 
This dramatic difference in phenotype may be a consequence of 
subtle differences betwen the two deletions or alternatively to a 
compensatory factor present in the unaffected boy. Neither boy was 
deleted for XJ5.1 (or pERT87-42). Whatever the reasons for the
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difference in phenotype, this deletion, in a normal individual, has 
serious implications for prenatal diagnosis based on deletion 
analysis. As there is no reason to suppose that such an anomaly
need be restricted to this region, it would now seem appropriate to
include unaffected male siblings of boys with DMD/BMD in any
deletion screening.
Similarly, but less dramatically, two affected brothers have 
been reported with classical BMD whose great-great uncle appears to 
have the same deletion and yet is much more mildly affected
(Forrest et al., 1987a).
4:2:9 Germline Mosaicism and DMD.
Recent reports (Lanman et al., 1987, Monaco et al., 1987 and 
Bakker et al., 1987a) have described females who are heterozygous 
for a given RFLP at the DMD locus, but have two or more offspring 
deleted for this same probe.
Transmission of deletions by unaffected males has also been 
reported e.g. transmission of a JBir deletion at the DMD locus to 
two daughters and to subsequent affected offspring (Darras and 
Francke, 1987) and of a pERT87-15 deletion to at least two 
daughters and subsequent affected offspring (Bech-Hansen et al., 
1987).
Three hypotheses have been put forward to explain this 
phenomenom (i) germline mosaicism (ii) translocation of the 
"deleted sequences" to an autosome in the parent and (iii) a 
"pre-mutation" or predisposition to a deletion which gives rise to 
the same deletion in multiple independent events (unlikely). The 
first hypothesis is favoured but the second could be formally 
excluded by in situ hybridisation.
Romeo et al., (1986) have similarly identified a BMD pedigree 
in which a deletion recurs. Their data is most readily explained if 
the grandmother represents a germ-line mosaic.
Germ-line mosaicism is not unique to DMD/BMD or to X-linked 
disorders. It was invoked to explain three sisters with the 
autosomal dominant disorder achondroplasia, born to normal parents 
(Fryns et al., 1983) and also an individual heterozygous for a 
rearranged Factor VIII (Hemophilia A) gene who transmitted a 40kb
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factor VIII deletion to one daughter and an affected son, the 
normal X-chromosome to two sons and two daughters and the 
rearranged X-chromosome to a further daughter (Gitschier, 1986).
In the light of these observations it is difficult to be 
convinced that a sporadic deleted individual truly represents a new 
mutation. It is thus possible that the mothers of SJ (3485) and NJ 
(5313) (who are heterozygous at two and four loci respectively for 
which their sons are deleted) are germline mosaics and could give 
rise to subsequent affected males. They should therefore be offered 
prenatal diagnosis.
4:2:10 The origin of DMD mutations.
The origin of the deleted chromosome has been demonstrated for 
two individuals, NJ (5313) and SJ (3485) for whom grandparental 
samples were available. The mutation in these two individuals 
occured in a maternal gamete, derived from grandmaternal chromosome 
in NJ (5313) and the grandpaternal chromosome in SJ (3485), with 
no apparent recombination. AW (7866) also represents a new 
mutation which arose in a maternal gamete.
Two further deleted individuals for whom grandparental samples 
were available, SS (5099, Wilcox et al. 1986) and AB (0120) did not 
represent new mutations. Their deletions were apparent in their 
maternal grandmothers.
New mutations are generally believed to account for one-third 
of individuals with DMD, based on the static frequency of the 
disorder in the population and a calculation using Haldane's 
formula (Haldane, 1935), which assumes that mutation rates are 
equal in male and female gametes and that male fertility in DMD is 
effectively nil. (Only one DMD male with a child has been reported
to date, (Thompson, 1978)).
This is supported by segregation analysis performed on 
siblings of affected cases of DMD. Carrier analysis based on 
creatine kinase measurement has also suggested that about a third 
of boys with DMD represent new mutations (reviewed in Moser, 1984) 
although these results were unavoidably based on incomplete 
ascertainment. In contrast, a low proportion of new mutations (four 
non-carrier mothers/ twenty isolated cases) has been observed for
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Lesch-Nyhan disease (Francke et al., 1976).
Witkowski et al. (1987) studied twenty seven three— generation 
families, six of which represented families with deletions. The 
deletion arose in the grandpaternal X-chromosome in two of these 
"deletion" families and in the grandmaternal X-chromosome in a 
third, giving rise to carrier females. The mutation occurred in a 
maternal gamete in the remaining three "deletion" families as for 
SJ(3485) and NJ(5313).
In this study the mothers of four boys were homozygous or 
hemizygous at all polymorphic loci shown to be deleted in their 
sons, and thus it was not possible to determine whether these 
individuals carried the deletion. Hemizygosity at a given locus is 
often difficult to prove by Southern analysis. This question could 
be best addressed by PFGE. Within the limits of resolution of the 
system, any probe which is close to, but not within, the deletion, 
may detect an anomalous fragment in addition to the fragment of 
normal size (which acts as an internal control). Kenwrick et al. 
(1987) described a similar phenomenon in a female DMD patient with 
an X;1 translocation using probes pERT84 and HIP25. PFGE might also 
allow the detection of a rearrangement, such as an inversion, which 
might result in a predisposition to deletions.
4:2:11 Possible mechanisms for the high frequency of deletions and 
duplications at the DMD locus.
Deletions seem to account for a higher proportion of mutations 
in certain disorders than in others at both the microscopic and 
molecular levels. Molecular (sub-microscopic) deletions represent 
18% (five in twenty eight) mutations in Lesch-Nyan disease (Yang et 
al., 1984) and 7% (one in fifteen) mutations in OTC deficiency 
(Rozen et al., 1985).
To a certain extent, the high proportion of deletions detected 
at the DMD locus (sections 4:2:4-4:2:6) is a consequence of its 
considerable size. Koenig et al. (1987) state that the incidence of 
deletions is no greater for any 200kb region of the DMD gene than 
for other disorders e.g. the FVIIlc locus (Youssoufian et al., 
1987) or the HPRT locus (Yang et al., 1984) although certain 
regions of the DMD gene are indisputedly more deletion-prone than
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others (sections 4:2:4—4:2:6).
The mechanism by which deletions arise at the DMD locus is not 
known, although it has been proposed that deletion-rich regions 
might contain direct or indirect repeats and/or sequences with 
strong homology to others elsewhere within the gene. These may 
create a region susceptible to non-homologous pairing, thus 
increasing the likelihood of unequal crossing over at diplotene in 
meiosis (and resulting in both deletions and duplications). 
Alternatively direct and/or indirect repeats might allow stem and 
loop structures to form during replication, which could result in 
DNA loss by intra-chromosomal recombination.
Characterisation of the molecular structure of GMGXll, which 
is only 1.2kb in size, by DNA sequencing and/or detection of 
homologous sequences elsewhere in the gene (e.g. by screening an 
X-chromosome specific library at low stringency) may help to 
resolve these possibilities.
Duplications have been reported in association with DMD/BMD. 
Berteleson et al., (1986) described a male with a duplication 
encompassing all pERT-87 sub-clones. This duplication was 
determined by DNA dosage studies. Hu et al. (1987) identified 
duplications of one (or more) exon(s) in three patients (two with 
DMD and one with BMD) amongst one hundred and twenty individuals 
with either DMD or BMD. RFLP studies indicated that one tandem 
duplication had not arisen by unequal exchange between non-sister 
chromatids and may have resulted from sister chromatid exchange. 
Den Dunnen et al. (1987) used pulse field gel electrophoresis to 
demonstrate the presence of a duplication at the JBir locus in an 
affected individual and in his mother.
The breakpoint has been precisely defined in the t(X;21) 
female DMD patient described by Verellen-Dumoulin et al. (1984). No 
extensive homology was observed between the chromosomes from which 
the translocation arose, in the vicinity of the breakpoint (Bodrug 
et al., 1987).
Monaco et al. (1987) observed that six deletion endpoints in 
the DXS164 locus occured in single copy, repeated and long 
interspersed repeat ("LINE", Singer, 1982) sequence homology 
sequences, so that there would appear to be little sequence
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specificity for deletion breakpoints.
It should be possible to gain insights into the means by which 
deletions arise at deletion-prone loci by comparison of the 
deletion junctions in affected individuals with the sequence in 
normal males. The many small deletions associated with GMGXll and 
p20 should prove particularly amenable to such a molecular 
analysis.
4:2:12 The DMD gene product "dystrophin" and its implications for 
future research.
Isolation and cellular localisation of the DMD gene product, 
"dystrophin" have recently been described. Fusion proteins derived 
from two distinct mouse cardiac muscle cDNA clones were used to 
raise antibodies which defined the gene product "dystrophin". These 
mouse cDNA clones and others showed over 90% homology to the first 
4.3kb of the human DMD cDNA at the level of both amino acid and 
DNA sequences (Koenig et al., 1987; Hoffman et al., 1987a).
Dystrophin is a 400kD protein representing 0.002% total 
protein in striated muscle, consistent with the low abundance of 
the DMD mRNA (0.01-0.001% total mRNA). Dystrophin is also present 
in cardiac muscle and at trace amounts in brain but was absent from 
muscle biopsies from two boys with DMD (Hoffman et al., 1987b).
The predicted structure of dystrophin was rich in alpha-helix, 
with significant homology to the actin binding site of 
alpha-actinin (Hammonds, 1987), suggesting a binding function for 
cell membranes or helical proteins. Recently, dystrophin has been 
shown to represent a minor constituent of triads, which are 
responsible for the release of calcium ions as a signal for 
myofibril contraction. DMD may thus result from aberrant calcium 
homeostasis, possibly due to the increased activity of 
calcium-dependent phospholipases (Hoffman et al., 1987c).
mdx, a muscular dystrophy mutation in the mouse which maps 
close to G6PD and HPRT, has a mild phenotype comparable to that of 
BMD in man. On the basis of its map position, it was initially 
proposed that mdx was homologous to EDMD, (Avner et al., 1987), 
which maps to Xq28-qter in man. However, cDNA clones from the DMD
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locus mapped in the same interval of the mouse X-chromosome as mdx 
(Brockdorff et al. 1987a, 1987b; Heilig et al., 1987), whilst
dystrophin was not expressed in two mdx mutations (Hoffman et al., 
1987b). This argued that mdx is the murine equivalent of DMD rather 
than EDMD and that mdx would represent an appropriate model for the 
study of DMD, despite its milder phenotype.
It should now be possible to determine defects at the protein 
level and to confirm proposals that DMD results from a complete 
absence of dystrophin whilst BMD is a consequence of a defective 
protein product, using material from muscle biopsies.
The key to an appropriate therapy for DMD may lie in 
determining why the disorder is so much more severe in man than in 
mouse. Hoffman et al. (1987b) suggest that fibrosis of muscle 
fibres in DIO, which is not observed in mdx, may prevent the 
regeneration of muscle fibres which occurs in mdx and account for 
the more severe phenotype. If this is so, agents which inhibit 
fibrosis may ameliorate DMD in man.
4:3 STEROID SULPHATASE (STS) DEFICIENCY.
In this section, linkage analysis with GMGX9 and the cloning 
of STS are summarised. The frequency of deletions detected with 
GMGX9 and other genomic probes are compared with those of cDNA 
clones, and possible mechanisms for the high deletion frequency 
observed at this locus are discussed. Flow cytometry (FACS) data, 
the absence of heterogeneity amongst these deletions, XY 
translocation breakpoints and the escape of STS from X-inactivation 
are presented. Finally, clinical applications of GMGX9 and possible 
applications of GMGX9 to future work are discussed.
4:3:1 Linkage studies with GMGX9 and the relationship of GMGX9 to 
STS cDNA clones.
GMGX9 was mapped to Xp22.3 by somatic cell hybrid mapping and 
more precisely localised to the vicinity of STS by virtue of 
co-segregation of GMGX9 deletions with steroid sulphatase 
deficiency (Gillard et al., 1987).
GMGX9 detected a high frequency polymorphism (PIC 0.44) and 
was included in a multi-point linkage analysis with distal Xp
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markers D2(DXS43), 782(PXS85), Dic56(DXS143) and Kg in both normal 
(TDH) families and families segregating for X-linked ichthyosis, 
(Yates et al., 1987b). A deletion of GMGX9 was considered as a 
third rare (null) allele for the purposes of this analysis. 
GMGX9(PXS237) was linked to STS with a maximum LOD score of 8.73 at 
0 recombination (with confidence limits of 0-0.07).
In practice, since both GMGX9 and STS cDNA clones are deleted 
in at least 86% males with XLI, and two co-deleted loci will be 
linked at zero recombination regardless of the distance between 
them, the precise distance between STS and GMGX9 remains unknown. 
The maximum distance between STS and GMGX9 will correspond to the 
smallest deleted region these individuals have in common. This is 
below the limit of resolution of FACS' analysis, as some deletions 
cannot be visualised by this technique, i.e. less than about 2Mb, 
which is normally assumed to represent 2% recombination.
Thus, the maximum error in assuming that GMGX9 and STS are 
tightly linked is small, providing that the distance between these 
loci does not differ substantially in deleted and non-deleted 
individuals.
The multi-point analysis gave the most likely order as 
D2-22cM-782-10cM-Dic56-5cM- (STS/GMGX9) -13cM-Xg-Xpter. This order 
was supported by the deletion of Xg, STS and GMGX9 (but not Dic56) 
in two males (1729 and 7079) with XY translocations.
STS cDNA clones were isolated independently by several groups 
using polyclonal antibodies (raised to purified STS protein) to 
screen placental cDNA libraries (constructed in lambda phage 
expresssion vectors), (Yen et al., 1987a; Ballabio et al., 1987a; 
Conary et al., 1987; Bonifas et al., 1987).
The 2.7kb STS cDNA clone of Yen et al. (1987a) failed to 
hybridise to RNA from fibroblasts of an affected individual and 
cross-reacted with STS antibodies when cloned into the mammalian 
expression vector pMSG. The cDNA clone of Ballabio et al. (1987a) 
was localised to Xp22.3 by in situ hybridisation. STS cDNA clones 
detected genomic deletions in eight out of ten (Yen et al., 1987a), 
eight out of eight (Ballabio et al., 1987a), two out of three 
(Conary et al., 1987) and fourteen out of fifteen (Bonifas et al., 
1987) patients with XLI, respectively. These results confirmed that
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these clones represented at least part of the STS gene. The 2.7kb 
mRNA transcript was sequenced and found to contain an open reading 
frame of 1542bp with a signal peptide of 22 amino acids and a 
coding region of 492 amino acids, (Yen et al., 1987a).
GMGX9 and the p422 and p2a4 STS cDNA clones (Ballabio et al., 
1987a) demonstrated the same pattern of deletion in forty-four 
individuals with XLI with only one exception, yet comparative 
mapping suggested that GMGX9 was not expressed. GMGX9 might 
therefore represent an intron or a flanking marker.
4:3:2 Deletion analysis of males with XLI.
GMGX9 detected deletions in thirty-seven of forty-four (86%) 
unrelated individuals with XLI. Thirty-eight of these forty-four 
individuals were deleted for p422, including the thirty-seven 
deleted for GMGX9.
Thirty-one affected males, including the exceptional male,"Ba" 
were screened with GMGX9, STB14 (a genomic clone at the 5' end of 
the STS gene), p2a4 (an STS cDNA clone), GMGXXY3 and GMGXY19 
(genomic probes independently isolated from X and Y chromosome 
libraries, (Mitchell et al., unpublished observations)). Four males 
were not deleted for any of these probes whilst twenty-six had 
deletions of (X-specific) bands of all five probes. Only one 
deletion, that of "Ba", could be resolved from the others, 
indicating that deletions at the STS locus represent a highly 
homogeneous group.
The STS gene was shown to span at least 140kb on the 
X-chromosome including at least ten exons, with introns from lOObp 
to over 20kb in size (Yen et al., 1987b). Twenty-one of a group 
of twenty-six males with XLI had entire gene (ten exon) deletions, 
whilst two had partial deletions. The first of these included all 
but the first exon whilst the second included at least 25kb and 4 
exons, (Shapiro et al., 1987). Thus these individuals also 
represented a highly homogeneous group of deletions (table 12).
"Ba" was deleted for the X—specific bands of p2a4, p422 and 
GMGXY19 but not those of GMGX9, STB14 or GMGXXY3. These probes can 
be divided into two groups accordingly. STB14 is at the 5' end of 
this deletion but GMGX9 and GMGXXY3 may lie to either side of it.
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This exceptional deletion demonstrates the value of deletion 
breakpoints.
It is difficult to determine the relative order of these 
probes, although they are all known to lie distal to Dic56. None of 
these probes, with the notable exception of GMGX9, detects an RFLP 
and thus ordering of these probes will depend on PFGE (in X-hybrids 
or females) or on screening of further deletions.
4:3:3 XY homology of probes which detected deletions in males with 
XLI.
Neither p2a4 nor GMGX9 demonstrate any homology to the Y 
chromosome, yet GMGXXY3 and GMGXY19, STB14 (Ballabio et al., 
unpublished observations) and the 2.7kb STS cDNA clone (Yen et al., 
1987a) all have homologues on Yq. Overlapping Y-specific genomic 
clones, detected with STS cDNA clones, have shown that Y homology 
is limited to the 5' end of the STS gene, and consists of two EcoRl 
fragments of 20kb and 1.5kb and an intervening intron of 15kb (Yen 
et al., 1987a, 1987b). Thus homologous sequences to STS on the
Y-chromosome represent a (non-functional) diverged gene or 
"pseudogene".
The Y-pseudogene was assigned to Yqll-Yqter using somatic cell 
hybrids (Yen et al., 1987a). Yq homologues have also been observed 
for other DNA probes in distal Xp e.g. M1A/DXS31 (Koenig et al., 
1984), CRI-S-232 (Donnis-Keller et al., 1987) and GMGXXY3 and
GMGXY19 (Mitchell, unpublished observations). Xg and MIC2X, 
however, which are analogous to STS in that they escape 
X-inactivation, have homologues on Yp.
Such observations suggest a peri-centric inversion on the Y 
chromosome, during its evolution from an ancestral sex-chromosome, 
which would result in an increased genetic distance between STS and 
the STS pseudo-gene and the transfer of the testes determining 
factor (TDF) close to the pairing region. It should be interesting 
to compare physical maps of the region around the X and Y 
homologues of STS and to assess the extent of their divergence.
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4:3:4 Deletion analysis of additional individuals with anomalies of 
distal Xp.
A number of individuals with anomalies of distal xp were 
investigated in an attempt to define new breakpoints which could 
distinguish betweeen the probes deleted in males with XLI and 
facilitate their ordering on distal Xp. The first of these, "Sa", 
had both Kallmann's syndrome (KAL) and XLI. His deletion proved to 
be no different from those of other individuals with XLI alone, by 
either molecular or FACS analysis.
KAL is thought to be proximal to STS, as several male 
individuals with 46,Yt(X;Y)(p22.3;qll.2) translocations
(effectively deleted for all of distal xp) are affected with XLI 
but not KAL.
Three further patients with KAL but not XLI were analysed but 
were not deleted for any of the probes tested. This may be due to 
deletions or point mutations not detected by available probes in 
Xp22.3. Alternatively, KAL may not be associated with a mutation in 
this region of the X-chromosome in these individuals.
Perrin et al. (1976) described a family segregating for 
"X-linked ichthyosis, hypogonadotropic hypogonadism, mental 
retardation and anosmia" which failed to demonstrate linkage with 
Xg (maximum LOD score of -0.096 at theta = 0.40). This indicates a 
distinct mutation from that of the families described by Ballabio
et al. (1986, 1987b) and an alternative localisation for KAL. STS
levels were not assessed in the family described by Perrin et al. 
(1976), however, so the diagnosis of XLI was not confirmed.
Two males with XY translocations, AM (1729) and JH (7079) were 
also studied. These boys were deleted for the (X-specific) bands of 
all probes deleted in males with XLI (GMGX9, GMGXXY3, GMGXY19, 
STB14 and p2a4) and also for MlA. MlA may be either distal or 
proximal to the other five deleted probes.
These results suggest that there are definite hotspots in
distal Xp which give rise to deletions and XY translocations 
associated with XLI and that these form two homogeneous groups or 
that there are as yet insufficient DNA probes to distinguish 
between individuals in each group. These possibilities might be 
resolved by cloning several translocation and deletion junctions.
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The majority of XX males have levels of STS activity 
characteristic of normal female individuals. At least three XX 
males have been reported to possess only a single dose of STS 
activity, (Pierella et al., 1981; Wieacker et al., 1983c). This may 
have arisen as a result of the loss of one STS locus through x-Y 
interchange. Such XX males would be hemizygous for GMGX9 and might 
represent novel breakpoints for inclusion in a a deletion panel.
Petit et al. (1987) described an X-specific polymorphic 
sequence, 68b, which was tightly linked to the pseudoautosomal 
region. They observed the loss of the paternal 68b allele in two 
of six XX males and possibly of a third (on dosage). Loss of the 
paternal Xg allele was demonstrated in one of these two XX males.
GMGX9 and STS are estimated to be 13cM proximal to xg (Yates 
et al., 1987b), which is itself X-specific and proximal to the 
pseudoautosomal region. Thus, loss of GMGX9 or STS in association 
with XY interchange might be predicted to occur more rarely than 
loss of either 68b or Xg.
Hindlll digests of seventeen XX males were analysed with 
GMGX9. Six XX males were heterozygotes. The remining individuals 
were appparently homozygous (by DNA dosage) for the 4kb allele and 
were consistent with the inheritance of one allele from each 
parent, (Jamieson and Affara, unpublished observations).
4:3:5 FACS analysis of deletions
FACS analysis was performed for individuals from sixteen 
Scottish families, thirteen of which were deleted for GMGX9. 
Deletions were visualised in eight of thirteen families deleted for 
GMGX9 (Cooke et al., in press). The largest deletions detected in 
males with X-linked ichthyosis were those of AB (4076), MG(1034)
and YM(9056) whose deletions correspond to 2.8% of the X chromosome 
i.e. 4Mbp or 8% of Xp. The deletion in AB (4076) could not be 
visualised microscopically using standard banding techniques. The 
smallest deletion was that of NJ (7750) which corresponded to 
1.2-1.5% of his x-chromosome. The deletions in five affected males, 
deleted for GMGX9 were not visualised by FACS analysis which 
demonstrates that hitherto undetected heterogeneity exists amongst 
these deletions.
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The eight individuals with FACS deletions are not clinically 
impaired in any way (other than by their ichthyosis) and in 
particular are not mentally retarded. This implies that there are 
relatively few genes encoding vital functions in the deleted 
segment. The ichthyotic males who demonstrate deletions on FACS 
analysis also have normal fertility (e.g. AB (4076) is a 
grandfather), in contrast to males with XY translocations, which 
suggests that XY pairing is not impeded in any way.
STS, GMGX9, GMGXXY3 and GMGXY19 must lie within a region of 
less than 2Mb (the smallest deletion detected by FACS analysis) as 
all these probes were deleted in JM (3673) whose deletion could not 
be detected in this way. The STS gene spans at least 140kb on the 
X-chromosome or just under one tenth of this distance (Yen et al., 
1987b).
4:3:7 Comments on the high deletion frequency at the STS locus 
and future work with GMGX9.
The knowledge of carrier status is of particular value to 
obstetricians as steroid sulphatase deficiency results in low 
estrogen levels and delayed onset of labour in pregnancy. Carrier 
status may be assessed by an assay of steroid sulphatase in 
hair-roots (Aitken, Perry & Ferguson-Smith, 1981). Levels in carrier 
females are usually considerably reduced. It is possible to use 
GMGX9 to acccurately predict carrier status in certain families e.g 
those segregating for a deletion in which the parents have 
differing alleles, or those for which GMGX9 is not deleted in 
affected individuals but for which the phase is known. Such studies 
are not possible with cDNA clones at the STS locus (Yen et al., 
1987a; Ballabio et al., 1987a; Conary et al., 1987; Bonifas et al.
1987) as no RFLPs have been described with these probes.
It was hoped to investigate the origin of new mutations using 
GMGX9 and additional DNA markers in distal Xp, in order to 
determine if deletions could arise in both male and female meioses.
A new mutation arising from errors in female meiosis might, for 
example, be indicated by an isolated deleted individual whose 
mother was heterozygous for GMGX9. None of the affected individuals 
in this study represented new mutations, however, which precluded
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such investigations.
Failure to determine new mutations at the STS locus may 
indicate that these are rare occurences and that the majority of 
individuals with XLI are due to familial rather than sporadic 
mutations. This could account for the observation that deletions at 
the STS locus form a fairly homogeneous group which are only rarely 
separable by molecular analysis e.g. one of thirty-eight 
individuals (this study) and two of twenty-three individuals 
(Shapiro et al., 1987, Tablel2). Alternatively deletion homogeneity 
could be explained by the existence of (a) preferential hotspot(s) 
for deletions.
FACS analysis suggests that further heterogeneity does exist, 
but is not detected by the available probes. The apparent lack of 
new mutations might thus be due to ascertainment bias, especially 
as multiple^affected males within a family are a good indicator 
for the X-linked form of ichthyosis and families with multiply 
affected males are of greatest value for linkage analysis.
The extraordinarily high proportion of deletions detected 
amongst mutations at the STS locus, might be a direct result of the 
proximity of STS to the pairing segment and of illegitimate 
recombination between the X and Y chromosomes, although the 
mechanism by which this might occur remains unclear. Reciprocal 
translocation between the X and Y chromosomes can often be excluded 
due to inheritance of Xg(a), (which also demonstrates the 
interstitial nature of these deletions). Deletions might also occur 
as a result of unequal cross-over events in female meiosis although 
this process should also result in duplications at the GMGX9 locus 
(which have not yet been observed).
In order to investigate the mechanisms by which XY 
translocations and deletions occur at the STS locus it will be 
necessary to characterise the region around the existing probes in 
detail. PFGE electrophoresis may provide a suitable frame-work in 
which to construct a physical map of the STS locus or to size and 
to analyse deletions not detectable by FACS analysis, although 
additional DNA markers may first be required. It may thus prove 
worthwhile to expand the GMGX9 locus by chromosome walking or even 
by chromosome jumping (Collins and Weissman, 1984) to obtain probes
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several hundred kb from GMGX9. Additional DNA markers might also 
permit more deletions to be resolved by Southern analysis.
A further DNA probe, CRI—S—232, recently described in distal 
Xp is also highly polymorphic (PIC value of 0.9), (Donnis-Keller et 
al., 1987) and may also prove useful in the analysis of STS 
mutations. This probe has a Yq homologue (which is not 
polymorphic), is linked to Dic56 and is about 15cm from several 
pseudoautosomal loci, (Knowlton et al., 1987).
A screen of "sporadic" STS deficient patients and their 
families might prove profitable in terms of defining the origin of 
mutations, whilst the screening of additional STS deficient 
individuals (and in particular those with complex phenotypes 
associated with XLI) or of patients with translocation breakpoints 
in distal Xp, should help to define additional breakpoints and to 
build up a deletion map.
There is evidence to suggest that the signal for resistance to 
X-inactivation is a function of the genes themselves (and not of 
their environment) in mice. For example, Sxr, which is active on 
the mouse Y chromosome, becomes subject to inactivation after 
transposition to the pairing region, whilst Sts is active within 
the pairing segment, (Keitges and Gartler, 1986). Yen et al. 
(1987b) report no significant difference in methylation comparing 
the 5' and 3' ends of the human STS gene on the active and inactive 
X-chromosomes, consistent with its escape from X-inactivation.
It should also prove possible to define the regions 
responsible for the escape of STS from X-inactivation by molecular 
means, providing that these control regions exert their action in 
cis. STS is not essential for cell proliferation and may thus prove 
an excellent model for investigating x-inactivation by means of 
site selected mutagenesis.
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4:4 GENE CLONING AND REVERSE GENETICS
Of those genes assigned to Xp, only a small proportion have 
been cloned including OTC, MIC2, and more recently CYBB (the 
chronic granulomatous disease gene), DMD and STS. OTC was cloned 
independently by two groups (Horwich et al., 1984 and Davies et
al.,1985) using the principle of interspecies homology, following 
the isolation of the rat gene from a rat liver cDNA library 
enriched for OTC rnRNA (Horwich et al., 1983). MIC2 (Darling et al., 
1986) and STS (Yen et al., 1987a; Ballabio et al., 1987a; Conary 
et al, 1987; Bonifas et al.,1987) were cloned by the "classical" 
approach which proceeds from the gene product to gene whilst CYBB 
(Royer-Pokora et al., 1986) and DMD (Monaco et al., 1986; Burghes 
et al., 1987) were cloned by "reverse genetics" which proceeds from 
the gene to the gene product (figure 17).
Glycerol kinase (GK), congenital adrenal hypoplasia (AHC) and 
Norries1 disease (NDP) have all been associated with molecular 
deletions of Xp and their positions are thus well defined. GK and 
AHC have been assigned to a 2Mbp region between J66H1 and Ll-4 and 
NDP to Xpll.3 close to Ll-28 (Gal et al., 1985a, 1986; de la
Chapelle et al., 1985). These three disorders are thus suitable 
candidates for the application of reverse genetics and should prove 
to be amongst the next Xp loci cloned.
Cloning of GK could be readily verified as glycerol kinase 
activity can be assayed in white blood cells. GK could also be 
cloned by classical methods. Isolated GK deficiency is not 
particularly deleterious, however,and cloning of this gene does not 
represent a clinical priority. AHC and NDP are far more serious 
conditions in which the primary defects are unknown. Cloning of 
these genes and of many others on Xp or elsewhere will thus only be 
possible by reverse genetics.
It is hoped that a complete map of Xp may eventually be 
constructed as part of a more ambitious plan to map the entire 
human genome with contiguous cosmid clones. These clones could 
prove an invaluable resource for reverse genetics and result in a 
rapid growth in the number of genes cloned, dependent solely on 
knowledge of their localisation. The precision of localisation 
should continue to improve as additional polymorphic loci are
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defined and it may be that linkage to a single band of a DNA
fingerprint (Jeffreys et al., 1986) will prove sufficient to enable 
many genes to be cloned by reverse genetics.
This project has centred on obtaining DNA sequences from 
specific intervals of the X-chromosome (Xp21 and Xp22.3) and on 
their application to the study of DMD and STS or to complex
phenotypes associated with either disorder. The principles involved 
are not specific to the X-chromosome, however, and could be applied 
to cloning sequences from any specific chromosome or chromosomal
interval and ultimately to cloning the genes for any human
disorders mapped to a specific interval.
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Figure 17: "Reverse genetics" and the classical approach to 
gene cloning.
(The classical approach proceedes clockwise from
recognition of a disorder whilst a "reverse" approach 
proceedes anti-clockwise).
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APPENDICES.
F HO LN AM EH W2 A9 F Ho LN AM EH W2 A9
X23/GMGX8 X24/GMGX10
X30/GMGX19
X47/GMGX9
Appendix 1: Hybridisation of X-specific inserts to EcoRX somatic 
cell hybrid mapping panels (refer to table 4). Continued overleaf.
(F,female control. Hybrids are as described in materials and 
methods (and see inset). Probes are labelled with both the number 
of the picked plaque and the "GMGX" number assigned to it (see 
table 5) ).
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X53/GMGXY12
X38/GMGX20
X60/GMGX16
X48/GMGX18
Appendix 1 (continued)
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X74/GMGX13
F Ho LN AM EH W2 A9 F HO LN AM EH W2 A9
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X66/GMGX11 X92/GMGX14
X110/GMGX23
X94/GMGX15
X112/GMGX12
Appendix 1 (continued)
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Appendix 2: Deletion studies in DMD/ BMD families based on
deletions of the pERT87 and XJ probes.
(A); Pedigrees of the nine boys with deletions detected by pERT87 
and/ or XJ probes (refer to table 6).
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Appendix 2: Deletion studies in DMD/ BMD families based on
deletions of the pERT87 and XJ probes.
(B); Hybridisation of GMGX9, GMGX10 and GMGXll to the deletion 
panel (refer to table 6).
(M,male control. Other individuals are described in the text. 
These results are summarised in table 6).
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Appendix 2: Deletion studies in DMD families based on deletions of 
the pERT87 and XJ probes. (C); Hybridisation of additional Xp 
probes to the deletion panel (refer to table 6). Continued 
overleaf.
(M,male control. Other individuals are described in the text. These 
results are summarised in table 6. Filters were PstI digests unless 
otherwise specified (in parenthesis).
Notes: The anomalous fragment detected by J47 in MJ is marked with 
an arrow. Anomalous fragment sizes detected by Ll-4 (Hinc II 
digests) in MJ and SJ (3485) may represent an RFLP, as a fragment 
of normal size was detected by Ll-4 in a Taql digest of MJ (refer 
to figure 6).
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Appendix 3: Deletion studies in males with DMD/BMD with GMGXll.
(A); Hybridisation of GMGXll to Hindi 11 digests of all boys. 
(Individuals listed in table 7 are identified by their pedigree 
numbers).
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Appendix 3: Deletion studies in males with DMD/BMD with GMGXll.
(B); Hybridisation of GMGXll to EcoRI digests of boys showing 
anomalous fragment sizes (refer to table 7). These are indicated by 
arrows (Individuals are identified by their pedigree numbers).
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Appendix 4: Deletion studies in males with DMD/BMD using p20, JBir 
and J66HI.
(A); examples of hybridisation of p20 to Hindlll digests of boys 
with DMD/BMD (see table 7). (Boys are identified by their pedigree 
numbers. For those families in which more than one individual is 
affected, boys are further identified by their initials).
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Appendix 4: Deletion studies in males with DMD/BMD using p20, JBir 
and J66HI. (B); examples of hybridisation of p20 to Mspl digests of 
boys with DMD/BMD (see table 7).
(Boys are identified by their pedigree numbers. For those families 
in which more than one individual is affected, boys are further 
identified by their initials. Note: the "doublet" observed with 
constant band 2 (1.5kb) was not seen in other Mspl digests probed 
with p20. This may be due to improved resolution of these 
particular gels (eg due to more prolonged electrophoresis) or to 
contamination in the batch of enzyme used for these digests. Track 
1406 is partially digested).
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Appendix 4: Deletion studies in males with DMD/BMD using p20, JBir 
and J66HI. (D); exarrples of hybridisation of J66HI to EcoRI digests 
of boys with DMD/BMD (table 7).
(Boys are identified by their pedigree numbers. For those families 
in which more than one individual is affected, boys are further 
identified by their initials. Anomalous fragments are indicated by 
an arrow).
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Appendix 5: Pedigrees of individuals with deletions or altered
restriction fragment lengths detected by GMGXll/ p20/ JBir or 
J66HI. (Pedigrees are shown only for those individuals listed in 
table 7 and are presented in the same order as table _ 7. The 
pedigree for SS and JD (5099) is presented in appendix 2. The 
family history of MJ is not known). Continued overleaf.
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Appendix 5 continued. Continued overleaf.
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Appendix 5 continued.
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XJ2.3 6.4
XJl.l 3.1
XJ1.2 2.0
XJ5.1 24
754 11
754-11 5.3
Appendix 6: RFLP analysis of the deletion in NJ (5313).
(A) Schematic representation of informative results.
87.1, PERT87.1; 87.15, pERT87.15? 87.30, pERT87.30. The following
digests were used 99.6, Pstl? pERT87.30, Bglli? pERT87.15, BamHi; 
PERT87.1, Mspl? XJ2.3, Tagi; XJl.l; Tag I; XJ1.2,- Bcli; XJ5.1, Sphi; 
754, Pstl? 754-11; Bglli.
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Appendix 6: RFLP analysis of the deletion in NJ (5313).
(B) Autoradiographs of results obtained. (pERT 87.15 results are 
not included. GF,grandfather; F,father; M,mother).
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99.6 13 
87.30 30 
87.15 6 
87.1 4.5 
XJ1.2 1.6 
XJ5.1 2 
754 9 
754-11 6.3
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o
99.6 22 22
87.30 30 8
87.15 7.1/2.3 9.4
87.1 1.8 1.8
XJ1.2 1.6 2.0
XJ5.1 17 17
754 11 9
754-11 5.3 5.3
99.6 22 13
87.30 30 30
87.15 7.1/2.3 7.1/2.3
87.1 1.8 4.5
XJ1.2 1.6 1.6
XJ5.1 17 24
754' 11 9
754-11 6.3 5.3
99.6 13 
87.30 30 
87.15 null
87.1 null 
XJ1.2 null 
XJ5.1 null 
754 9 
754-11 6.3
Appendix 7: RFLP analysis of the deletion in SJ (3485).
(A) Schematic representation of informative results. 
87.1; pERT87.1*, 87.15; pERT87.15; 87.30, pERT87.30. The following 
digests were used 99.6/ Pstl; pERT87.30; Bglli; pERT87.15; BamHi; 
PERT87.1, Mspi; XJ1.2, Bell; XJ5.1; SphI? 754> Psti; 754-11; Bglli.
Page 19^ -
GM M SJ GM M SJ GM M SJ
PERT87.30 
(Bglli)
PERT87.1
XJl.2(BelI) XJ5.1(SphI) 754(Pstl)
GM M SJ
754-ll(Bglli)
Appendix 7: RFLP analysis of the deletion in SJ (3485). (B)
Autoradiographs of results obtained (pERT 87.15 results are not 
included. GM,grandmother; M,mother).
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*87.30 8 30
87.1 1.8 4.5
XJ2.3 null 7.8 
XJl.l null 3.8 
XJ1.2 null 1.6 
XJ5.1 null 24 
754 11 9
754-11 5.3 6.3
k 87.30 8 30
87.1 1.8 1.8
XJ2.3 null 6.4 
XJl.l null 3.1 
XJ1.2 null 2.0 
XJ5.1 null 17 
754 11 11
754-11 5.3 5.3
87.30 8
87.1 1.8
XJ2.3 null
XJl.l null
XJ1.2 null
XJ5.1 null
754 11
754-11 5.3
(* phase inferred from AB)
Appendix 8: RFLP analysis of the deletion in AB (0120).
(A) Schematic representation of informative results.
87.1, pERT87.1; 87.15/ pERT87.15; 87.30/ pERT87.30. The following 
digests were used pERT87.30, Bglli; pERT87.1/ Mspl; XJ2.3, Tagi; 
XJl.l, Tagi* XJ1.2, Bcli; XJ5.1; Sphi; 754, Psti; 754-11, Bglli.
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Appendix 8: RFLP analysis of the deletion in AB (0120).
(B) Autoradiographs of results obtained (pERT 87.1 results are not 
included. GM/grandmother; M,mother; C;control female).
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Appendix 9: RFLP results for the sisters of JB (5097), PE (5311) 
and AW (7866).
(A) XJl.2 (Bell) results for the sister of JB (5097).
(B) p20 (Mspl) results for the sister of AW (7866).
(C) pERT87.1 (Mspl), pERT 87.30 (Bglli) and XJ5.1 (SphI) results 
for the sister of PE (5311).
(C;female control; F/father; M,mother; S,sister).
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Appendix 10: Results obtained with GMGX9 in TDH 
Scottish pedigrees segregating for XLI.
families and six
(A) (i) Hybridisation of GMGX9 to mothers from TDH families.
(Heterozygous individuals are identified by their pedigree 
numbers).(ii) Hybridisation of GMGX9 to family 3825 (De). (iii) 
Hybridisation of GMGX9 to family 3906 (Ja). (iv) Hybridisation of 
GMGX9 to family 5272 (Ni).
(G;grandfather; F,father; 1-4, first to fourth sons respectively. 
The result for the second son in family 3825 (De) is not included).
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Appendix 10: Results obtained with GMGX9 in TDH families and six 
Scottish pedigrees segregating for XLI.
(B) Schematic illustration of results with GMGX9 in TDH families 
informative for GMGX9. ("A",4kb allele; "B",'2.5/1.5kb allele).
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Appendix 10: Results obtained with GMGX9 in TDH families and six
Scottish pedigrees segregating for XLI.
(C) Schematic illustration of results with GMGX9 in six of the 
Scottish families segregating for X-linked ichthyosis. ("A",4kb 
allele; "B", 2.5/1.5kb allele; deletion).
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Appendix 11: Hybridisation of GMGX9 to the Italian family (ITAL).
(A) Schematic representation of the results obtained. ("A" 4kb 
allele; "B",-2.5/1.5kb allele; deletion).
(B) Autoradiograph of hybridisation with GMGX9. (This blot was 
provided by A. Ballabio.)
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Appendix 12: Deletion analysis with GMGX9 in German and Dutch
families segregating for XLI.
(A) Schematic representation of the segregation of GMGX9 in German 
families. ("A">4kb allele; "B",2.5/1.5kb allele; deletion).
Continued overleaf.
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Appendix 12A continued.
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Appendix 12: Deletion analysis with GMGX9 in German and Dutch 
families segregating for XLI.
(B) Deletion analysis with GMGX9 in four Dutch males with XLI. (C; 
male control).
(C) Hybridisation with GMGX9 and GMGY10 to members of three German 
families, (i) Hybridisation with GMGX9. (ii) Hybridisation of the 
same filter with a Y-specific probe GMGY10 (Affara et al, 1986).
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(ii) Dic56(BclI)
Appendix 13: Examples of hybridisations with distal Xp probes to 
males with XLI (refer to table 9). Continued overleaf.
(i) Hybridisation of STB14 to affected males and relatives from 
families 4076, 3000, 7474 and 7685. ((M),mother of affected male).
(ii) Hybridisation of Dic56 to the individuals shown in (i) above 
and also to a male with an XY translocation (7079) and individuals 
from families 7605, 7304, 8056 and 4076, which segregate for XLI. 
(C;female control; (M),mother of affected male; (D),daughter of 
affected male).
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(iv) MlA(EcoRI)
(v) p2a4(EcoRI)
Appendix 13 (continued): Examples of hybridisations with distal Xp 
probes to males with XLI (refer to table 9).
(iii) Hybridisation of pl9b to affected males from families 7605,
4076, 7664, 7750, 7304, 8056, 5626, 8009, 4143, 3000. (C, female
control; (M),mother of affected male; (GM),grandmother of affected 
male; (D)/daughter of affected male)
(iv) Hybridisation of MlA to affected males from families 2994,
1034, 4024, 1348, 3496, 0698 and 3307.
(v) Hybridisation of p2a4 to the affected males indicated in (iv) 
above).
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Appendix 14: Deletion analysis with distal Xp probes in three
males, SS (8012), JG (8049) and RR (8050), with Kallman's syndrome.
(C,female control; (D),daughter of affected male. Other individuals 
from families segregating for XLI are also included).
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Appendix 15: Deletion analysis with distal Xp probes in two males, 
AM (1729) and JH (7079) with XY translocations.
(C,-female control; (M),mother; (F);father? (S),sister. A male with 
XLI from family 7474 is also included).
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